<SEC-DOCUMENT>0001104659-21-033359.txt : 20210308
<SEC-HEADER>0001104659-21-033359.hdr.sgml : 20210308
<ACCEPTANCE-DATETIME>20210308170855
ACCESSION NUMBER:		0001104659-21-033359
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20210308
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210308
DATE AS OF CHANGE:		20210308

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HEALTHEQUITY, INC.
		CENTRAL INDEX KEY:			0001428336
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0131

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36568
		FILM NUMBER:		21722840

	BUSINESS ADDRESS:	
		STREET 1:		15 WEST SCENIC POINTE DRIVE
		STREET 2:		SUITE 100
		CITY:			DRAPER
		STATE:			UT
		ZIP:			84020
		BUSINESS PHONE:		801-727-1000

	MAIL ADDRESS:	
		STREET 1:		15 WEST SCENIC POINTE DRIVE
		STREET 2:		SUITE 100
		CITY:			DRAPER
		STATE:			UT
		ZIP:			84020

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHEQUITY INC
		DATE OF NAME CHANGE:	20080227
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm218956d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:hqy="http://healthequity.com/20210308">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_US%2DGAAP%2D2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_hqy_healthequity.com_20210308 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20210308_20210308 -->
<!-- Field: Set; Name: xdx; ID: xdx_052_edei%2D%2DEntityCentralIndexKey_0001428336 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
  <ix:hidden>
    <ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:EntityCentralIndexKey">0001428336</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2021-03-08to2021-03-08" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
    </ix:hidden>
  <ix:references>
    <link:schemaRef xlink:href="hqy-20210308.xsd" xlink:type="simple" />
    </ix:references>
  <ix:resources>
    <xbrli:context id="From2021-03-08to2021-03-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-08</xbrli:startDate>
        <xbrli:endDate>2021-03-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    </ix:resources>
  </ix:header>
</div>


<p style="margin: 0"></p>

<p style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM&#160;<span id="xdx_900_edei--DocumentType_c20210308__20210308_zCFmqYSaZtWi"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section&#160;13 or 15(d)&#160;of</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>The Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event
reported): <b><span id="xdx_90A_edei--DocumentPeriodEndDate_c20210308__20210308_ztw0aFyTXzPk"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">March 8, 2021</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="1" style="border-bottom: Black 1pt solid; font: bold 18pt Times New Roman, Times, Serif; text-align: center"><p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 18pt Times New Roman, Times, Serif"><b><span id="xdx_90E_edei--EntityRegistrantName_c20210308__20210308_zqmVP1zU6R9b"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:EntityRegistrantName">HealthEquity, Inc.</ix:nonNumeric></span></b></span></p></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="1" style="font: normal 18pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b style="font-style: normal; font-weight: normal">(Exact
    name of registrant as specified in charter)</b></span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90B_edei--EntityIncorporationStateCountryCode_c20210308__20210308_zYfupFZhYA8"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>
    <td style="padding-bottom: 1pt; vertical-align: bottom; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Commission File No. <span id="xdx_908_edei--EntityFileNumber_c20210308__20210308_zht6LOFyALa5"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:EntityFileNumber">001-36568</ix:nonNumeric></span></span></td>
    <td style="padding-bottom: 1pt; vertical-align: bottom; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_edei--EntityTaxIdentificationNumber_c20210308__20210308_zeMCKsLlen7i"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:EntityTaxIdentificationNumber">52-2383166</ix:nonNumeric></span></span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State or Other Jurisdiction<br />
 of Incorporation)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Commission<br />
File Number)</p>
<span style="font: 10pt Times New Roman, Times, Serif"></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(IRS Employer<br /> Identification No.)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span id="xdx_901_edei--EntityAddressAddressLine1_c20210308__20210308_zTiwF8ehognd"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:EntityAddressAddressLine1">15 West Scenic Pointe Drive</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span id="xdx_90C_edei--EntityAddressAddressLine2_c20210308__20210308_z8rm9yRwG03d"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:EntityAddressAddressLine2">Suite&#160;100</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span id="xdx_909_edei--EntityAddressCityOrTown_c20210308__20210308_zb3QbqdJ9Nne"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:EntityAddressCityOrTown">Draper</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressStateOrProvince_c20210308__20210308_zandu4l8V67i"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Utah</ix:nonNumeric></span> <span id="xdx_900_edei--EntityAddressPostalZipCode_c20210308__20210308_zBw4e0SeBWG7"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:EntityAddressPostalZipCode">84020</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Address of principal executive offices) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>(<span id="xdx_907_edei--CityAreaCode_c20210308__20210308_zvF5UvVRLed4"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:CityAreaCode">801</ix:nonNumeric></span>) <span id="xdx_902_edei--LocalPhoneNumber_c20210308__20210308_zxquGj9ys0Yl"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:LocalPhoneNumber">727-1000</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Registrant&#8217;s
telephone number, including area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Not applicable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since last report.)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form&#160;8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<span style="text-decoration: underline">see</span> General Instruction A.2 below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_907_edei--WrittenCommunications_c20210308__20210308_z7IYrVTFlip3" style="font-family: Wingdings"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></td><td style="text-align: justify">Written communications pursuant to Rule&#160;425 under
the Securities Act (17 CFR 230.425)</td>
</tr></table>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_902_edei--SolicitingMaterial_c20210308__20210308_zXzya30Nywjl" style="font-family: Wingdings"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></td><td style="text-align: justify">Soliciting material pursuant to Rule&#160;14a-12 under
the Exchange Act (17 CFR 240.14a-12)</td>
</tr></table>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_90D_edei--PreCommencementTenderOffer_c20210308__20210308_zkrSowGJTDm8" style="font-family: Wingdings"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under
the Exchange Act (17 CFR 240.14d-2(b))</td>
</tr></table>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_908_edei--PreCommencementIssuerTenderOffer_c20210308__20210308_zwxLcLzZ9Asg" style="font-family: Wingdings"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under
the Exchange Act (17 CFR 240.13e-4(c))</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section&#160;12(b)&#160;of
the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 37%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Title&#160;of&#160;Each&#160;Class</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 26%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Trading&#160;Symbol(s)</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name&#160;of&#160;each&#160;exchange&#160;on&#160;which<br />
&#160;registered</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_edei--Security12bTitle_c20210308__20210308_zU4dbPY1s26f"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:Security12bTitle">Common stock, par value $0.0001 per share</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90F_edei--TradingSymbol_c20210308__20210308_zUPO85x5B2Al"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:TradingSymbol">HQY</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_edei--SecurityExchangeName_c20210308__20210308_z7EnkZgTgyZ9"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The NASDAQ Global Select Market</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="margin: 0pt 0; text-indent: 0.5in; font-size: 10pt">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="margin: 0pt 0; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin: 0pt 0; text-align: right; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;Emerging
growth company <span style="font-family: Wingdings"><span id="xdx_901_edei--EntityEmergingGrowthCompany_c20210308__20210308_z5vbAxa00Shg"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="margin: 0pt 0; text-indent: 0.5in; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="margin: 0pt 0">&#160;</p>

<p style="margin: 0pt 0"><b>Item 1.01 Entry into a Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 8, 2021 (the &#8220;Closing Date&#8221;),
HealthEquity, Inc., a Delaware corporation (&#8220;HealthEquity&#8221;), entered into and completed certain transactions contemplated
by a Stock Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with the holders of 100% of the outstanding capital stock
(collectively, &#8220;Sellers&#8221;) of Fort Effect Corp. d/b/a Luum, a Washington corporation (&#8220;Luum&#8221;), and Evan
McCordick, solely in his capacity as representative of Sellers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Purchase Agreement provides that
HealthEquity will purchase from Sellers 100% of the outstanding capital stock of Luum (the &#8220;Shares&#8221; and such
transaction, the &#8220;Acquisition&#8221;). Pursuant to the Purchase Agreement, HealthEquity paid an aggregate purchase
price (the &#8220;Purchase Price&#8221;) consisting of (a) $47,227,442.73 in cash, which amount represents the Closing Consideration as defined in, and calculated pursuant to, the Purchase Agreement
("Closing Consideration"), and (b) up to $20 million in contingent payments payable during
the two-year period following the Closing Date based upon certain revenue achievements set forth in the Purchase Agreement. A
portion of the Base Consideration (as defined in the Purchase Agreement) in an amount equal to $500,000 in cash was deposited
into an escrow account to satisfy certain net working capital and other customary adjustments to the Closing
Consideration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Purchase Agreement contains
customary representations, warranties and covenants for a transaction of this type, including representations and warranties
by (a)&#160; Sellers regarding, among other things, (i)&#160;Luum&#8217;s corporate organization and capitalization,
(ii)&#160;the accuracy of Luum&#8217;s financial statements provided to HealthEquity, (iii)&#160;the absence of certain
changes or events relating to Luum since December 31, 2020, (iv)&#160;compliance with law and (v) title to their respective
Shares and (b) HealthEquity regarding, among other things, its corporate organization. The Purchase Agreement also contains
post-closing indemnification obligations with respect to which $250,000 of the Base Consideration (as defined in the Purchase
Agreement) was deposited into an escrow account to be available to satisfy certain claims for indemnification that
HealthEquity may have under the Purchase Agreement. In addition, HealthEquity and Sellers jointly shared in the cost of a
customary buy-side representation and warranty insurance policy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In consideration of the Purchase Price,
certain Sellers agreed to a customary non-compete preventing such Sellers from participating in certain competitive activities
for a period of three years following the Closing Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Purchase Agreement has been included
to provide investors with information regarding its terms. It is not intended to provide any other factual information about HealthEquity,
Luum or their respective subsidiaries or affiliates. The representations, warranties and covenants contained in the Purchase Agreement
were made only for purposes of the Purchase Agreement and as of specific dates, were solely for the benefit of the parties to the
Purchase Agreement, may be subject to limitations agreed upon by the contracting parties, including being qualified by confidential
disclosures made for the purposes of allocating contractual risk between the parties to the Purchase Agreement instead of establishing
these matters as facts, and may be subject to standards of materiality applicable to the contracting parties that differ from those
applicable to investors. Investors are not third-party beneficiaries under the Purchase Agreement and should not rely on the representations,
warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the parties
thereto or any of their respective subsidiaries or affiliates. Moreover, information concerning the subject matter of representations
and warranties may change after the date hereof, which subsequent information may or may not be fully reflected in HealthEquity&#8217;s
public disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing description of the Purchase
Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Purchase Agreement,
a copy of which is filed as Exhibit 2.1 and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 7.01. Regulation FD Disclosure</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 8, 2021, HealthEquity, Inc.
(&#8220;HealthEquity&#8221;) issued a press release announcing that HealthEquity had entered into and completed certain
transactions contemplated by a stock purchase agreement, pursuant to which, and on the terms and subject to the
conditions set forth therein, HealthEquity had acquired 100% of the outstanding capital stock of Fort Effect Corp, d/b/a Luum
(&#8220;Luum&#8221;). Luum will operate as a wholly owned subsidiary of HealthEquity. A copy of HealthEquity&#8217;s press
release announcing the transaction is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information in this Item 7.01, including the corresponding Exhibit 99.1, is being furnished with the U.S. Securities and Exchange
Commission (SEC) and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01 Financial Statements and Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><b>(d) Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 72px; text-align: center"><span style="font-size: 10pt"><b>Exhibit</b></span></td>
    <td style="width: 10px">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Number</b></span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><a href="tm218956d1_ex2-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt"><b>2.1</b></span></a></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="tm218956d1_ex2-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Stock Purchase Agreement, dated as of March 8, 2021 between HealthEquity, Inc., the Sellers listed on Schedule 1 and Evan McCordick, solely as the Sellers&#8217; Representative.* </span></a></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><a href="tm218956d1_ex99-1.htm"><span style="font-size: 10pt"><b>99.1</b></span></a></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="tm218956d1_ex99-1.htm"><span style="font-size: 10pt">Press Release dated March 8, 2021.</span></a></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><b>104</b></td>
    <td>&#160;</td>
    <td style="text-align: justify">Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;* Schedules and exhibits have been
omitted pursuant to Item 601(b)(2)&#160;of Regulation&#160;S-K.&#160;HealthEquity hereby undertakes to furnish supplementally copies
of any of the omitted schedules upon request by the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.3in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">Dated: March 8, 2021</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-size: 10pt"><b>HealthEquity, Inc.</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; width: 52%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 5%"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 43%; text-align: justify"><span style="font-size: 10pt"><i>/s/
Tyson Murdock</i></span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Name: </span></td>
    <td style="vertical-align: bottom; text-align: justify">Tyson Murdock</td></tr>
<tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Title:</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-size: 10pt">Executive Vice President and Deputy
    Chief Financial Officer</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5LppWRO2jRUWsIkXE19huJdhmyyb+HclbGlvEZWFZZr4ZIUKxoqWukeE0zzM4YNPWyiHkWCGjKdA70vUmAX9zvGjrWBnXvT8wJc+gZ8YDeS680Fnv2mKZgJwMR9EwmoGcJnEM+60IvnpKptIlGqdVDcqUsGdqWaNT/OoTDupJhppXV3VEtppMAtFA9vIbYhnFsKO7ehBfLWRZKoKwm0CsmG7tt+ZmHTWwqLHxXbZH/xt8AD1TSYE= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>tm218956d1_ex2-1.htm
<DESCRIPTION>EXHIBIT 2.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>Exhibit 2.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>Execution Version&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>STOCK PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>by and among</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>HEALTHEQUITY, INC.,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE SELLERS LISTED ON SCHEDULE I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>and</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EVAN MCCORDICK,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>solely as the Sellers&#8217;
Representative</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Dated as of March 8,
2021</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 0.75pt; border-top: Black 0.75pt solid; border-bottom: Black 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Page</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD COLSPAN="2" STYLE="text-align: left">Article I&nbsp;&nbsp;&nbsp;DEFINITIONS</TD>
    <TD STYLE="text-align: right">1</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left; width: 20%">Section 1.1&nbsp;</TD>
    <TD STYLE="text-align: left; width: 70%">Certain Definitions</TD>
    <TD STYLE="text-align: right; width: 10%">1</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 1.2&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Terms Generally</TD>
    <TD STYLE="text-align: right">14</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD COLSPAN="2" STYLE="text-align: left">Article II&nbsp;&nbsp;&nbsp;SALE AND PURCHASE</TD>
    <TD STYLE="text-align: right">15</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 2.1&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;Agreement to Sell and Purchase</TD>
    <TD STYLE="text-align: right">15</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 2.2&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;Closing</TD>
    <TD STYLE="text-align: right">15</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 2.3&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Closing Deliverables</TD>
    <TD STYLE="text-align: right">15</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 2.4&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Purchase Price</TD>
    <TD STYLE="text-align: right">17</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 2.5&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Closing Calculations</TD>
    <TD STYLE="text-align: right">18</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 2.6&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Final Consideration Calculation</TD>
    <TD STYLE="text-align: right">18</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 2.7&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Post-Closing Adjustment Payment</TD>
    <TD STYLE="text-align: right">19</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 2.8&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Escrow Amounts</TD>
    <TD STYLE="text-align: right">20</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 2.9&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Withholding Taxes</TD>
    <TD STYLE="text-align: right">20</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 2.10&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Rights Not Transferable</TD>
    <TD STYLE="text-align: right">20</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 2.11&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Company Options</TD>
    <TD STYLE="text-align: right">21</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 2.12&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Earn-Out</TD>
    <TD STYLE="text-align: right">21</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD COLSPAN="2" STYLE="text-align: left">Article III&nbsp;&nbsp;&nbsp;REPRESENTATIONS AND WARRANTIES OF THE SELLERS</TD>
    <TD STYLE="text-align: right">23</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.1&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Organization; Good Standing; Qualification and Power</TD>
    <TD STYLE="text-align: right">23</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.2&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Authorization</TD>
    <TD STYLE="text-align: right">24</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.3&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Title</TD>
    <TD STYLE="text-align: right">24</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.4&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Non-contravention</TD>
    <TD STYLE="text-align: right">24</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.5&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Consents and Approvals</TD>
    <TD STYLE="text-align: right">24</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.6&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Capitalization of the Company</TD>
    <TD STYLE="text-align: right">24</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.7&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Subsidiaries; Equity Investments</TD>
    <TD STYLE="text-align: right">26</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.8&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Bankruptcy, Etc</TD>
    <TD STYLE="text-align: right">26</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.9&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Financial Statements</TD>
    <TD STYLE="text-align: right">26</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.10&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Liabilities</TD>
    <TD STYLE="text-align: right">26</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.11&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Internal Accounting Controls</TD>
    <TD STYLE="text-align: right">27</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.12&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Accounts Receivable</TD>
    <TD STYLE="text-align: right">27</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.13&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Certain Business Practices</TD>
    <TD STYLE="text-align: right">27</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.14&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Absence of Certain Developments</TD>
    <TD STYLE="text-align: right">29</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.15&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Compliance with Law</TD>
    <TD STYLE="text-align: right">30</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.16&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Sufficiency of Assets; Title to Properties</TD>
    <TD STYLE="text-align: right">30</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.17&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Tax Matters</TD>
    <TD STYLE="text-align: right">31</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.18&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Intellectual Property</TD>
    <TD STYLE="text-align: right">32</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.19&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Insurance</TD>
    <TD STYLE="text-align: right">36</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.20&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Litigation</TD>
    <TD STYLE="text-align: right">36</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.21&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Bank Accounts</TD>
    <TD STYLE="text-align: right">37</TD></TR>

</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --> </FONT>-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left; width: 20%">Section 3.22&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left; width: 70%">Material Customers and Suppliers</TD>
    <TD STYLE="text-align: right; width: 10%">37</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.23&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Labor Matters</TD>
    <TD STYLE="text-align: right">37</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.24&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Employee Benefits</TD>
    <TD STYLE="text-align: right">39</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.25&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Environmental and Safety</TD>
    <TD STYLE="text-align: right">41</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.26&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Related Party Transactions</TD>
    <TD STYLE="text-align: right">42</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.27&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Material Contracts</TD>
    <TD STYLE="text-align: right">42</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.28&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Sufficiency of Assets</TD>
    <TD STYLE="text-align: right">45</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.29&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Exclusivity of Representations</TD>
    <TD STYLE="text-align: right">45</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.30&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Brokers or Finders</TD>
    <TD STYLE="text-align: right">45</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.31&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Books and Records</TD>
    <TD STYLE="text-align: right">45</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 3.32&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Privacy and Data Security</TD>
    <TD STYLE="text-align: right">45</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD COLSPAN="2" STYLE="text-align: left">Article IV&nbsp;&nbsp;&nbsp;REPRESENTATIONS AND WARRANTIES OF THE PURCHASER</TD>
    <TD STYLE="text-align: right">46</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 4.1&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Organization; Good Standing; Qualification and Power</TD>
    <TD STYLE="text-align: right">46</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 4.2&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Authorization</TD>
    <TD STYLE="text-align: right">46</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 4.3&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Investment Intent</TD>
    <TD STYLE="text-align: right">47</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 4.4&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Brokers or Finders</TD>
    <TD STYLE="text-align: right">47</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 4.5&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Investigation; Reliance</TD>
    <TD STYLE="text-align: right">47</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 4.6&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">No Violations; Consents and Approvals</TD>
    <TD STYLE="text-align: right">47</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 4.7&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Litigation</TD>
    <TD STYLE="text-align: right">47</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD COLSPAN="2" STYLE="text-align: left">Article V&nbsp;&nbsp;&nbsp;SURVIVAL AND INDEMNIFICATION</TD>
    <TD STYLE="text-align: right">47</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 5.1&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Survival of Representations, Warranties</TD>
    <TD STYLE="text-align: right">47</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 5.2&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Indemnification by the Sellers</TD>
    <TD STYLE="text-align: right">48</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 5.3&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Indemnification by the Purchaser</TD>
    <TD STYLE="text-align: right">49</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 5.4&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Claim Procedures</TD>
    <TD STYLE="text-align: right">50</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 5.5&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Calculation of Losses</TD>
    <TD STYLE="text-align: right">51</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 5.6&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Treatment of Indemnification Payments</TD>
    <TD STYLE="text-align: right">51</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 5.7&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Escrow Accounts; Order of Recovery</TD>
    <TD STYLE="text-align: right">51</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 5.8&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Other Limitations and Agreements</TD>
    <TD STYLE="text-align: right">52</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD COLSPAN="2" STYLE="text-align: left">Article VI&nbsp;&nbsp;&nbsp;AGREEMENTS</TD>
    <TD STYLE="text-align: right">53</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 6.1&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Non-Competition; Non-Solicitation and Interference</TD>
    <TD STYLE="text-align: right">53</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 6.2&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Termination of Related Party Contracts</TD>
    <TD STYLE="text-align: right">54</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 6.3&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Representative; Power of Attorney</TD>
    <TD STYLE="text-align: right">54</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 6.4&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Release</TD>
    <TD STYLE="text-align: right">55</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 6.5&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">R&amp;W Insurance Policy</TD>
    <TD STYLE="text-align: right">55</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 6.6&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Employee Matters</TD>
    <TD STYLE="text-align: right">56</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 6.7&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Director and Officer Indemnification</TD>
    <TD STYLE="text-align: right">57</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 6.8&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Tax Matters</TD>
    <TD STYLE="text-align: right">57</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD COLSPAN="2" STYLE="text-align: left">Article VII&nbsp;&nbsp;&nbsp;MISCELLANEOUS</TD>
    <TD STYLE="text-align: right">57</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 7.1&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">No Third Party Beneficiaries</TD>
    <TD STYLE="text-align: right">57</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 7.2&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Expenses</TD>
    <TD STYLE="text-align: right">57</TD></TR>

</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --> </FONT>-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left; width: 20%">Section 7.3&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left; width: 70%">Confidentiality</TD>
    <TD STYLE="text-align: right; width: 10%">58</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 7.4&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Entire Agreement</TD>
    <TD STYLE="text-align: right">58</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 7.5&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Successors and Assigns</TD>
    <TD STYLE="text-align: right">58</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 7.6&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Counterparts</TD>
    <TD STYLE="text-align: right">58</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 7.7&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Notices</TD>
    <TD STYLE="text-align: right">58</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 7.8&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Amendments and Waivers</TD>
    <TD STYLE="text-align: right">58</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 7.9&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Incorporation of Annexes, Disclosure Schedules and Exhibits</TD>
    <TD STYLE="text-align: right">59</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 7.10&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Disclosure Schedules</TD>
    <TD STYLE="text-align: right">59</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 7.11&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Construction</TD>
    <TD STYLE="text-align: right">59</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 7.12&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Independence of Representations and Warranties</TD>
    <TD STYLE="text-align: right">59</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 7.13&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Remedies</TD>
    <TD STYLE="text-align: right">59</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 7.14&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Further Assurances</TD>
    <TD STYLE="text-align: right">60</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 7.15&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Severability</TD>
    <TD STYLE="text-align: right">60</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 7.16&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Governing Law</TD>
    <TD STYLE="text-align: right">60</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 7.17&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Exclusive Jurisdiction and Service of Process</TD>
    <TD STYLE="text-align: right">60</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-left: 0.375in; text-align: left">Section 7.18&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: left">Waiver of Jury Trial</TD>
    <TD STYLE="text-align: right">60</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit A</U></FONT></TD>
    <TD STYLE="width: 90%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Escrow Agreement</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit B</U></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Spousal Consent</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit C</U></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current Assets and Current Liabilities</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit D</U></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">R&amp;W Insurance Policy</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit E</U></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">License Termination and Confirmatory Assignment Agreement</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Schedule I</U></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Funds Flow Memorandum</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Schedule II</U></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earn-Out</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --> </FONT>-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>STOCK PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This STOCK PURCHASE
AGREEMENT, dated as of March 8, 2021 (this &#8220;<U>Agreement</U>&#8221;), by and among HealthEquity, Inc., a Delaware corporation
(the &#8220;<U>Purchaser</U>&#8221;), each of the shareholders of the Company set forth on <U>Schedule I</U> hereto (each, a &#8220;<U>Seller</U>,&#8221;
and collectively, the &#8220;<U>Sellers</U>&#8221;) and Evan McCordick, solely in his capacity as the Sellers&#8217; representative
(the &#8220;<U>Sellers&#8217; Representative</U>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Sellers
own 13,316,799 shares, which constitute all outstanding shares of the capital stock (the &#8220;<U>Shares</U>&#8221;) of Fort Effect
Corp. d/b/a Luum, a Washington corporation (the &#8220;<U>Company</U>&#8221;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, on the terms
and subject to the conditions set forth in this Agreement, each Seller will sell to the Purchaser, and the Purchaser will purchase
from each Seller, all of such Seller&#8217;s Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in
consideration of the mutual promises herein made and in consideration of the representations, warranties and covenants herein contained,
and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, each party hereto,
intending to be legally bound, hereby agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">Article
I</FONT><FONT STYLE="color: red"><BR>
</FONT>DEFINITIONS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 1.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Certain Definitions</U>. As used herein, the following terms shall have the following respective meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>2019 Balance
Sheet</U>&#8221; has the meaning set forth in <U>Section 3.9</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Adjustment
Escrow Account</U>&#8221; has the meaning set forth in <U>Section 2.3(b)(ii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Adjustment
Escrow Amount</U>&#8221; means an amount in cash equal to $500,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Affiliate</U>&#8221;
means, with respect to any Person, any (a) officer or director (or the equivalent) of such Person, (b) spouse, parent, sibling
or descendant (including adopted or stepchildren) of such Person (or a spouse, parent, sibling or descendant (including adopted
or stepchildren) of any officer or director (or the equivalent) of such Person) and (c) any other Person that, directly or indirectly,
through one or more intermediaries, controls, or is controlled by, or is under common control with, such Person. The terms &#8220;<U>control</U>&#8221;
and &#8220;<U>controlled</U>&#8221; include the possession, directly or indirectly, of the power to direct the management and policies
of a Person, whether through the ownership of voting securities, by contract or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Affordable
Care Act</U>&#8221; means the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation
Act of 2010.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Agreement</U>&#8221;
has the meaning set forth in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Annual Financial
Statements</U>&#8221; has the meaning set forth in <U>Section 3.9</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Anti-Corruption
Laws</U>&#8221; has the meaning set forth in <U>Section 3.13(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Assets</U>&#8221;
means, with respect to any Person, all of the assets, rights, interests and other properties, real, personal and mixed, tangible
and intangible, owned by such Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Audit Firm</U>&#8221;
has the meaning set forth in <U>Section 2.6(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Balance Sheet
Date</U>&#8221; has the meaning set forth in <U>Section 3.9</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Base Consideration</U>&#8221;
has the meaning set forth in <U>Section 2.4</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Bonds</U>&#8221;
has the meaning set forth in <U>Section 3.19(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Business
Day</U>&#8221; means any day other than a Saturday, Sunday or any other day on which banking institutions in the State of Utah
or State of Washington are not open for the transaction of normal banking business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Business
Employee</U>&#8221; means each individual listed on the Business Employee List as of the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Business
Employee List</U>&#8221; means the letter provided by the Company to Purchaser simultaneously with the execution and delivery of
this Agreement, which letter contains a true and complete list of each individual who is employed by, or is actively providing
services to, the Seller Group Companies, together with such individual&#8217;s title or position, age, employing entity, work location,
full-time or part-time status, accrued vacation, dates of service, years of credit service, current rate of hourly wage or salary,
annual target cash bonus opportunity, any other compensatory entitlements, and each Company Plan in which he or she participates
or is eligible to participate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Cap</U>&#8221;
has the meaning set forth in <U>Section 5.2(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>CARES Act</U>&#8221;
means the Coronavirus Aid, Relief, and Economic Security Act of 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Cash</U>&#8221;
means, with respect to the Company, all bank deposits and other cash that may be fully withdrawn on demand and cash equivalents,
in each case, determined as of immediately prior to the Closing; <U>provided</U>, that to the extent not taken into account in
the foregoing determination, the amount of Cash as of any date shall be (a) net of bank overdrafts, (b) adjusted for deposits in
transit and outstanding checks and (c) reduced by cash or cash equivalents that (i) are not freely and immediately useable by the
Company as of the Closing (such as security deposits and amounts held as collateral), (ii) are only freely useable if fees or taxes
would become payable upon their immediate use or (iii) constitute (A) business interruption insurance proceeds, (B) cash reserved
to repair or replace assets affected by a casualty loss or (C) insurance or indemnification proceeds paid to the Company to reimburse
or compensate the Company for third-party payments made, or required to be made, by the Company or indemnifiable losses suffered
by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Change
in Control Payment</U>&#8221; means any transaction, retention, change in control or similar bonuses, severance payments and
other employee-related change of control payments payable by any of the Seller Group Companies as of or after the Closing
Date relating to Contracts entered into prior to the Closing Date (including the employer portion of any withholding,
payroll, employment or similar Taxes, if any, associated therewith, whether payable on the Closing Date or at a later time,
and whether payable by the Seller Group Companies) as a result of, or in connection with, the consummation of the
transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Claim</U>&#8221;
has the meaning set forth in <U>Section 5.4(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Claim Notice</U>&#8221;
has the meaning set forth in <U>Section 5.4(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Closing</U>&#8221;
has the meaning set forth in <U>Section 2.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Closing Balance
Sheet</U>&#8221; has the meaning set forth in <U>Section 2.5</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Closing Consideration</U>&#8221;
has the meaning set forth in <U>Section 2.4</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Closing Date</U>&#8221;
has the meaning set forth in <U>Section 2.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Closing Indebtedness</U>&#8221;
means the Indebtedness determined as of immediately prior to the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Closing Statement</U>&#8221;
has the meaning set forth in <U>Section 2.6(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Code</U>&#8221;
means the Internal Revenue Code of 1986.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Commuter
Revenue</U>&#8221; means &#8220;administrative&#8221; or &#8220;services&#8221; fee revenue (as such terms are used by the Purchaser
in the ordinary course preparation of the Purchaser&#8217;s financial statements) of the Purchaser (and not, for the avoidance
of doubt, the Company) generated directly from the sale of a tax-advantaged benefits program under Section 132(f) of the Code and
administered on the Purchaser&#8217;s technology platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Company</U>&#8221;
has the meaning set forth in the Recitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Company Capital
Stock</U>&#8221; means the Company Common Stock, the Company Limited Common Stock, the Company Preferred Stock, and any other shares
of capital stock, if any, of the Company, taken together.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Company Common
Stock</U>&#8221; means shares of common stock, no par value per share, of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Company Computer
Systems</U>&#8221; means the information technology and computer systems (including all Software, hardware, and firmware, and including
all network, information technology and telecommunication hardware and other equipment) owned, leased, licensed or used by the
Company relating to the transmission, storage, maintenance, organization, presentation, generation, processing or analysis of data
and information (whether or not in electronic format) used in the conduct of the business of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Company Contributor</U>&#8221;
has the meaning set forth in <U>Section 3.18(f)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Company Equity
Plan</U>&#8221; means the Fort Effect Corp. 2015 Stock Plan, as amended through the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Company Fundamental
Representations</U>&#8221; means the representations and warranties contained in <U>Section 3.1</U> (Organization; Good Standing;
Qualification and Power), <U>Section 3.2</U> (Authorization), <U>Section 3.3</U> (Title), <U>Section 3.6</U> (Capitalization),
and <U>Section 3.30</U> (Brokers).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Company Intellectual
Property</U>&#8221; has the meaning set forth in <U>Section 3.18(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Company IP
Agreements</U>&#8221; has the meaning set forth in <U>Section 3.27(k)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Company Limited
Common Stock</U>&#8221; means shares of limited common stock, no par value per share, of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Company Option</U>&#8221;
shall mean an option to purchase shares of Company Common Stock issued under the Company Equity Plan, whether vested or unvested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Company Plan</U>&#8221;
means each &#8220;employee benefit plan&#8221; within the meaning of Section&nbsp;3(3) of ERISA (whether or not subject to ERISA)
and all other compensation and benefits plans, policies, trust funds, programs, arrangements or payroll practices, including Multiemployer
Plans, and each other stock purchase, stock option, restricted stock, profit sharing, pension, savings, severance, retention, employment,
consulting, commission, change-of-control, collective bargaining, bonus, incentive, deferred compensation, employee loan, fringe
benefit, insurance, welfare, post-retirement health or welfare, health, life, tuition refund, service award, company car, scholarship,
relocation, disability, accident, sick pay, sick leave, accrued leave, vacation, holiday, termination, unemployment, restrictive
covenant, and other benefit plan, policy, trust fund, program, arrangement or payroll practice, whether or not subject to ERISA
(including any related funding mechanism now in effect or required in the future), whether formal or informal, oral or written,
funded, unfunded, insured or self-insured, in each case, that is sponsored, established, maintained, contributed to or required
to be contributed to by any of the Seller Group Companies, or under which any of the Seller Group Companies has any current or
potential liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Company Preferred
Stock</U>&#8221; means shares of preferred stock, no par value per share, of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Company Products
and Services</U>&#8221; has the meaning set forth in <U>Section 3.18(n)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Company Securities</U>&#8221;
means the Company Capital Stock and any other Equity Interests in the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Competitive
Activities</U>&#8221; means the business of the Company as currently conducted and as currently contemplated to be conducted, including
providing a SaaS platform for commute management and commuter benefit administration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Contracts</U>&#8221;
means any and all written and unwritten agreements, contracts, deeds, arrangements, purchase orders, and other instruments and
interests therein, and all amendments thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Corporate
Transaction</U>&#8221; means, with respect to Purchaser or the Company, (a) the acquisition of a majority of the voting power (including,
to the extent applicable, the acquisition of the ability to control the election of a majority of the directors or similar governing
body) of such entity by another Person or group of related Persons by means of any transaction or series of related transactions
(including, without limitation, any stock acquisition, any consolidation or merger of such entity with or into any other Person,
or any other corporate reorganization), other than any consolidation, merger or reorganization in which the holders of shares of
capital stock representing a majority of the voting power of such entity immediately prior to such consolidation, merger or reorganization
continue to hold shares of capital stock representing a majority of the voting power of the surviving entity (or, if the surviving
entity is a wholly owned subsidiary, its parent) immediately after such consolidation, merger or reorganization or (b) the sale,
exclusive license or other disposition of all or substantially all of such entity&#8217;s assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>COVID-19
Law</U>&#8221; means the CARES Act, the Families First Coronavirus Response Act of 2020, the Consolidated Appropriations Act, 2021,
or any other Law intended to address the consequences of COVID-19.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Deductible</U>&#8221;
has the meaning set forth in <U>Section 5.2(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Disclosure
Schedules</U>&#8221; means the disclosure schedules with respect to the representations, warranties and covenants of the Sellers
contained in this Agreement, with sections corresponding to the numbered and lettered sections contained herein, delivered separately
by the Sellers to the Purchaser simultaneously with the execution and delivery of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Dispute Notice</U>&#8221;
has the meaning set forth in <U>Section 2.6(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>EIDL Loan</U>&#8221;
means the Secured Disaster Loan for the sum of $150,000 made by the U.S. Small Business Administration to the Company pursuant
to a Loan Authorization Agreement dated June 25, 2020 and a Note and Security Agreement of even date therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Environmental
and Safety Requirements</U>&#8221; means all Laws, Orders, contractual obligations and all common law concerning public
health and safety, worker health and safety, and pollution or protection of the environment, including all those relating to
the presence, use, production, generation, handling, transportation, treatment, storage, disposal, distribution, labeling,
testing, processing, discharge, release, threatened release, control or cleanup of any hazardous materials, substances or
wastes, chemical substances or mixtures, pesticides, pollutants, contaminants, toxic chemicals, petroleum products or
byproducts, asbestos, polychlorinated biphenyls, noise or radiation, including the Solid Waste Disposal Act, as amended, 42
U.S.C. &sect;&sect; 6901&#8211;6992k, the Clean Air Act, as amended, 42 U.S.C. &sect;&sect; 7401 et seq., the Federal Water
Pollution Control Act, as amended, 33 U.S.C. &sect;&sect; 1251 et seq., the Emergency Planning and Community Right-to-Know
Act, as amended, 42 U.S.C. &sect;&sect; 11001 et seq., the Comprehensive Environmental Response, Compensation, and Liability
Act, as amended, 42 U.S.C. &sect;&sect; 9601 et seq., the Hazardous Materials Transportation Uniform Safety Act, as amended,
49 U.S.C. &sect;&sect; 1804 et seq., the Occupational Safety and Health Act of 1970, as amended, 29 U.S.C. &sect;&sect; 651
et seq., and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Equity Interests</U>&#8221;
means, with respect to any Person, (i)&nbsp;any share of capital stock of, or other ownership, membership, partnership, joint venture
or equity interest in, such Person, (ii)&nbsp;any indebtedness, securities, options, warrants, call, subscription or other rights
of, or granted by, such Person or any of its Affiliates that are convertible into, or are exercisable or exchangeable for, or giving
any Person any right to acquire any such share of capital stock or other ownership, partnership, joint venture or equity interest,
in all cases, whether vested or unvested, (iii)&nbsp;any stock appreciation right, phantom stock, interest in the ownership or
earnings of such Person or other equity equivalent or equity-based award or right, or (iv)&nbsp;any Indebtedness having the right
to vote (or convertible into or exchangeable for securities having the right to vote) on any matters on which any holder of securities
of such Person may vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>ERISA</U>&#8221;
means the Employee Retirement Income Security Act of 1974, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>ERISA Affiliate</U>&#8221;
means each entity, trade or business that is, or was at the relevant time, a member of a group described in Section 414(b), (c),
(m) or (o) of the Code or Section 4001(b)(1) of ERISA that includes or included any of the Seller Group Companies, or that is,
or was at the relevant time, a member of the same &#8220;controlled group&#8221; as any of the Seller Group Companies pursuant
to Section 4001(a)(14) of ERISA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Escrow Agent</U>&#8221;
means Citibank, N.A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Escrow Agreement</U>&#8221;
means that certain Escrow Agreement, dated as of the date hereof, by and among the Escrow Agent, the Purchaser and the Sellers&#8217;
Representative, substantially in the form attached hereto as <U>Exhibit A</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Escrow Amount</U>&#8221;
means an amount in cash equal to the sum of the Adjustment Escrow Amount and the Indemnity Escrow Amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Escrow Excess
Amount</U>&#8221; has the meaning set forth in <U>Section 2.7(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Escrow Shortfall
Amount</U>&#8221; has the meaning set forth in <U>Section 2.7(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Estimated
Cash</U>&#8221; has the meaning set forth in <U>Section 2.5</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Estimated
Closing Indebtedness</U>&#8221; has the meaning set forth in <U>Section 2.5</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Estimated
Closing Statement</U>&#8221; has the meaning set forth in <U>Section 2.5</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Estimated
Net Working Capital</U>&#8221; has the meaning set forth in <U>Section 2.5</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Estimated
Transaction Expenses</U>&#8221; has the meaning set forth in <U>Section 2.5</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Expiration
Date</U>&#8221; means the date that is 18 months from the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Final Consideration</U>&#8221;
means (i) the Base Consideration, <U>plus</U> (ii) the amount of Cash as finally determined pursuant to <U>Section 2.6</U>, <U>less</U>
(iii) the amount of Closing Indebtedness as finally determined pursuant to <U>Section 2.6</U>, <U>plus</U> (iv) the amount, if
any, by which the Net Working Capital as finally determined pursuant to <U>Section 2.6</U> exceeds the Target Net Working Capital,
<U>less</U> (v) the amount, if any, by which the Net Working Capital as finally determined pursuant to <U>Section 2.6</U> is less
than the Target Net Working Capital, <U>less</U> (vi) the amount of Transaction Expenses as finally determined pursuant to <U>Section
2.6</U>, <U>less</U> (vii) the Escrow Amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Financial
Statements</U>&#8221; has the meaning set forth in <U>Section 3.9</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Fortitude
Note</U>&#8221; means the Demand Promissory Note issued by the Company to Fort Effect Company Corp. having a variable principal
amount and dated March 8, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Fraud</U>&#8221;
means, with respect to Purchaser or the Sellers, an actual and intentional fraud with respect to the making of any representation
or warranty in this Agreement or with respect to any certificate delivered pursuant to this Agreement, including the Estimated
Closing Statement; provided, however, that such actual and intentional fraud of Purchaser or the Sellers shall only be deemed to
exist if such party had knowledge of the breach when the related representations and warranties were made with the express intention
that the other party would rely thereon to its detriment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Fundamental
Documents</U>&#8221; means the documents by which any Person (other than an individual) establishes its legal existence or which
govern its internal affairs, as in effect from time to time including any amendments thereto. For example, the &#8220;Fundamental
Documents&#8221; of a corporation would be its certificate or articles of incorporation and bylaws, each as may be amended from
time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>GAAP</U>&#8221;
means generally accepted accounting principles in the United States, as in effect on the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Government
Officials</U>&#8221; has the meaning set forth in <U>Section 3.13(a)(i)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Governmental
Entity</U>&#8221; means any court, administrative agency, tribunal, department, bureau or commission or other governmental authority
or instrumentality, domestic or foreign, federal, state or local.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Indebtedness</U>&#8221;
means, as of any date of determination, with respect to the Company, (a)&nbsp;all principal and accrued (but unpaid) interest
owing by the Company for indebtedness for borrowed money or any notes payable, (b)&nbsp;all obligations of the Company as
lessee under leases required by GAAP to be recorded by the Company as capital leases, (c) the deferred purchase price of
property, assets or services (excluding trade payables and accrued expenses arising in the ordinary course of business) of
the Company, (d) all obligations of the Company under exchange rate contracts or interest rate protection agreements, (e) any
obligation to reimburse the issuer of any letter of credit, surety bond, performance bond or other guarantee of contractual
performance, in each case to the extent drawn or otherwise not contingent, (f) any Tax Debt, (g) any liabilities with respect
to past or present litigation, (h) any long-term deferred revenue, (i) any guaranty of any liability or obligation described
in the immediately preceding clauses (a) through (h), (j)&nbsp;any payments, fines, fees, penalties or other amounts
applicable to or otherwise incurred in connection with or as a result of any prepayment or early satisfaction of any
obligation described in the immediately preceding clauses (a) through (i), and (k) any outstanding severance or termination
obligations and associated Liabilities with respect to employees (or other service providers) whose employment (other
service) terminated prior to the Closing Date, any unfunded or underfunded Liabilities pursuant to any pension,
post-termination or retiree health and welfare benefit or nonqualified deferred compensation plan or arrangement and any
earned but unpaid compensation (including salary, bonuses and paid time off) for any period prior to the Closing Date, in
each case, together with the employer portion of any withholding, payroll, employment or similar Taxes, if any, associated
therewith, whether payable on the Closing Date or at a later time, and whether payable by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Indemnified
Party</U>&#8221; has the meaning set forth in <U>Section 5.4(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Indemnifying
Party</U>&#8221; has the meaning set forth in <U>Section 5.4(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Indemnity
Escrow Account</U>&#8221; has the meaning set forth in <U>Section 2.3(b)(iii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Indemnity
Escrow Amount</U>&#8221; means an amount in cash equal to $250,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Intellectual
Property</U>&#8221; means all of the following, worldwide, whether registered, unregistered or registrable: (a) trademarks and
service marks, trade dress, logos, product configurations, trade names and other indications of origin, applications or registrations
in any jurisdiction and all goodwill associated therewith; (b) all patents, and all applications for patents, in any jurisdiction,
including all provisionals, re-issues, continuations, divisions, continuations-in-part, re-examinations, renewals and extensions;
(c) trade secrets inventions, trade secrets, discoveries, improvements, ideas, know-how, methodology, models, algorithms, formulae,
systems, processes, technology, research, schematics, data and database rights, customer and supplier lists (whether patentable
or not) and other rights in confidential and other nonpublic information that derive economic value from not being generally known
and not being readily ascertainable by proper means, including the right in any jurisdiction to limit the use or disclosure thereof;
(d) copyrights copyrightable works, writings, designs, mask works, Software (in any form or format), content and any other original
works of authorship in any medium, including applications or registrations in any jurisdiction for the foregoing and all moral
rights in the foregoing; (e) industrial designs, and utility models; (f) Internet websites, domain names and applications and registrations
pertaining thereto; (g) social media accounts, the usernames and passwords associated therewith, and all content contained therein;
(h) any other intellectual property or proprietary rights of any kind, nature or description; and (i) any tangible embodiments
of the foregoing (in whatever form or medium).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Interfering
Activities</U>&#8221; means (i) encouraging, soliciting or inducing, or in any manner attempting to encourage, solicit or
induce, any Person who is employed by, an agent of, or a service provider to, the Company within the 12-month period prior to
the Closing to terminate (or, in the case of an agent or service provider, terminate or reduce) such Person&#8217;s
employment, agency or service, as the case may be, with the Company; <U>provided</U>, that the foregoing shall not be
violated by general advertising not targeted at employees of the Company; (ii) hiring any Person who was employed by the
Company, within the twelve-month period prior to the date of such hiring; or (iii) encouraging, soliciting or inducing, or in
any manner attempting to encourage, solicit or induce, any customer, supplier, licensee or other business relation (or any
Subsidiary of any such customer, supplier, licensee or other business relation) of the Company to cease doing business with
or materially reduce the amount of business conducted with (including by providing similar services or products to any such
Person) the Company, or in any way interfere in an adverse manner with the relationship between any such customer, supplier,
licensee or business relation and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Interim Balance
Sheet</U>&#8221; has the meaning set forth in <U>Section 3.9</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Interim Financial
Statements</U>&#8221; has the meaning set forth in <U>Section 3.9</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>IRS</U>&#8221;
means the Internal Revenue Service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Knowledge</U>&#8221;
means, as to any Person, all facts of which such Person shall have, or would have, notice or actual knowledge following reasonable
inquiry. References to the &#8220;Knowledge of the Sellers&#8221; and the &#8220;Sellers&#8217; Knowledge&#8221; mean all facts
of which Sohier Hall, Matt Hall, Tyler Simpson, Maria Berardo and Joey McGahan shall have, or would have, notice or actual knowledge
following reasonable inquiry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Law</U>&#8221;
means any constitution, law, statute, treaty, rule, directive, requirement, regulation or Order of, or promulgated by, any Governmental
Entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Liability</U>&#8221;
means any liability or obligation, whether known or unknown, asserted or unasserted, absolute or contingent, accrued or unaccrued,
liquidated or unliquidated and whether due or to become due, regardless of when asserted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>License Termination
and Confirmatory Assignment Agreement</U>&#8221; means that certain License Termination and Confirmatory Assignment Agreement,
to be entered into on the Closing Date, between Fortitude Corp. (formerly 1866374 Ontario Inc. and formerly Fort Effect Company
Corp.) (&#8220;<U>Fortitude</U>&#8221;) and the Company, substantially in the form attached hereto as <U>Exhibit E</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Licensed
Software</U>&#8221; has the meaning set forth in <U>Section 3.18(h)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Lien</U>&#8221;
means any lien (statutory or otherwise), claim, security interest, pledge, bailment (in the nature of a pledge or for purposes
of security), mortgage, deed of trust, the grant of a power to confess judgment, conditional sale or title retention agreement
(including any lease in the nature thereof), charge, encumbrance, easement, reservation, restriction, cloud, right of first refusal
or first offer, option, right-of-way, encroachment or other similar arrangement or rights of third parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Listed Intellectual
Property</U>&#8221; has the meaning set forth in <U>Section 3.18(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Loss</U>&#8221;
means any loss, Liability, demand, claim, action, cause of action, cost, damage, deficiency, Tax, penalty, fine or expense, whether
or not arising out of any claims by or on behalf of any third party, including interest, penalties, reasonable attorneys&#8217;
fees and expenses and all reasonable amounts paid in defense or settlement of any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Management
Promissory Notes</U>&#8221; means the (i) Full Recourse Secured Promissory Note dated as of September 11, 2019, by Sohier Hall
in favor of the Company in principal amount of $92,004.84, (ii) Full Recourse Secured Promissory Note dated as of November 30,
2019, by Matt Hall in favor of the Company in principal amount of $92,004.84 and (iii) Full Recourse Secured Promissory Note dated
as of November 30, 2019, by Tyler Simpson in favor of the Company in principal amount of $92,004.84.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Management
Shareholders</U>&#8221; means Sohier Hall, Matt Hall and Tyler Simpson.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Material
Adverse Effect</U>&#8221; means any condition, change, effect or event, individually or in the aggregate, that has had, or is reasonably
expected to have, a material adverse effect on (i) the Assets, Liabilities, business, operating results, or condition (financial
or otherwise) of the Company, or (ii) the ability of the Company to consummate the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Material
Contract</U>&#8221; has the meaning set forth in <U>Section 3.27</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Material
Customer</U>&#8221; has the meaning set forth in <U>Section 3.22</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Multiemployer
Plan</U>&#8221; means a &#8220;multiemployer plan&#8221; as defined in Section&nbsp;3(37) or 4001(a)(3) of ERISA or Section&nbsp;414(f)
of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Net Working
Capital</U>&#8221; means an amount (whether positive or negative) equal to (a) all current Assets (excluding Cash and deferred
Tax Assets) of the Company required by GAAP to be set forth on the face of a balance sheet, which current Assets will include only
the line items set forth on <U>Exhibit C</U> under the heading &#8220;Current Assets&#8221;, <U>less</U> (b) all current Liabilities
(excluding any deferred Tax Liabilities) of the Company required by GAAP to be set forth on the face of a balance sheet (including
all current deferred revenue, and excluding Indebtedness and Transaction Expenses), which current Liabilities will include only
the line items set forth on <U>Exhibit C</U> under the heading &#8220;Current Liabilities&#8221;, in each case, determined as of
immediately prior to the Closing in accordance with GAAP applied on a basis consistent with the Company&#8217;s historical accounting
practices and methodology (but solely to the extent such practices and methodology are consistent with GAAP). For the avoidance
of doubt, the calculation of Net Working Capital shall not include any purchase accounting adjustments or any amounts related to
transactions for Tesla&#8217;s Commuter Benefit Elections (&#8220;<U>TCBE</U>&#8221;), such as amounts from invoices stating TCBE
reported in the current Asset or current Liability account(s), including SVB Clearing Account, Accounts Receivable, Accounts Payable,
AP Clearing, Customer Holdings Accounts, and Commute with Enterprise payments and Emburse Inc. payments included in the current
Liability account(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Open Source
Software</U>&#8221; means any software that is or that contains or is derived in any manner (in whole or in part) from any software
that is licensed under any license that has been approved by the Open Source Initiative and listed on https://opensource.org/licenses/alphabetical
or that is based on any similar licensing or distribution models.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Optionholder</U>&#8221;
shall mean a holder of Company Options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Orders</U>&#8221;
means judgments, writs, decrees, injunctions, orders, awards, compliance agreements or settlement agreements of or with any Governmental
Entity or arbitrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Owned Intellectual
Property</U>&#8221; means (a) any Intellectual Property owned or purported to be owned by the Company, and (b) all Intellectual
Property to be assigned by Fortitude to the Company pursuant to the License Termination and Confirmatory Assignment Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Permits</U>&#8221;
means all permits, licenses, authorizations, registrations, franchises, approvals, consents, certificates, variances and similar
rights obtained, or required to be obtained, from Governmental Entities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Permitted
Liens</U>&#8221; means only (a) statutory Liens for Taxes not yet due and payable or being contested in good faith by appropriate
proceedings; (b) workers or unemployment compensation Liens arising in the ordinary course of business consistent with past practice;
(c) mechanic&#8217;s, materialman&#8217;s, supplier&#8217;s, vendor&#8217;s or similar Liens arising in the ordinary course of
business consistent with past practice securing amounts that are not delinquent or past due or that are being contested in good
faith; and (d) zoning ordinances, easements and other restrictions of legal record affecting real property which would be revealed
by a survey or a search of public records and would not, individually or in the aggregate, materially interfere with the value
or usefulness of such real property to the business of the Company as presently conducted and as contemplated to be conducted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Person</U>&#8221;
shall be construed broadly and shall include an individual, a partnership (general or limited), a corporation, a limited liability
company, an association, a joint stock company, a trust, a joint venture, an unincorporated organization, any other entity and
any Governmental Entity (or any department, agency or political subdivision thereof).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Personal
Data</U>&#8221; means information that identifies, relates to, describes, is reasonably capable of being associated with, or could
reasonably be linked, directly or indirectly, with a particular individual or household, and when referring to a Data Protection
Requirement, has the same meaning as the similar or equivalent term defined thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Policies</U>&#8221;
has the meaning set forth in <U>Section 3.19(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>PPP Lender</U>&#8221;
means Silicon Valley Bank.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>PPP Loan</U>&#8221;
means the loan in principal amount of $673,184 issued to the Company by the PPP Lender pursuant to the promissory note dated April
20, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Pro Rata
Consideration Share</U>&#8221; means, with respect to each Seller, the percentage set forth opposite such Seller&#8217;s name under
the &#8220;Pro Rata Consideration Share&#8221; column of the table set forth on <U>Schedule I</U> hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Pro Rata
Earn-Out Portion</U>&#8221; means, (a) with respect to each Seller, the percentage set forth opposite such Seller&#8217;s name
under the &#8220;Pro Rata Earn-Out Portion&#8221; column of the table set forth on <U>Schedule I</U> hereto and (b) with respect
to each Optionholder, the percentage set forth opposite such Optionholder&#8217;s name under the &#8220;Pro Rata Earn-Out Portion&#8221;
column of the table set forth on <U>Schedule I</U> hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Pro Rata
Indemnification Share</U>&#8221; means, with respect to each Seller, the percentage set forth opposite such Seller&#8217;s name
under the &#8220;Pro Rata Indemnification Share&#8221; column of the table set forth on <U>Schedule I</U> hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Pro Rata
Surplus Share</U>&#8221; means, with respect to each Seller, the percentage set forth opposite such Seller&#8217;s name under the
 &#8220;Pro Rata Surplus Share&#8221; column of the table set forth on <U>Schedule I</U> hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Proceeding</U>&#8221;
means any action, suit, proceeding, complaint, claim, charge, hearing, labor dispute, inquiry or investigation before or by a Governmental
Entity or an arbitrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Proprietary
Software</U>&#8221; has the meaning set forth in <U>Section 3.18(h)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Purchase
Price</U>&#8221; means an amount equal to the Final Consideration, <U>plus</U> the Escrow Amount (if any released to the Sellers).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Purchaser</U>&#8221;
has the meaning set forth in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Purchaser
Fundamental Representations</U>&#8221; means the representations and warranties contained in <U>Section 4.1</U> (Organization;
Good Standing; Qualification and Power), <U>Section 4.2</U> (Authorization) and <U>Section 4.4</U> (Brokers or Finders).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Purchaser
Group Companies</U>&#8221; means the Purchaser and its Subsidiaries (including the Company following the Closing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Purchaser
Indemnified Parties</U>&#8221; has the meaning set forth in <U>Section 5.2(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Qualified
Revenue</U>&#8221; means, without duplication, (1) revenue of the Company (and not, for the avoidance of doubt, the Purchaser)
generated directly from the sale of the Company&#8217;s products and services (including the sale of such products and services
into the Purchaser&#8217;s existing customer base), which revenue is properly booked by the Company in accordance with GAAP applied
on a basis consistent with the Company&#8217;s historical accounting practices and methodology (including treatment of installation
fees) (but solely to the extent such practices and methodology are consistent with GAAP) and is calculated net of any write-offs,
discounts or rebates and excluding revenue associated with any notes or accounts receivable that are past due more than 90 days
or are otherwise subject to contest, claim, defense or right of setoff; (2) Commuter Revenue generated following the Closing from
an exclusive customer of the Company (<I>i.e.</I>, a customer of the Company that is using a product or service of the Company
and not a commuter customer of the Purchaser, in each case determined at the time of sale); and (3) Commuter Revenue generated
following the Closing from a new or renewed commuter customer of the Purchaser (<I>i.e.</I>, a commuter customer of the Purchaser
that became or renewed as a customer of the Purchaser following the Closing), if such new or renewed customer is Company-Sourced;.
For purposes of clause (3) above, a customer will be deemed to be &#8220;<U>Company-Sourced</U>&#8221; if such customer (a) is
reflected in the Purchaser&#8217;s customer relationship management software program (<I>e.g.</I>, Salesforce) as having been first
introduced to the Purchaser by a Continuing Employee or (b) is a customer of both the Purchaser and the Company prior to the Closing
and a Continuing Employee, individually or together with other Continuing Employees, makes a material contribution to or provides
material assistance with the renewal of such customer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>R&amp;W Insurance
Policy</U>&#8221; means the buy-side Representation and Warranty Insurance Policy to be obtained by Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Related Party
Contract</U>&#8221; has the meaning set forth in <U>Section 6.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Release</U>&#8221;
has the meaning set forth in <U>Section 6.4(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Restricted
Period</U>&#8221; means the period commencing on the date of this Agreement and ending on the third anniversary of the Closing
Date hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Seller</U>&#8221;
has the meaning set forth in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Seller Claims</U>&#8221;
has the meaning set forth in <U>Section 6.4(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Seller Group
Companies</U>&#8221; means the Company and each of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Seller Indemnified
Parties</U>&#8221; has the meaning set forth in <U>Section 5.3(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Sellers&#8217;
Representative</U>&#8221; has the meaning set forth in the Preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Shortfall
Amount</U>&#8221; has the meaning set forth in <U>Section 2.7(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Small Business
Act</U>&#8221; means the Small Business Act (15 U.S.C. 636(a)) after giving effect to the implementation of the CARES Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Software</U>&#8221;
means all computer software, including assemblers, applets, compilers, source code, object code, binary libraries, development
tools, design tools, user interfaces, virtualization processes, hypervisors, application, performance and database logs, in any
form or format, however fixed, and all associated documentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Source Code</U>&#8221;
means, collectively, any software source code, or any portion or aspect of the software source code, or any proprietary information
or algorithm contained in or relating to any software source code, including material related documentation, of any Intellectual
Property owned or purported to be owned by the Company or any other product or service marketed or currently proposed to be marketed
by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Subsidiary</U>&#8221;
means any particular Person (other than an individual) with respect to which a specified Person has a direct or indirect controlling
ownership interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Sullivan
Note</U>&#8221; means the Demand Promissory Note issued by the Company to Hugh Sullivan having a principal amount of $50,000 and
dated November 13, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Target Net
Working Capital</U>&#8221; means $850,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Tax</U>&#8221;
or &#8220;<U>Taxes</U>&#8221; means (i) any and all federal, state, local, foreign and other taxes, levies, fees, imposts,
duties and charges of whatever kind (including any interest, penalties or additions to the tax imposed in connection
therewith or with respect thereto), including taxes imposed on, or measured by, income, franchise, profits or gross receipts,
and also <I>ad valorem</I>, value added, sales, use, service, real or personal property, escheat or unclaimed property,
capital stock, license, payroll, withholding, employment, social security, workers&#8217; compensation, unemployment
compensation, utility, severance, production, excise, stamp, occupation, premium, windfall profits, transfer and gains taxes
and customs duties, whether disputed or not; (ii) Liability for the payment of any amounts of the type described in (i) as a
result of being a member of an affiliated, consolidated, combined, unitary or aggregate group; and (iii) Liability for the
payment of any amounts as a result of an express or implied obligation to indemnify any other Person with respect to the
payment of any amounts described in (i) or (ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Tax Debt</U>&#8221;
means, as of a particular time with respect to the Company, without duplication, (a) all Taxes deferred and unpaid as of such time
under any COVID-19 Law and (b) all Taxes attributable to any taxable period (or portion thereof) ending on or before the Closing
Date that are unpaid as of the Closing, which shall (i) be computed on the basis of a closing of the books of the Seller Group
Companies as of the end of the Closing Date and (ii) include all Taxes imposed on any income deferred under Section 451(c) of the
Code to a tax period (or portion thereof) ending after the Closing Date. For the avoidance of doubt, &#8220;Tax Debt&#8221; shall
(i) be computed without regard of any Liabilities for Taxes reflected on a Tax Return filed after the Closing Statement becomes
final pursuant to <U>Section 2.6</U>, and (ii) not include any Liability for Taxes resulting from any action by Purchaser or its
Affiliates on or after the Closing Date, including filing or amending any Tax Return of the Seller Group Companies or making any
Tax election or change in accounting method or accounting period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Tax Return</U>&#8221;
means returns, reports, information statements and other documentation (including any additional or supporting material) filed
or maintained, or required to be filed or maintained, in connection with the calculation, determination, assessment, claim for
refund or collection of any Tax and shall include any amended returns required as a result of examination adjustments made by the
IRS or other Tax Governmental Entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Transaction
Expenses</U>&#8221; means the aggregate fees and expenses of the Company incurred in connection with the transactions contemplated
hereby that are payable as of or following the Closing and have not been paid on or prior to the Closing, including (i)&nbsp;any
such fees and expenses payable to professionals (including investment bankers, attorneys, accountants and other consultants and
advisors) retained by the Company, (ii)&nbsp;any Change in Control Payments, (iii) the employer portion of any withholding, payroll,
employment or similar Taxes, if any, associated with amounts payable in respect to each Company Option, whether or not payable
on the Closing Date or at a later time, and whether payable by the Seller Group Companies), and (iv) fifty percent (50%) of all
premiums, fees, costs, and expenses of the R&amp;W Insurance Policy (whether incurred by the Company directly or by the Purchaser).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<U>Works</U>&#8221;
has the meaning set forth in <U>Section 3.18(g)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section
1.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B><U>Terms
Generally</U>. The definitions in <U>Section 1.1</U> shall apply equally to both the singular and plural forms of the terms
defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms.
The words &#8220;include&#8221;, &#8220;includes&#8221; and &#8220;including&#8221; shall be deemed to be followed by the
phrase &#8220;without limitation&#8221;. The words &#8220;herein&#8221;, &#8220;hereof&#8221; and &#8220;hereunder&#8221; and
words of similar import refer to this Agreement (including the Exhibits and Schedules to this Agreement) in its entirety and
not to any part hereof unless the context shall otherwise require. All references herein to Articles, Sections, Exhibits and
Schedules shall be deemed references to Articles and Sections of, and Exhibits and Schedules to, this Agreement unless the
context shall otherwise require. The article and section headings contained in this Agreement are inserted for convenience
only and shall not affect in any way the meaning or interpretation of this Agreement. Unless the context shall otherwise
require, any references to any agreement or other instrument or statute or regulation are to it as amended and supplemented
from time to time (and, in the case of a statute or regulation, to any successor provisions). Accounting terms used but not
otherwise defined herein shall have the meanings given to them under GAAP. Any reference to any supranational, national,
federal, state, local, or foreign statute or Law shall be deemed also to refer to all rules and regulations promulgated
thereunder, unless the context requires otherwise. Any reference in this Agreement to a &#8220;day&#8221; or a number of
 &#8220;days&#8221; (without explicit reference to &#8220;Business Days&#8221;) shall be interpreted as a reference to a
calendar day or number of calendar days. If any action is to be taken or given on or by a particular calendar day, and such
calendar day is not a Business Day, then such action may be deferred until the next Business Day. All references to
 &#8220;$&#8221; or &#8220;dollars&#8221; shall mean United States Dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">Article
II</FONT><BR>
SALE AND PURCHASE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 2.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Agreement to Sell and Purchase</U>. At the Closing, upon the terms and subject to the conditions set forth in this
Agreement, each Seller shall sell, assign, transfer, convey and deliver all of such Seller&#8217;s Shares free and clear of all
Liens to the Purchaser, and the Purchaser shall purchase and accept all of such Shares from such Seller in exchange for such Seller&#8217;s
Pro Rata Consideration Share of the Purchase Price, which shall be delivered and paid in accordance with this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 2.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Closing</U>. The closing of the transactions contemplated by this Agreement (the &#8220;<U>Closing</U>&#8221;) shall
take place by remote electronic exchange of documents (by facsimile, .pdf, e-mail or other form of electronic communication) on
the date hereof, or at such other date and time as the parties hereto may agree. The actual date of the Closing is herein referred
to as the &#8220;<U>Closing Date</U>&#8221;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section
2.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B><U>Closing Deliverables</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At the Closing, the Sellers shall deliver, or cause to be delivered, to the Purchaser or its designee:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>for each Seller, the original certificates or a declaration of lost stock certificate in a form reasonably satisfactory
to Purchaser representing such Seller&#8217;s Shares, together with stock transfer powers satisfactory in form and substance to
Purchaser, such that Purchaser shall have received in the aggregate certificates representing all outstanding Shares owned by all
Sellers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a duly executed certificate, in form and substance as prescribed by Treasury Regulations promulgated under Code Section
1445, stating that the Company is not, and has not been, during the relevant period specified in Section 897(c)(1)(A)(ii) of the
Code, a &#8220;United States real property holding corporation&#8221; within the meaning of Section 897(c) of the Code;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>for each Seller who is married, a spousal consent, substantially in the form attached hereto as <U>Exhibit B</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a counterpart of the Escrow Agreement duly executed by the Sellers&#8217; Representative;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a certificate of existence with respect to the Company issued by the Secretary of State of the State of Washington no earlier
than five (5) Business Days prior to the Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a certificate, dated the Closing Date, duly executed by the Sellers&#8217; Representative, certifying that true and complete
copies of the Company&#8217;s Fundamental Documents, as in effect on the Closing Date, are attached to such certificate;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>evidence satisfactory to the Purchaser with respect to the resignation of all directors and officers (in their capacity
as officers and not employees) of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(x) pay-off and termination letters in form and substance reasonably acceptable to the Purchaser in connection with the
repayment and termination of the Fortitude Note and the Sullivan Note, (y) evidence of release of Liens related to the EIDL Loan
and (y) evidence that the Management Promissory Notes have been repaid;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ix)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>evidence satisfactory to the Purchaser with respect to the termination of all Related Party Contracts in accordance with
the terms of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a receipt duly executed by the Sellers evidencing the receipt of the Closing Consideration;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>evidence satisfactory to the Purchaser that each current and former employee and contractor of the Company involved in the
development of any product or Intellectual Property of the Company has signed a confidentiality, non-infringement and invention
assignment agreement in a form satisfactory to the Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT STYLE="background-color: white">evidence
satisfactory to the Purchaser </FONT>of either (i)&nbsp;a written consent executed by such number of eligible shareholders as
is required by the terms of Section&nbsp;280G(b)(5)(B) of the Code so as to render the parachute payment provisions of
Section 280G of the Code inapplicable to any and all accelerated vesting payments, benefits, options and/or stock provided
pursuant to agreements, <FONT STYLE="background-color: white">contracts</FONT>, Company Plans or arrangements that might
otherwise result, separately or in the aggregate, in the payment of any amount and/or the provision of any benefit that would
not be deductible by reason of Section 280G of the Code, with such shareholder approval or non-approval obtained in a manner
which satisfies all applicable requirements of Section 280G(b)(5)(B) of the Code and the Treasury Regulations thereunder,
including Q&amp;A-7 of Section 1.280G-1 of such Treasury Regulations or (ii) that no payments or benefits which could
reasonably be construed, individually or in combination with any other such payment, to constitute an &#8220;excess parachute
payment&#8221; (as defined in Section 280G(b)(1) of the Code) shall be paid or payable or provided to any &#8220;disqualified
individual&#8221; (as such term is defined in Treasury Regulations Section 1.280G-1);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xiii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>evidence satisfactory to the Purchaser of the termination of the Company&#8217;s obligations under that certain letter agreement,
dated August 20, 2020, by and between the Company and Cyndx Advisors LLC (d/b/a CDX Advisors), together with a full and final release
of claims against the Company with respect thereto; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xiv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>deliver, or caused to be delivered, to the Purchaser a duly executed copy of the License Termination and Confirmatory Assignment
Agreement by each of the Company and Fortitude.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At the Closing, the Purchaser shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>pay, or cause to be paid, by wire transfer of immediately available funds to the Sellers the Closing Consideration in the
amounts and to the accounts of the Sellers (or their designees) set forth on the funds flow memorandum attached hereto as <U>Schedule
I</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>pay, or cause to be paid, by wire transfer of immediately available funds to the Company for further distribution to each
Optionholder, the portion of the Closing Consideration payable with respect to Company Vested Options held by such Optionholder,
in the amounts set forth on the funds flow memorandum attached hereto as <U>Schedule I;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>deposit with the Escrow Agent the Adjustment Escrow Amount, which shall be held in a separate account (the &#8220;<U>Adjustment
Escrow Account</U>&#8221;) and shall be managed and paid out in accordance with and subject to the terms and conditions of this
Agreement and the Escrow Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>deposit with the Escrow Agent the Indemnity Escrow Amount, which shall be held in a separate account (the &#8220;<U>Indemnity
Escrow Account</U>&#8221;) and shall be managed and paid out in accordance with and subject to the terms and conditions of this
Agreement and the Escrow Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>repay, or cause to be repaid, by wire transfer of immediately available funds the Indebtedness in the amounts and to the
accounts set forth on the funds flow memorandum attached hereto as <U>Schedule I</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>pay, or cause to be paid, by wire transfer of immediately available funds the Transaction Expenses in the amounts and to
the accounts set forth on the funds flow memorandum attached hereto as <U>Schedule I</U>; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>deliver, or caused to be delivered, to the Sellers a counterpart of the Escrow Agreement duly executed by the Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section
2.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B><U>Purchase
Price</U>. The &#8220;<U>Closing Consideration</U>&#8221; shall consist of an amount in cash equal to (i) $50,000,000 (the
 &#8220;<U>Base Consideration</U>&#8221;), <U>plus</U> (ii) the Estimated Cash, (iii) <U>less </U>the Estimated Closing
Indebtedness, <U>plus</U> (iv) the amount, if any, by which the Estimated Net Working Capital exceeds the Target Net Working
Capital, <U>less</U> (v) the amount, if any, by which the Estimated Net Working Capital is less than the Target Net Working
Capital, <U>less</U> (vi) the Estimated Transaction Expenses, <U>less</U> (vii) the Escrow Amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 2.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Closing Calculations</U>. The Sellers&#8217; Representative has prepared and delivered to the Purchaser (a)&nbsp;an
estimated consolidated balance sheet of the Company as of the Closing Date (for the avoidance of doubt, before taking into account
the consummation of the transactions contemplated hereby) (the &#8220;<U>Closing Balance Sheet</U>&#8221;); (b)&nbsp;a statement
(the &#8220;<U>Estimated Closing Statement</U>&#8221;) setting forth a good faith calculation of the Sellers&#8217; estimate of
(i)&nbsp;Cash (the &#8220;<U>Estimated Cash</U>&#8221;), (ii)&nbsp;Closing Indebtedness (the &#8220;<U>Estimated Closing Indebtedness</U>&#8221;),
(iii)&nbsp;Net Working Capital (the &#8220;<U>Estimated Net Working Capital</U>&#8221;), and (iv)&nbsp;Transaction Expenses (&#8220;<U>Estimated
Transaction Expenses</U>&#8221;); and (c)&nbsp;the resulting calculation of the Closing Consideration. The Estimated Closing Statement
and the determinations contained therein shall be prepared in accordance with this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 2.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Final Consideration Calculation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Promptly following the Closing, but in any event no later than 90 days thereafter, the Purchaser shall prepare or cause
to be prepared and delivered to the Sellers&#8217; Representative a statement (the &#8220;<U>Closing Statement</U>&#8221;) setting
forth the Purchaser&#8217;s good faith calculation of Cash, Closing Indebtedness, Net Working Capital and Transaction Expenses
and the resulting calculation of the Final Consideration. The Closing Statement shall be prepared, and Cash, Closing Indebtedness,
Net Working Capital and Transaction Expenses shall be determined, in accordance with this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Closing Statement shall be accompanied by all relevant backup materials and schedules relating to the calculation of
Cash, Closing Indebtedness, Net Working Capital and Transaction Expenses, in reasonably acceptable detail. The Purchaser shall
make such information, personnel and resources available to the Sellers&#8217; Representative as may be reasonably necessary to
enable the Sellers&#8217; Representative to review the Closing Statement; <U>provided</U>, that the obligation of the Purchaser
to provide such information, personnel and resources shall be limited to normal business hours with reasonable prior notice and
in such a manner so as not to interfere unreasonably with the conduct of its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>In
the event that the Sellers&#8217; Representative disputes the calculation of Cash, Closing Indebtedness, Net Working Capital
or Transaction Expenses set forth in the Closing Statement, the Sellers&#8217; Representative shall notify the Purchaser in
writing (the &#8220;<U>Dispute Notice</U>&#8221;) of the amount, nature and basis of such dispute, within 30 days after
delivery of the Closing Statement. In the event of such a dispute, the Purchaser and the Sellers&#8217; Representative shall
first use their diligent good faith efforts to resolve such dispute among themselves. If the Purchaser and the Sellers&#8217;
Representative are unable to resolve the dispute within 30 days after delivery of the Dispute Notice, then any remaining
items in dispute shall be submitted to a nationally recognized accounting firm that has not provided services to either
Purchaser or the Company and is jointly chosen by the Purchaser and the Sellers&#8217; Representative (the &#8220;<U>Audit
Firm</U>&#8221;). If any dispute is submitted to the Audit Firm, then the Purchaser and the Sellers&#8217; Representative
shall (i) execute any agreement(s) required by the Audit Firm to accept its engagement in accordance with this <U>Section
2.6(c)</U>, (ii) furnish or caused to be furnished to the Audit Firm such work papers and other documents and information
relating to the disputed issues (including information of the Company) as the Audit Firm may reasonably request and are
available to such party, and (iii) be afforded the opportunity to present to the Audit Firm, with a copy to the other party,
material relevant to the Audit Firm&#8217;s determination. The Audit Firm shall review only those items that are in dispute
and shall not attribute a value to any disputed amount greater than the greatest amount proposed by either party nor an
amount less than the least amount proposed by either party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The written decision of the Audit Firm shall be rendered within no more than 60 days from the date that the matter is referred
to such firm and shall be final and binding on the parties hereto and, in the absence of fraud or manifest error, shall not be
subject to dispute or review. Following any such dispute resolution (whether by mutual agreement of the parties or by written decision
of the Audit Firm), the calculation of Cash, Closing Indebtedness, Net Working Capital and Transaction Expenses set forth in the
Closing Statement (as determined in such dispute resolution) shall be determined final. The costs and expenses of the Audit Firm
shall be allocated by the Audit Firm between the Purchaser, on the one hand, and the Sellers&#8217; Representative (for the account
of the Sellers), on the other hand, based upon the percentage that the portion of the contested amount not awarded to each party
bears to the amount actually contested by such party. For example, if the Sellers&#8217; Representative claims the Closing Consideration
is $1,000 greater than the amount determined by the Purchaser, and the Purchaser contests only $500 of the amount claimed by the
Sellers&#8217; Representative, and if the Audit Firm ultimately resolves the dispute by awarding the Sellers&#8217; Representative
(for the benefit of the Sellers) $300 of the $500 contested, then the costs and expenses of arbitration shall be allocated 60%
(<U>i.e.</U>, 300 &divide; 500) to the Purchaser and 40% (<U>i.e.</U>, 200 &divide; 500) to the Sellers&#8217; Representative (for
the account of the Sellers).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Immediately upon the expiration of the 30 day period for giving the Dispute Notice, if no such notice is given, or upon
the delivery of written notice by the Sellers&#8217; Representative to the Purchaser that no such notice will be given, the Purchaser&#8217;s
calculations set forth in the Closing Statement shall be final and binding on the parties hereto and shall not be subject to dispute,
appeal or review.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 2.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Post-Closing Adjustment Payment</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If the Final Consideration is greater than the Closing Consideration, promptly after the final determination of the Final
Consideration pursuant to <U>Section 2.6</U>, (i) the Purchaser shall pay to each Seller an amount in cash equal to such Seller&#8217;s
Pro Rata Surplus Share of such difference by wire transfer of immediately available funds to an account designated in writing by
such Seller, and (ii) the Purchaser and the Sellers&#8217; Representative shall deliver a joint written instruction to the Escrow
Agent to pay to each Seller such Seller&#8217;s Pro Rata Indemnification Share of the funds in the Adjustment Escrow Account by
wire transfer of immediately available funds to an account designated in writing by such Seller.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>If
the Final Consideration is less than the Closing Consideration, promptly after the final determination of the Final
Consideration pursuant to <U>Section 2.6</U>, the Purchaser and the Sellers&#8217; Representative shall deliver a joint
written instruction to the Escrow Agent to pay to the Purchaser the absolute value of such difference (the
 &#8220;<U>Shortfall Amount</U>&#8221;) by wire transfer of immediately available funds from the funds in the Adjustment
Escrow Account to an account designated in writing by the Purchaser. In the event that the funds available in the Adjustment
Escrow Account are in excess of the Shortfall Amount (such excess, the &#8220;<U>Escrow Excess Amount</U>&#8221;), the
Purchaser and the Sellers&#8217; Representative shall, simultaneously with the delivery of the instruction described in the
first sentence of this <U>Section&nbsp;2.7(b),</U> deliver a joint written instruction to the Escrow Agent to pay to each
Seller such Seller&#8217;s Pro Rata Indemnification Share of the Escrow Excess Amount by wire transfer of immediately
available funds to an account designated in writing by such Seller. In the event that the funds available in the Adjustment
Escrow Account are less than the Shortfall Amount (such deficit, the &#8220;<U>Escrow Shortfall Amount</U>&#8221;), the
Purchaser may choose, in its sole discretion, either (i) for the Purchaser and the Sellers&#8217; Representative to,
simultaneously with the delivery of the instruction described in the first sentence of this <U>Section&nbsp;2.7(b)</U>,
deliver a joint written instruction to the Escrow Agent to pay to the Purchaser the Escrow Shortfall Amount by wire transfer
of immediately available funds from the Indemnity Escrow Account to an account designated in writing by the Purchaser, or
(ii) for the Sellers to, within five (5) Business Days of the final determination of the Final Consideration pursuant to <U>Section
2.6</U>, pay to the Purchaser an amount in cash equal to the Escrow Shortfall Amount by wire transfer of immediately
available funds to an account designated in writing by the Purchaser. In the case of clause (ii) of the previous sentence,
the Sellers shall be severally liable in accordance with their respective Pro Rata Indemnification Share of such Escrow
Shortfall Amount to the Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 2.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Escrow Amounts</U>. The funds in the Adjustment Escrow Account shall be available to satisfy any amounts payable
to the Purchaser and the Sellers pursuant to <U>Sections 2.7(a)</U> and <U>2.7(b)</U>, and the funds in the Indemnity Escrow Account
shall be available to satisfy any amounts payable by the Sellers to the Purchaser pursuant to <U>Section 2.7(b)</U> and to satisfy
any Losses for which indemnification is provided by the Sellers in accordance with and subject to the terms and conditions of <U>Article
V</U>. The Escrow Agent shall be directed to hold the funds in the Adjustment Escrow Account and the Indemnity Escrow Account as
security for any such obligations pursuant to the terms and conditions of the Escrow Agreement. On or promptly after the Expiration
Date, the Purchaser and the Sellers&#8217; Representative shall deliver a joint written instruction to the Escrow Agent to pay
to each Seller by wire transfer of immediately available funds, to an account designated in writing by such Seller, such Seller&#8217;s
Pro Rata Indemnification Share of the funds remaining in the Indemnity Escrow Account (if any), <U>less</U> any portion thereof
that is subject to a pending claim pursuant to <U>Article V</U>. Upon final resolution of any such unresolved claim in respect
of which amounts had been retained (to the extent not utilized to satisfy such unresolved claims), the Purchaser and the Sellers&#8217;
Representative shall deliver a joint written instruction to the Escrow Agent to pay such retained amounts to each Seller based
on such Seller&#8217;s Pro Rata Indemnification Share in accordance with the preceding sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 2.9<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Withholding Taxes</U>. The Purchaser shall be entitled to deduct and withhold from the consideration otherwise payable
to the Sellers pursuant to this Agreement such amounts required to be deducted and withheld in accordance with applicable Law with
respect to Taxes, which amounts shall be promptly paid over to the appropriate Taxing authority. To the extent that amounts are
so withheld, such withheld amounts shall be treated for all purposes of this Agreement as having been paid to the Sellers in respect
of which such deduction and withholding was made by the Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 2.10<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Rights Not Transferable</U>. The rights of the Sellers hereunder are personal in nature and, except with the written
consent of Purchaser, are non-transferable and non-assignable, except that each securityholder shall be entitled to assign such
securityholder&#8217;s rights by will, by the laws of intestacy or by other similar operation of law. Any attempted transfer of
such right by any holder thereof (otherwise than as permitted by the immediately preceding sentence) shall be null and void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 2.11<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Company Options</U>. At or immediately prior to the Closing Date, each Company Option outstanding immediately prior
to the Closing Date, whether vested or unvested, will be automatically cancelled and the Purchaser will pay or cause the Company
to pay to each Optionholder (a) on the next regularly scheduled payroll payment date occurring at least three (3) Business Days
following the Closing Date the amount in cash, without interest (subject to any applicable withholding pursuant to <U>Section&nbsp;2.9</U>),
equal to the amount set forth on the funds flow memorandum attached hereto as <U>Schedule&nbsp;I</U> and (b) such Optionholder&#8217;s
Pro Rata Earn-Out Portion of the Initial Earn-Out Amount and the Subsequent Earn-Out Amount, if any, set forth opposite such Optionholder&#8217;s
name on the funds flow memorandum attached hereto as <U>Schedule&nbsp;I</U>, in accordance with <U>Section 2.12</U>. At or immediately
prior to the Closing Date, the Company shall take all actions necessary to: (i) cause each Company Option to be treated in accordance
with this <U>Section 2.11</U>, (ii) terminate the Company Equity Plan as of the Closing Date and (iii) ensure that, after the Closing
Date, neither the Purchaser, any of its Affiliates or the Company will be required to deliver Company Common Stock or other Equity
Interests of the Purchaser or the Company to any Person pursuant to or in settlement of Company Options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 2.12<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Earn-Out</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>If
Qualified Revenue from the period beginning on January 1, 2021 and ending on January 31, 2022 (the &#8220;<U>Initial Earn-Out
Period</U>&#8221;) is greater than or equal to $9,000,001, the Purchaser shall pay, or cause to be paid, to the Sellers (or
their designees) and the Optionholders, in accordance with their respective Pro Rata Earn-Out Portions, an amount as set
forth under &#8220;Earnout Amount Payable&#8221; corresponding to the Initial Earn-Out Period on <U>Schedule II</U> in cash
by wire transfer of immediately available funds to one or more accounts designated in writing by the Sellers&#8217;
Representative to the Purchaser, up to an aggregate amount of $5,000,000 (the &#8220;<U>Initial Earn-Out Amount</U>&#8221;).
If Qualified Revenue during the period beginning on February 1, 2022 and ending on January 31, 2023 (the &#8220;<U>Subsequent
Earn-Out Period</U>&#8221;) is greater than or equal to $15,000,001, the Purchaser shall pay, or cause to be paid, to the
Sellers (or their designees) and the Optionholders, in accordance with their respective Pro Rata Earn-Out Portions an amount
as set forth under &#8220;Earnout Amount Payable&#8221; corresponding to the Subsequent Earn-Out Period on <U>Schedule II</U>
in cash by wire transfer of immediately available funds to one or more accounts designated in writing by the Sellers&#8217;
Representative to the Purchaser up to an aggregate amount of $15,000,000 (the &#8220;<U>Subsequent Earn-Out Amount</U>&#8221;
and together with the Initial Earn-Out Amount, the &#8220;<U>Earn-Out Amount</U>&#8221;). If (i) Qualified Revenue during the
Initial Earn-Out Period was greater than or equal to $9,000,001, but less than $11,000,001, and (ii) Qualified Revenue during
the Subsequent Earn-Out Period is greater than or equal to $15,000,001, the Purchaser shall pay, or cause to be paid,
simultaneously with the payment of the Subsequent Earn-Out Amount, to the Sellers (or their designees) and the Optionholders,
in accordance with their respective Pro Rata Earn-Out Portions, an amount in cash equal to $5,000,000 <I>less</I> the Pro
Rata Earn-Out Portion of the Initial Earn-Out Amount (as defined on <U>Schedule II</U>) actually paid to the Sellers (or
their designees) and the Optionholders in accordance with <U>Schedule II</U> by wire transfer of immediately available funds
to one or more accounts designated in writing by the Sellers&#8217; Representative to the Purchaser. In the event that the
Purchaser is obligated to pay the Earn-Out Amount pursuant to this <U>Section 2.12(a)</U>, such payment shall be made in
accordance with <U>Section 2.12(f) </U>and <U>Section 2.12(g)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Sellers acknowledge that upon and following the Closing (i) there is no assurance that the Sellers will be issued the
Earn-Out Amount, and the Purchaser has not promised or projected any payment of the Earn-Out Amount, (ii) the Purchaser does not
owe any fiduciary or other similar duty to the Sellers with respect to the achievement of the Qualified Revenue set forth in this
<U>Section 2.12</U> or the payment of the Earn-Out Amount, and (iii) the Purchaser and the Sellers solely intend the express provisions
of this Agreement to govern their contractual relationship.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Following the Closing and until expiration of the Subsequent Earn-Out Period, the Purchaser shall and shall cause its Affiliates
to use commercially reasonable efforts to achieve the maximum Earn-Out Amounts set forth on <U>Schedule II</U>, including but not
limited to providing the Company with reasonable working capital resources to execute any operational mandates placed on the Company
by the Purchaser or its Affiliates not directly related to generating Qualified Revenue, and not intentionally take any action
with the primary purpose of avoiding or reducing Qualified Revenue or preventing the Company from satisfying the Earn-Out Amount
targets set forth on <U>Schedule II</U>. Notwithstanding the foregoing, the Purchaser and its Affiliates shall be permitted to
cause the Company (i) to wind-down and cease to offer the Company&#8217;s pre-tax commuter benefit product and (ii) to implement
enhanced security and privacy measures, and in no event shall any acts (or omissions) in respect thereof be deemed to constitute
a breach of the Purchaser&#8217;s and its Affiliates obligations under this <U>Section 2.12(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Upon the occurrence of a Corporate Transaction prior to expiration of the Subsequent Earn-Out Period or breach by Purchaser
of any covenant set forth in <U>Section 2.12(c)</U> or <U>Section 2.12(d)</U> (each, a &#8220;<U>Triggering Event</U>&#8221;),
the Purchaser shall pay, or cause to be paid, to the Sellers (or their designees) and the Optionholders, in accordance with their
respective Pro Rata Earn-Out Portions, an amount in cash equal to (i) if the Triggering Event occurs prior to expiration of the
Initial Earn-Out Period, $20,000,000, (ii) if the Triggering Event occurs after expiration of the Initial Earn-Out Period but prior
to expiration of the Subsequent Earn-Out Period and Qualified Revenue during the Initial Earn-Out Period was less than or equal
to $9,000,000, $15,000,000 or (iii) if the Triggering Event occurs after expiration of the Initial Earn-Out Period but prior to
expiration of the Subsequent Earn-Out Period and Qualified Revenue during the Initial Earn-Out Period was greater than or equal
to $9,000,001, $20,000,000 <I>less</I> the Pro Rata Earn-Out Portion of the Initial Earn-Out Amount (as defined on <U>Schedule
II</U>) actually paid to the Sellers (or their designees) and the Optionholders in accordance with <U>Schedule II</U>, in each
case by wire transfer of immediately available funds to one or more accounts designated in writing by the Sellers&#8217; Representative
to the Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>The
Purchaser shall deliver to the Sellers&#8217; Representative a written statement setting forth the Qualified Revenue for the
Initial Earn-Out Period and the resulting Initial Earn-Out Amount, if any, due to the Sellers, at least ten (10) Business
Days prior to February 28, 2022, including (i) an income statement of the Company for the Initial Earn-Out Period prepared in
accordance with GAAP applied on a basis consistent with the Company&#8217;s historical accounting practices and methodology,
(ii) reasonably detailed documentation and workpapers supporting the calculation of each component of the Qualified Revenue
for the Initial Earn-Out Period and the resulting Initial Earn-Out Amount and (iii) a quarterly calculation of Qualified
Revenue within thirty (30) days following the end of each fiscal quarter during the Initial Earn-Out Period. The
Sellers&#8217; Representative shall have twenty (20) Business Days following receipt of such statement to object to any
information, figure, data or calculation therein, and if the Sellers&#8217; Representative does not so object, the statement
prepared by the Purchaser shall be considered final, valid and binding for the Initial Earn-Out Period, and the Initial
Earn-Out Amount will be payable to the Sellers on February 28, 2022. If the Sellers&#8217; Representative objects in writing
prior to the end of such twenty (20) Business Days period, the Purchaser and the Sellers&#8217; Representative shall work in
good faith to resolve such objections. If the Purchaser and the Sellers&#8217; Representative cannot resolve such objections
after 30 calendar days of attempting to do so, such parties shall engage the Audit Firm to settle the dispute, the timing and
procedures of which shall mirror as closely as possible those set forth in <U>Section 2.6</U>, <I>mutatis mutandis</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Purchaser shall deliver to the Sellers&#8217; Representative a written statement setting forth the Qualified Revenue
for the Subsequent Earn-Out Period and the resulting Subsequent Earn-Out Amount, if any, due to the Sellers, at least ten (10)
Business Days prior to February 28, 2023, including (i) an income statement of the Company for the Subsequent Earn-Out Period prepared
in accordance with GAAP applied on a basis consistent with the Company&#8217;s historical accounting practices and methodology,
(ii) reasonably detailed documentation and workpapers supporting the calculation of each component of the Qualified Revenue for
the Subsequent Earn-Out Period and the resulting Subsequent Earn-Out Amount and (iii) a quarterly calculation of Qualified Revenue
within thirty (30) days following the end of each fiscal quarter during the Subsequent Earn-Out Period. The Sellers&#8217; Representative
shall have twenty (20) Business Days following receipt of such statement to object to any information, figure, data or calculation
therein, and if the Sellers&#8217; Representative does not so object, the statement prepared by the Purchaser shall be considered
final, valid and binding for the Subsequent Earn-Out Period, and the Subsequent Earn-Out Amount will be payable to the Sellers
on February 28, 2023. If the Sellers&#8217; Representative objects in writing prior to the end of such twenty (20) Business Days
period, the Purchaser and the Sellers&#8217; Representative shall work in good faith to resolve such objections. If the Purchaser
and the Sellers&#8217; Representative cannot resolve such objections after 30 calendar days of attempting to do so, such parties
shall engage the Audit Firm to settle the dispute, the timing and procedures of which shall mirror as closely as possible those
set forth in <U>Section 2.6</U>, <I>mutatis mutandis</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">Article
III</FONT><FONT STYLE="color: red"><BR>
</FONT>REPRESENTATIONS AND WARRANTIES OF THE SELLERS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as set forth
in the section of the Disclosure Schedules that specifically relates to such section of this <U>Article III</U>, the Sellers represent
and warrant to the Purchaser as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section
3.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B><U>Organization;
Good Standing; Qualification and Power</U>. The Company is duly formed and validly existing under the Laws of the State of
Washington, has all requisite power and authority to own, lease and operate its properties and Assets and to carry on its
business as presently being conducted and as contemplated to be conducted, and is qualified to do business and in good
standing in every jurisdiction in which the operation of the business of the Company requires it to be so qualified, except
where the failure to be so qualified or in good standing would not have a Material Adverse Effect. The Fundamental Documents
of the Company, true and complete copies of which have been delivered to the Purchaser, are in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Authorization</U>. Each Seller has the requisite power and authority to enter into this Agreement and to consummate
the transactions contemplated hereby. The execution and delivery of this Agreement and the consummation of the transactions contemplated
hereby by each Seller has been duly authorized by all necessary action on the part of such Seller. This Agreement has been duly
executed and delivered by each Seller and, assuming this Agreement constitutes the valid and binding obligation of the Purchaser,
constitutes the valid and binding obligation of each Seller, enforceable against each Seller in accordance with its terms, except
as such enforcement is limited by bankruptcy, insolvency and other similar laws affecting the enforcement of creditors&#8217; rights
generally and for limitations imposed by general principles of equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Title</U>. Each Seller (a) has good and valid title to such Seller&#8217;s Shares and at the Closing will transfer
to the Purchaser good and valid title to the Shares, free and clear of any Liens or limitations or restrictions of any nature whatsoever,
except for restrictions on transfer imposed under applicable securities laws, and (b) is the sole record and beneficial owner of
the Shares set forth opposite such Seller&#8217;s name on <U>Schedule I</U> hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Non-contravention</U>. The execution, delivery and performance of this Agreement by each Seller and the consummation
of the transactions contemplated hereby and compliance with the provisions hereof do not and will not (a) violate any Law to which
the Sellers, the Company or any of their respective Assets are subject; (b) violate any provision of the Fundamental Documents
of the Company; (c) violate, conflict with, result in a breach of, constitute (with due notice or lapse of time or both) a default
under, result in the acceleration of, create in any Person the right to accelerate, terminate, modify or cancel, require any notice
under, or otherwise give rise to any Liability under, any Contract to which any Seller or the Company is a party or by which any
of them is bound or to which any of their respective properties or Assets is subject; or (d) result in the creation or imposition
of any Lien upon any of the properties or Assets of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Consents and Approvals</U>. <U>Schedule 3.5</U> sets forth a true and complete list of each consent, waiver, authorization
or approval of any Governmental Entity or any other Person, and each declaration to or notice or filing or registration with any
such Governmental Entity or Person, that is required of or to be made by the Company or any Seller in connection with the execution
and delivery of this Agreement by any of them or the performance by any of them of their respective obligations hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Capitalization of the Company</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></FONT>The
authorized capital stock of the Company consists of (i) 15,000,000 shares of Company Common Stock, of which 7,424,890 shares
are issued and outstanding and 243,500 shares have been reserved for issuance upon the exercise of outstanding Company
Options, (ii) 10,000,000 shares of Company Limited Common Stock, of which no shares are issued and outstanding, and (iii)
5,891,909 shares of Company Preferred Stock, 5,000,000 shares of which are designated Series Seed Preferred Stock, all of
which are issued and outstanding, 891,906 shares of which are designated Series Seed-1 Preferred Stock, all of which are
issued and outstanding, 1 share of which is designated Series JP-1 Preferred Stock, which is issued and outstanding, 1 share
of which is designated Series JP-2 Preferred Stock, which is issued and outstanding and 1 share of which is designated Series
JP-3 Preferred Stock, which is issued and outstanding. As of the Agreement Date, the Company Capital Stock is held by the
Persons with the domicile addresses and in the amounts set forth on <U>Schedule 3.6(a)</U> which further sets forth for each
such Person the number, class, and series of shares held by such Person, the issue date and original purchase price of such
shares, the identifier of the applicable Company stock certificate or Company book-entry number(s) representing such shares.
All outstanding shares of Company Capital Stock are duly authorized, validly issued, fully paid and non&#45;assessable and
are not subject to preemptive rights created by statute, the Fundamental Documents, or any Contract to which the Company is a
party or by which it is bound. There are no, and there have never been, any outstanding shares of Company Capital Stock that
constitute restricted stock or that are otherwise subject to a repurchase or redemption right. There are no declared or
accrued but unpaid dividends with respect to any shares of Company Capital Stock. Except as set forth in this <U>Section
3.6(a)</U>, the Company has no other capital stock authorized, issued or outstanding. No Person holds any issued and
outstanding shares of Company Capital Stock other than the Sellers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>All outstanding shares of Company Capital Stock have been issued in compliance with all Laws, and were issued and
transferred in accordance with any right of first refusal or similar right or limitation, including those in the Fundamental Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Except for the Company Equity Plan, the Company has never adopted, sponsored or maintained any stock option plan
or any other plan or Contract providing for equity compensation to any Person (whether payable in shares, cash or otherwise). Except
for the Company Options set forth in Schedule 3.6(e), there are currently no, and at the Closing there shall not be any, options,
warrants, calls, rights, convertible securities, commitments or agreements of any character, written or oral, to which the Company
is a party or by which the Company is bound obligating the Company to issue, deliver, sell, repurchase or redeem, or cause to be
issued, delivered, sold, repurchased or redeemed, any Company Shares or obligating the Company to grant, extend, accelerate the
vesting of, change the price of, otherwise amend or enter into any such option, warrant, call, right, commitment or agreement.
Except as set forth in <U>Section 3.6(a)</U>, the Company has never granted or issued any options or warrants to purchase Shares,
stock appreciation, phantom stock, profit participation, profit interest, restricted stock, restricted stock units or other similar
rights with respect to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Except as contemplated hereby, there are no voting trusts, proxies, or other Contracts with respect to the voting
stock of the Company. There are no agreements to which the Company is a party relating to the registration, sale or transfer (including
agreements relating to rights of first refusal, co-sale rights or &#8220;drag along&#8221; rights) of any Company Capital Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></FONT><U>Schedule&nbsp;3.6(e)</U>
sets forth a true and complete list of each current or former employee, officer, director, consultant or other service
provider of the Seller Group Companies who holds a Company Option, which schedule shows for each Company Option the date such
Company Option was granted, the expiration date, the number of shares of Company Common Stock subject to the Company Option,
the applicable exercise price, and the applicable vesting schedule (and the terms of any acceleration rights thereof),
whether such Company Option includes an &#8220;early exercise feature,&#8221; the Tax status of each Company Option under
Section 422 of the Code, for each holder who is not a current employee of the Seller Group Companies, whether such Person has
ever been an employee of the Seller Group Companies and the holder&#8217;s state of residence or, for any holder who is not a
resident of the United States, country of residence. With respect to each Company Option listed on <U>Schedule&nbsp;3.6(e)</U>,
(i)&nbsp;each grant of a Company Option was duly authorized no later than the date on which the grant of such Company Option
was by its terms effective (the &#8220;<U>Grant Date</U>&#8221;) by all necessary corporate action, including, as applicable,
approval by the board of directors of the Company or a committee thereof, or a duly authorized delegate thereof, and any
required approval by the shareholders of the Company by the necessary number of votes or written consents, and the award
agreement governing such grant, if any, was duly executed and delivered by each party thereto within a reasonable time
following the Grant Date, (ii)&nbsp;each Company Option was granted in compliance in all material respects with all
applicable Laws (including all applicable federal, state and local securities Laws) and all of the terms and conditions of
the Company Equity Plan and has an exercise price that is equal or greater than the fair market value of the underlying
shares of Company Common Stock on the applicable Grant Date, (iii) each such grant was properly accounted for in all material
respects in accordance with GAAP in the financial statements (including the related notes) of the Company in accordance with
the Exchange Act and all other applicable Laws, and (iv)&nbsp;no modifications have been made to any Company Options
following the Grant Date. <U>Section&nbsp;3.6(e)</U> of the Disclosure Schedule sets forth each employee or other Person with
an offer letter or other contract or Company Plans that contemplates a grant of, or right to purchase or receive:
(i)&nbsp;options or other equity awards with respect to the equity of the Company (or other Seller Group Company) or
(ii)&nbsp;other securities of the Company, that in each case, have not been issued or granted as of the date of this
Agreement, together with the number of such options, other equity awards or other equity securities and any promised terms
thereof. The treatment of Company Options under this Agreement, complies in all respects with applicable Law and with the
terms and conditions of the Company Equity Plan and the applicable Company Option agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No bonds, debentures, notes or other Indebtedness of the Company or any of its subsidiaries (i)&nbsp;having the right to
vote on any matters on which stockholders may vote (or which is convertible into, or exchangeable for, securities having such right)
or (ii)&nbsp;the value of which is in any way based upon or derived from capital or voting stock of the Company, are issued or
outstanding as of the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The allocation of the Closing Consideration, the Earn-Out Amount and all other amounts payable to the Sellers hereunder
as set forth in this Agreement, including <U>Schedule I</U> hereto, is consistent with, and does not violate any of the Fundamental
Documents, as amended as of immediately prior to the Closing, the Company Equity Plan, or any Contract applicable to any Company
Securities or Indebtedness of the Company or any of its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>No event has occurred, and no circumstance or condition exists, that has resulted in, or that will or would reasonably
be expected to result in any liability of the Company&nbsp;to any current, former or alleged holder of securities of the Company&nbsp;in
such Person&#8217;s capacity (or alleged capacity) as a holder of such securities, whether related to the Purchase or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<!-- Field: Split-Segment; Name: a4 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT> The information contained in <U>Schedule I</U> is true, correct and complete as of immediately prior to the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Subsidiaries; Equity Investments</U>. The Company does not directly or indirectly own or control, or hold any rights
to acquire, any shares of capital stock or any other securities or interests in any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Bankruptcy, Etc</U>. The Company is not involved in any Proceeding by or against it as a debtor before any Governmental
Entity under title 11 of the United States Bankruptcy Code or any other insolvency or debtors&#8217; relief act or Law or for the
appointment of a trustee, receiver, liquidator, assignee, sequestrator or other similar official for any part of the Assets of
the Company. The Company is not, and after giving effect to the consummation of the transactions contemplated at the Closing, will
not be &#8220;insolvent&#8221; within the meaning of Section 101(32) of title 11 of the United States Bankruptcy Code or any applicable
state fraudulent conveyance or transfer Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.9<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Financial Statements</U>. The Sellers have delivered to the Purchaser true and complete copies of, (a) the unaudited
balance sheet of the Company as of December 31, 2019 (the &#8220;<U>2019 Balance Sheet</U>&#8221;) and the related statements of
operations, changes in members&#8217; equity and cash flows for the fiscal year ended December 31, 2019 (collectively, the &#8220;<U>Annual
Financial Statements</U>&#8221;) and (b) the unaudited balance sheet of the Company as of December 31, 2020 (the &#8220;<U>Interim
Balance Sheet</U>&#8221;) and the related statements of operations, changes in members&#8217; equity and cash flows for the twelve-month
period ended December 31, 2020 (collectively, the &#8220;<U>Interim Financial Statements</U>,&#8221; and together with the Annual
Financial Statements and the Closing Balance Sheet, the &#8220;<U>Financial Statements</U>&#8221;). The Financial Statements (i)
have been prepared based on the books and records of the Company (which are true and correct in all respects), (ii) present fairly,
in all respects, the financial position, results of operations and changes in cash flow of the Company as of such dates and for
the periods then ended (subject to the absence of footnotes and normal year-end adjustments consistent with prior periods), and
(iii) have been prepared in accordance with GAAP consistently applied throughout the periods covered thereby. Since December 31,
2020 (the &#8220;<U>Balance Sheet Date</U>&#8221;), except as required by applicable Law or GAAP, there has been no change in any
accounting principle, procedure or practice followed by the Company or in the method of applying any such principle, procedure
or practice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.10<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Liabilities</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company does not have any Liability, including any Tax Liability due and payable, which is not reflected on the
Closing Balance Sheet or that would be required to be reflected or reserved against on a balance sheet prepared in accordance with
GAAP. Except as set forth on the Closing Balance Sheet, the Company is not, directly or indirectly, liable upon or with respect
to (by discount, repurchase or otherwise), or obligated in any way to provide funds in respect of, or to guarantee or assume, as
debt, any obligation or dividend of any Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company has no outstanding Indebtedness as of the date hereof. There are no outstanding loans or Indebtedness
involving, on the one hand, the Company and on the other hand, any of the Sellers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT> Each of the certifications, representations and disclosures made by the Company and its representatives in connection
with its application for receipt and subsequent application for forgiveness of the PPP Loan were true and correct and the Company
qualified and properly applied for the PPP Loan in accordance with the terms of the Small Business Act and the CARES Act. There
has not been, and following the date hereof there will not be, a reasonable ground for any Governmental Entity to require the Company
to repay the PPP Loan. The PPP Loan has been fully forgiven and the Company does not have any continuing Liability in respect thereof.
Other than the PPP Loan, the Company has not participated in any COVID-19-related programs (including the federal Paycheck Protection
Program) or sought benefits or relief thereunder or under any other COVID-19-related Laws or Orders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>The Company complied in all respects with, and satisfies all of the criteria for, the PPP Loan set forth in the Small
Business Act (including, without limitation, Section 7(a) of the Small Business Act) and the CARES Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.11<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Internal Accounting Controls</U>. The Company has established a system of internal accounting controls sufficient
to provide reasonable assurance that: (a) transactions are executed in accordance with management&#8217;s general or specific authorizations;
(b) transactions are recorded as necessary to permit preparation of financial statements in conformity with the Company&#8217;s
historical practices and to maintain asset accountability; (c) access to assets is permitted only in accordance with management&#8217;s
general or specific authorization; and (d) the recorded accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.12<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Accounts Receivable</U>. All notes and accounts receivable arising out of or relating to the business of the Company
have been included on the Closing Balance Sheet. All notes and accounts receivable payable to or for the benefit of the Company
reflected on the Closing Balance Sheet are (or will be) current and collectible in amounts not less than the aggregate amount thereof
(net of reserves established in accordance with GAAP applied consistently with prior practice) carried (or to be carried) on the
books of the Company, none of such notes or accounts receivable is past due more than 90 days and there is no contest, claim, defense
or right of setoff with any account debtor of an accounts receivable relating to the amount or validity of such accounts receivable.
The Company does not advance premiums or other monies to customers nor does it have any Contracts with customers pursuant to which
the Company is obligated to provide services to the customer without charge to the customer or at a discount to the customer, whether
as a result of the time period the Company has provided services to the customer, as a result of the volume of products or services
provided to the customer or otherwise. The Company has not offered any material rebates to any of its customers which would be
redeemed or used by any such customer at any time after the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.13<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Certain Business Practices</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each of the Company and its Affiliates is, and at all times has been, in compliance with all applicable domestic and international
anti-bribery laws, rules, and regulations, including the U.S. Foreign Corrupt Practices Act of 1977, as amended, and all other
applicable anti-bribery and anti-corruption laws of those jurisdictions in which it does business (collectively, &#8220;<U>Anti-Corruption
Laws</U>&#8221;). Neither the Company nor any of its Affiliates nor any of their respective directors, managers, officers, employees,
stockholders, members or agents or, to the Sellers&#8217; Knowledge, other Persons acting or purporting to act on their behalf,
has:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>offered, promised, paid, given, authorized or approved the payment or giving of any money, gift or other thing of value,
directly or indirectly, to or for the benefit of any employee, official, representative, or other person acting on behalf of any
government or department, agency or instrumentality thereof (including any public college or university, and any commercial entity
owned or controlled by a government), or of any public international organization, or any political party or official thereof,
or candidate for political office (collectively, &#8220;Government Officials&#8221;), for the purpose of: (x) influencing any act
or decision of such Government Official in his, her, or its official capacity; or (y) inducing such Government Official to do,
or omit to do, an act in violation of the lawful duty of such Government Official, or (z) securing any improper advantage; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>acted or attempted to act in any manner which would subject the Company or any of its Affiliates to liability under any
Anti-Corruption Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>There are, and have been, no allegations, investigations, inquiries, actions or proceedings with regard to a potential violation
of any Anti-Corruption Law by the Company or any of its Affiliates or any of their respective current or former directors, managers,
officers, employees, stockholders, members or agents, or, to the Sellers&#8217; Knowledge, other Persons acting or purporting to
act on their behalf.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company has conducted its business in all material respects in accordance with applicable provisions of the United States&#8217;
economic sanctions and export control laws and regulations, including the Arms Export Control Act, the International Traffic in
Arms Regulations, the Export Administration Act, the International Emergency Economic Powers Act, the Trading with the Enemy Act,
the Export Administration Regulations, and regulations administered by the Office of Foreign Assets Control (31 CFR Part V), and
other applicable export laws of the countries where it conducts business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Without limiting the foregoing:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Company has obtained all export licenses, registrations, approvals and other authorizations required for its exports
of products, software and technology from the United States and reexports of products, software and technology subject to the laws
of the United States;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Company is and at all times has been in compliance with the terms of such applicable export licenses, registrations,
approvals and other authorizations;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Company has not received any written communication alleging that it is not or may not be in compliance with, or has,
or may have any, Liability under, any such applicable export licenses, registrations, approvals and other authorizations&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> there are no pending or, to the Sellers&#8217; Knowledge, threatened Proceedings against or involving the Company with
respect to such export licenses, registrations, approvals and other authorizations&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>there are no actions, conditions or circumstances pertaining to the Company&#8217;s export transactions that would reasonably
be expected to give rise to any material future claims involving a Governmental Entity; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Company is not subject to United States trade sanctions and has not participated directly or indirectly in any transaction
that involves any commodity, software, technical data, products or services with a Person that is (i) located in, organized under
the laws of, or the government of a country that is subject to comprehensive United States trade sanctions (currently Cuba, Iran,
North Korea, Sudan, and Syria), or owned or controlled by any such Person, or (ii) denied United States&nbsp;export privileges
or otherwise specially designated or debarred by the government of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section
3.14<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B><U>Absence
of Certain Developments</U>. Since the Balance Sheet Date, the Company has operated in all material respects in the ordinary
course of business consistent with past practice, and there has been no: (a) event, circumstance or condition, which has had,
or would reasonably be expected to have, a Material Adverse Effect; (b) declaration, setting aside or payment of any dividend
or other redemption or distribution with respect to the shares of the Company; (c) issuance of shares or options, warrants or
rights to acquire shares of the Company; (d) loss, destruction or damage in excess of $50,000 to any Asset of the Company,
whether or not insured; (e) incurrence, guarantee, assumption, acceleration or prepayment of any Indebtedness or the
refunding of any such Indebtedness by the Company; (f) entered into any employment contract or collective bargaining
agreement, written or oral, or modified the terms of any such contract or agreement; (g) granted any increase in the base
compensation of any of its directors, officers, or employees outside the ordinary course of business; (h) adopted, amended,
modified, or terminated any bonus, profit sharing, incentive, severance, or other plan, contract, or commitment for the
benefit of any of its directors, officers, or employees (or taken any such action with respect to any other benefit plan);
(i) made any other change in employment terms for any of its directors, officers, or employees outside the ordinary course of
business; (j) waiver of any right of the Company with a value in excess of $50,000, or settlement or release of any
Proceeding or Claim; (k) loan, advance or extension of credit by the Company, except for advances for reimbursable travel
expenses made in the ordinary course of business consistent with past practice, or capital contribution to or investment in
any Person by the Company; (l) acquisition, disposition, lease, license or transfer of any Asset of the Company involving
more than $50,000 (or any Contract therefor), or any other material transaction by the Company other than for fair value and
in the ordinary course of business consistent with past practice; (m) material capital expenditure outside of the ordinary
course of business consistent with past practice; (n) (i) sale, license, sublicense, assignment, abandonment, allowance to
lapse, dedication to the public domain, pledge, encumber, disposal of or transfer of any Owned Intellectual Property, other
than non-exclusive licenses granted in the ordinary course of business consistent with past practice, or (ii) disclosure of
any trade secrets or proprietary Source Code to a third party, other than pursuant to a valid and binding confidentiality
agreement or other binding obligation of confidentiality the Company entered into in the ordinary course of business
consistent with past practice; (o) Lien created by the Company, with respect to any of its properties or Assets, except for
Permitted Liens; (p) acceleration, termination, modification or cancellation of any Contract (or series of related Contracts)
involving more than $50,000 to which the Company is a party or by which the Company is bound and, to the Knowledge of the
Sellers, no Person has notified the Company that it intends to take any such action; (q) change in accounting methods,
principles or practices used in preparing the Financial Statements or to the working capital policies applicable to the
Company, except as required by GAAP; (r) material write-down or write-up of the value of any Asset of the Company, or
write-off of any accounts receivable or notes receivable or any portion thereof; or (s) commitment on behalf of the Company
to do any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.15<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Compliance with Law</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i) The Company has not been in, is not in, and does not have any Liability in respect of any, violation of any Laws or
Orders, (ii) no event has occurred or circumstance exists that (with or without notice or lapse of time) would constitute or result
in a violation by the Company of, or failure on the part of the Company to comply with in any material respect, any Laws or Orders
and (iii) the Company has not had and does not have any Liability suffered or incurred as a result of any violation of or noncompliance
with any Laws or Orders, in each case that are or were applicable to it or the conduct or operation of its business or the ownership
or use of any of its Assets, and no Proceeding is pending or, to the Knowledge of the Sellers, threatened against the Company,
alleging any such violation or noncompliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company has all Permits necessary for the conduct of its business as presently conducted and as currently contemplated
to be conducted, and (i) each of the Permits is in full force and effect; (ii) the Company is in material compliance with the terms,
provisions and conditions thereof; (iii) there are no outstanding violations, notices of noncompliance, Orders or Proceedings adversely
affecting any of the Permits; and (iv) no condition (including the execution of this Agreement and the consummation of the transactions
contemplated hereby) exists and no event has occurred which (whether with or without notice, lapse of time or the occurrence of
any other event) would reasonably be expected to result in the suspension or revocation of any of the Permits other than by expiration
of the term set forth therein. <U>Schedule 3.15</U> sets forth a list of all the Permits of the Company, and the Sellers have provided
to the Purchaser true and complete copies of all such Permits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.16<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Sufficiency of Assets; Title to Properties</U>. Except as provided in <U>Schedule 3.16</U>, the assets, properties,
rights and Contracts of the Company and its subsidiaries constitute all of the assets, properties, rights, claims and Contracts
(whether tangible or intangible, or person, real or mixed) material to or necessary to operate the business of the Company as presently
conducted therein. The Company does not own any real property. The Company (a) owns good, valid and marketable title, free and
clear of all Liens (other than Permitted Liens), to all of its tangible Assets, and (b) is not obligated under any Contract, or
subject to any restriction, that presently materially impairs, has materially impaired, or would in the future materially impair
the Company&#8217;s right, title or interest in or to any of its respective tangible Assets. The Company owns, leases under valid
leases or has use of and/or valid access under valid agreements to all facilities, machinery, equipment and other tangible Assets
necessary for the conduct of its business as presently conducted. With respect to the property and Assets it leases, the Company
is in compliance with such leases and holds a valid leasehold interest free of any Liens, other than to the lessors of such property
or Assets or Permitted Liens.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.17<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B>Tax Matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company has timely filed when due all Tax Returns required by applicable Law to be filed by or with respect to it and
all such Tax Returns are true, correct and complete in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>All Taxes due and payable by or with respect to the Company (whether or not shown on any Tax Return) or for which the Company
may be liable, have been timely paid, and any Liability of the Company for Taxes not yet due and payable, or which are being contested
in good faith, does not exceed the amount shown on the face of the Interim Balance Sheet (disregarding timing differences) as adjusted
for the period thereafter through the Closing Date assuming the business is operated in the ordinary course.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company has made available to the Purchaser for inspection complete and correct copies of all income and all other material
Tax Returns of the Company for all taxable periods for which the relevant statute of limitations has not expired.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>There is no Proceeding or audit that is presently in progress, pending or threatened in writing against, or with respect
to, the Company in respect of any Tax or assessment, nor is any Proceeding for additional Tax or assessment asserted by any Taxing
authority. No deficiency or adjustment has been proposed, asserted, assessed or threatened by any Taxing authority against or with
respect to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Schedule 3.17</U> sets forth each jurisdiction in which the Company is subject to Taxes. No claim has been made in writing
by any Tax authority in a jurisdiction where the Company has not filed a Tax Return that it is or may be subject to Tax by such
jurisdiction, nor, to the Knowledge the Sellers, is any such assertion threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company is not a party to or bound by any Contract (including Tax allocation, sharing, indemnity, or similar agreement
or arrangement) providing for the payment of Taxes, payment for Tax losses, entitlements to refunds or similar Tax matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company has (i) withheld and paid all Taxes required to be withheld in connection with any amounts paid or owing to
any shareholder, employee, creditor, independent contractor or other third party and (ii) complied with all applicable information
reporting requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>There is no outstanding request for any extension of time within which to pay any Taxes or file any Tax Returns (other than
automatic filing extensions granted in the ordinary course), or waiver or extension of any applicable statute of limitations for
the assessment or collection of any Taxes of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company is not a party to or bound by any closing agreement, private letter rulings, technical advance memoranda, offer
in compromise, or any other agreement or arrangement with any Taxing authority, nor is there any outstanding request for such rulings
or agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> The Company has not distributed the stock of another Person, or had its stock distributed by another Person, in a transaction
that was purported or intended to be governed in whole or in part by Section 355 or Section 361 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>There are no Liens for Taxes upon any Assets of the Company other than Permitted Liens.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company (i) has not been a member of an affiliated group filing a consolidated, combined or unitary Tax Return under
federal, state, local or foreign Law and (ii) does not have any Liability for the Taxes of any Person under Treasury Regulations
Section 1.1502-6 (or any similar provision of Law), as a transferee or successor, by Contract, or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company has not participated in a &#8220;reportable transaction&#8221; required to be disclosed pursuant to Treasury
Regulations Section 1.6011-4(b) or any predecessor thereof (or any similar provision of Law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company has collected all appropriate sales Taxes and has obtained the appropriate exemption certificates to except
the Company from collecting any sales Tax that would otherwise be due.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company has not been a United States real property holding company within the meaning of Code Section 897(c)(2) during
the period specified in Code Section 897(c)(1)(A)(ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company will not be required to include any item of income in, or exclude any item of deduction from, taxable income
for any taxable period (or portion thereof) beginning after the Closing Date as a result of any: (i) change in method of accounting
for or use of improper method of accounting in a taxable period ending prior to the Closing Date; (ii) &#8220;closing agreement&#8221;
as described in Section 7121 of the Code (or any similar provision of Law) executed prior to the Closing Date; (iii) election pursuant
to Section 108(i) of the Code; (iv) installment sale or open transaction disposition made on or prior to the Closing; or (v) prepaid
amount received or deferred revenue accrued prior to the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company has not applied for or received any relief from Taxes or other Tax benefit under any COVID-19 Law, including
claiming an employee retention credit or deferring any amount of employer or employee payroll Taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.18<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Intellectual Property</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company owns all right, title and interest in and to, or has a valid and enforceable license to use, all Intellectual
Property used or held for use in or necessary for the conduct of its business as currently conducted and as contemplated to be
conducted (&#8220;<U>Company Intellectual Property</U>&#8221;). The Company is in material compliance with all contractual obligations
relating to the Intellectual Property it uses pursuant to license or other agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Neither
the conduct of the business of the Company (as previously conducted or currently conducted) nor the use of any Company
Product or Service or Owned Intellectual Property infringes, misappropriates or violates, and has not infringed,
misappropriated or violated, any Intellectual Property of any Person and does not constitute unfair competition or unfair
trade practices under the laws of any jurisdiction. <U>Schedule 3.18(b)</U> sets forth a true, accurate, and complete list of
all communications received by the Company regarding any such alleged, suspected or actual infringement, misappropriation,
violation, or breach of any Company IP Agreement. There is no Proceeding pending or, to the Knowledge of the Sellers,
threatened against the Company (i) in which it is alleged that the Company infringes, misappropriates or violates the
Intellectual Property of any Person or (ii) contesting or otherwise challenging the Company&#8217;s ownership or use, or the
validity or enforceability of any Company Intellectual Property. The Company has not received any written communication that
involves an offer to license or grant any rights or immunities under any third party Intellectual Property. To the Knowledge
of the Sellers, no Person is or has been infringing, misappropriating or violating the rights of the Company in or to any
Company Intellectual Property that is owned by the Company and there is and has not been any unauthorized use or disclosure
of any Company Intellectual Property. The Company has not asserted any Proceeding against any Person or other third party
related to any actual, suspected, or alleged infringement, misappropriation, or other violation or dilution of any Company
Intellectual Property or breach of any Company IP Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Schedule 3.18(c)</U> sets forth a true, accurate and complete list of all (i) registered trademarks and material unregistered
trademarks; (ii) patents and invention disclosures; (iii) registered copyrights; (iv) Internet domain names and social media accounts;
and (v) as applicable, applications for the foregoing (collectively, &#8220;<U>Listed Intellectual Property</U>&#8221;), owned
by the Company, in each case listing, as applicable, (A) current owner; (B) date of application, registration and/or issuance;
(C) the jurisdiction where the application or registration is located; and (D) the application or registration number. All registration,
maintenance and renewal fees currently due in connection with all Listed Intellectual Property have been paid and all documents,
recordations and certificates in connection with such Listed Intellectual Property currently required to be filed have been filed
with the relevant patent, copyright, trademark, or other authorities in the United States or foreign jurisdictions, as the case
may be, for the purposes of prosecuting, maintaining and perfecting such Listed Intellectual Property and recording the Company&#8217;s
ownership interests therein. The Company exclusively owns all right, title and interest in the Owned Intellectual Property, in
each case, free and clear of all Liens. No Listed Intellectual Property is the subject of any Proceeding before any Governmental
Entity, registration or other authority in any jurisdiction, including any office action or other form of preliminary or final
refusal of registration. The Company is not subject to any Proceeding or outstanding Order, Contract or stipulation that restricts
or impairs in any manner, the use, transfer or licensing by Seller of any Company Intellectual Property. The consummation of the
transactions contemplated hereby will not alter or impair the Company&#8217;s ownership of or right to use any Company Intellectual
Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>The
Company is not under any obligation to pay royalties or other payments in connection with any Company IP Agreement or
restricted from assigning its rights respecting any Company Intellectual Property that is owned by the Company. The Company
will not, as a result of the execution and delivery of this Agreement, be in breach of any Company IP Agreement. There are no
pending disputes regarding the scope of such Company IP Agreements, performance under the Company IP Agreements, or with
respect to payments made or received under such Company IP Agreements, and all Company IP Agreements are valid, binding and
in full force and effect. No Company IP Agreement grants any third party exclusive rights to or under any Company
Intellectual Property or, grants any third party the right to sublicense any Company Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company has taken commercially reasonable steps in accordance with standard industry practices to safeguard and maintain
the secrecy and confidentiality of, and its proprietary rights in and to, all non-public Company Intellectual Property. All use,
disclosure, or appropriation of any confidential or nonpublic information owned by the Company to a third party has been pursuant
to the terms of a written Contract (including, without limitation, confidentiality, nondisclosure, or similar agreements), between
the Company and such third party. Each current and each former employee, consultant, and contractor of the Company who has or had
access to any confidential or non-public information owned by the Company or included in any Company Intellectual Property has
executed and delivered to the Company a written agreement regarding the protection of such confidential or non-public information.
None of the non-public Company Intellectual Property that is owned by the Company has been used, disclosed, or appropriated without
authorization. No present or former officer, director, employee, agent, contractor or consultant of the Company has misappropriated
any trade secrets or other confidential, non-public or proprietary information of any other Person in the course of the performance
of responsibilities to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No present or former officer, director, employee, agent, contractor or consultant of the Company holds any right, title,
license, claim or interest, directly or indirectly, in whole or in part, in or to any Company Intellectual Property. The Company
has secured from all present or former officers, directors, employees, agents, contractors and consultants who independently or
jointly contributed to the conception, reduction to practice, creation, or development of any Company Intellectual Property (each
such officer, director, employee, agent, contractor or consultant a &#8220;<U>Company Contributor</U>&#8221; ) unencumbered, unrestricted,
and exclusive ownership of all such Company Contributor&#8217;s Intellectual Property in such contribution which the Company does
not already own by operation of law and no such Company Contributor has retained any rights or licenses with respect thereto. Without
limiting the foregoing, each current and former employee, officer, agent, contractor and consultant of the Company has fully executed
a valid and enforceable proprietary information and inventions agreement or similar agreement, which fully and effectively presently
assigns, conveys and otherwise transfers to the Company all unencumbered and unrestricted right, title and interest in and to all
of such Company Contributor&#8217;s rights in and to any Intellectual Property developed for or on behalf of the Company (and deems
any copyrightable works therein to be works made for hire for the Company). To the Knowledge of the Sellers, no current or former
employee, officer, agent, contractor or consultant is or was, as the case may be, in violation thereof. No current or former employee,
officer, agent, contractor or consultant of the Company has excluded works or inventions made prior to his, her or its employment
or consulting relationship with the Company from his, her or its assignment of inventions pursuant to such employee, officer or
consultant&#8217;s proprietary information and inventions agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><U>Schedule
3.18(g)</U> sets forth: (i) all Software owned, or purported to be owned, by the Company that is used by, necessary for, or
otherwise material to the Business (the &#8220;<U>Proprietary Software</U>&#8221;) and (ii) all other Software used by the
Company (the &#8220;<U>Licensed Software</U>,&#8221; and together with the Proprietary Software, the
 &#8220;<U>Software</U>&#8221;), excluding generally commercially available, non-custom off-the-shelf software that is
licensed to the Company on non- discriminatory terms pursuant to shrink-wrap, click-wrap, click-through, or similar
non-exclusive, royalty-free, object code licenses, granted in the ordinary course of business, having annual aggregate fees
of less than $50,000, used solely for the internal business operations of the Company. The Company owns all right, title and
interest in and to the Proprietary Software, in each case, free and clear of all Liens, and has valid license to use,
reproduce, modify, distribute and sublicense all copies of the Licensed Software to the extent necessary in connection with
the Company&#8217;s actual use of the Licensed Software, and the Company has not sold, licensed, leased or otherwise
transferred or granted any interest or rights in or to any portion of the Software other than in the ordinary course of
business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither the Company nor any Person acting on behalf of the Company has disclosed or delivered to any Person, or permitted
the disclosure or delivery to any escrow agent or other Person, of any Source Code. No event has occurred, and no circumstance
or condition exists, that (with or without notice or lapse of time) will, or would reasonably be expected to, result in the disclosure
or delivery by the Company, or any Person acting on behalf of the Company, of any Source Code. No third party owns any right, title
or interest in or to any Source Code. <U>Schedule 3.18(h)</U> identifies each Contract pursuant to which the Company has deposited,
or is or may be required to deposit, with an escrow agent or any other Person any Source Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither the Proprietary Software nor, to the Knowledge of the Sellers, the Licensed Software contains any computer code
or any other mechanisms which is intended to (i) disrupt, disable, erase or harm in any way such Software&#8217;s operation, or
cause such Software to damage or corrupt any data, hardware, storage media, programs, equipment or communications, or (ii) permit
any Person to access such Software or any data, hardware, storage media, programs, equipment or communications without authorization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company maintains (i) machine readable copies of the Proprietary Software and (ii) reasonably complete technical documentation
or user manuals for material releases or versions thereof currently in use by the Company, currently made available to the customers
of the Company or currently supported by the Company. The Company maintains at least one copy of the Source Code for all Proprietary
Software, and such code is maintained under strict confidentiality and in accordance with industry-standard safekeeping for proprietary
source code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No Proprietary Software or, to the Knowledge of Sellers, Licensed Software, contains, is derived from, is distributed, integrated
or bundled with, or links to or otherwise uses, any Open Source Software or materials that are distributed as &#8220;free software,&#8221;
or under similar licensing or distribution terms (including the GNU General Public License, GNU Lesser General Public License,
Mozilla Public License, and other licenses of a similar type or kind), in any manner that (i) requires or conditions (or purports
to require or condition) the use or distribution of any Company Intellectual Property or Licensed Software on the disclosure, licensing
or distribution of any Company Intellectual Property or the granting of any right to decompile, reverse engineer or create derivative
works of any Company Intellectual Property or Licensed Software, or (ii) otherwise imposes any material limitation, restriction
or condition on the right or ability of the Company to use or distribute any Company Intellectual Property. The Company has been
and currently is in compliance with all licenses to Open Source Software that is used in its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> The Company Computer Systems are sufficient in all material respects for the Company&#8217;s current needs in the operation
of its business as presently conducted, and in the past 24 months, there have been no failures, crashes, security breaches or other
adverse events affecting the Computer Systems that have caused material disruption to the business of the Company. The Company
Computer Systems provide for the back-up and recovery of material data, consistent with recovery plans, procedures, and facilities
implemented by the Company and the Company has implemented and maintains commercially reasonable disaster recovery plans, procedures
and facilities. The Company has taken commercially reasonable steps (including implementing and monitoring compliance with adequate
measures with respect to technical and physical security) to protect the integrity and security of the Computer Systems and the
information stored therein, processed thereon or transmitted therefrom from misuse or unauthorized use, access, disclosure or modification
by third parties, and there has been no such misuse or unauthorized use, access, disclosure or modification. The Company exclusively
owns or has a valid right to access and use the Company Computer Systems that are used in the conduct of its business, including
valid licenses to use all of the software programs present on the computers and other software-enabled electronic devices that
it owns or leases or that it has otherwise provided to its employees for their use in connection with the Company&#8217;s business.
The Company Computer Systems do not contain any computer code or any other mechanisms which may (i) disrupt, disable, erase, or
harm in any way the operation of the business of the Company, or cause damage to or corrupt any data, hardware, storage media,
programs, equipment or communications, or (ii) permit any Person to access, without authorization from the Company, any product
or system containing or used in conjunction with any Company Products and Services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company has not now or has ever been a member or promoter of, or a contributor to, any industry standards body or any
similar organization that could reasonably be expected to require or obligate the Company to grant or offer to any Person or other
third party any license or right to any Owned Intellectual Property. Additionally, no Owned Intellectual Property was acquired
from any Person or other third party which is now or has ever been a member or promoter of, or a contributor to, any industry standards
body or any similar organization that could reasonably be expected to have required or obligated such Person or other third party
to grant or offer to any other Person or other third party any license or right to such Owned Intellectual Property. The Company
does not have a present obligation (and there is no substantial basis to expect that there will be a future obligation) to grant
or offer to any other Person or any other third party any license or right to any Owned Intellectual Property by virtue of the
Company&#8217;s or any other Person&#8217;s or other third party&#8217;s membership in, promotion of, or contributions to any industry
standards body or any similar organization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>All
products, technology, and services produced, marketed, licensed, sold, distributed, or performed by or on behalf of the
Company (&#8220;<U>Company Products and Services</U>&#8221;) currently comply in all material respects with all applicable
warranties and contractual commitments relating to the use, functionality, and performance of such Company Products and
Services, and there are no pending or threatened Proceedings alleging any such failure. There exist no technical deficiencies
or problems with any Company Products and Services that adversely affect the performance of such Company Products and
Services in any material respect or that cause any such Company Products and Services to fail to substantially conform to
their written specifications in any material respect, other than routine, non-material software bugs or glitches that may be
remedied in the ordinary course of the businesses of the Company. For all Software used by the Company in providing any
Company Products and Services, the Company has implemented any and all security patches that are generally available for that
Software. To the extent that any third party owned Intellectual Property is incorporated into, integrated or bundled with, or
used by the Company in the development, manufacture, compilation, use, or other exploitation of any Company Products and
Services, the Company has all necessary rights to use or exploit all such third party owned Intellectual Property, subject to
the terms of any applicable Company IP Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No (i) funding, facilities, or personnel of any Governmental Entity, or (ii) funding, facilities, or personnel of a university,
college, or other educational institution or research center was used in the development of any Owned Intellectual Property. No
Company Contributor performed services for any (i) Governmental Entity, (ii) university, college, or other educational institution,
or (iii) research center, all of the foregoing during any period of time during which such Company Contributor was also performing
services for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.19<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Insurance</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Schedule 3.19</U> sets forth a true and complete list of all fidelity bonds, letters of credit, cash collateral, performance
bonds and bid bonds issued to or in respect of the Company (collectively, the &#8220;<U>Bonds</U>&#8221;) and all policies of title
insurance, liability and casualty insurance, property insurance, auto insurance, business interruption insurance, tenant&#8217;s
insurance, workers&#8217; compensation, life insurance, disability insurance, excess or umbrella insurance and any other type of
insurance insuring the properties, Assets, employees and/or operations of the Company (collectively, the &#8220;<U>Policies</U>&#8221;).
The Sellers have provided true, complete and accurate copies of all such Policies and Bonds to the Purchaser. All premiums payable
under all such Policies and Bonds have been paid timely and the Company has complied fully with the terms and conditions of all
such Policies and Bonds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>All Policies and Bonds are in full force and effect and will not terminate or lapse by reason of the consummation of the
transactions contemplated by this Agreement. The Company is not in default under any provisions of the Policies or Bonds, and there
is no claim by the Company or any other Person pending under any of the Policies or Bonds as to which coverage has been questioned,
denied or disputed by the underwriters or issuers of such Policies or Bonds. The Company has not received any written notice from
or on behalf of any insurance carrier or other issuer issuing such Policies or Bonds that insurance rates or other annual premium
or fee in effect as of the date hereof will hereafter be substantially increased (except to the extent that insurance rates or
other fees may be increased for all similarly situated risks), or that there will be a non-renewal, cancellation or increase in
a deductible (or an increase in premiums in order to maintain an existing deductible) of any of the Policies or Bonds in effect
as of the date hereof. The Policies and Bonds maintained by the Company are adequate in accordance with industry standards, the
requirements of any applicable leases and Contracts and are in at least the minimum amounts required by, and are otherwise sufficient
for purposes of, any currently applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section
3.20<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B><U>Litigation</U>.
There is no Proceeding pending or, to the Knowledge of the Sellers, threatened by or against, or affecting the Assets of, the
Company or against any manager, officer, employee or equityholder or, to the Knowledge of the Sellers, agent of the Company
in his, her or its capacity as such or relating to his, her or its employment services or relationship with the Company or
any of its Affiliates, and the Company is not bound by any Order. The Company has no Proceeding pending against any
Governmental Entity or other Person. The Company has not been engaged in a dispute with any customer which, either
individually or in the aggregate, has materially affected or would be reasonably likely to materially affect the
Company&#8217;s operations. To the Knowledge of the Sellers, there is no basis for any Person to assert a claim against the
Sellers or the Company based upon the Sellers entering into this Agreement or the consummation of the transactions
contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.21<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Bank Accounts</U>. <U>Schedule 3.21</U> sets forth all of the bank accounts of the Company, together with the authorized
signatories for such accounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.22<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Material Customers and Suppliers</U>. <U>Schedule 3.22</U> sets forth the 20 largest customers of the Company by
revenue (each, a &#8220;<U>Material Customer</U>&#8221;) and the 5 largest suppliers of the Company by expense (each a &#8220;<U>Material
Supplier</U>&#8221;), in each case for the 12-month periods ended December 31, 2019 and December 31, 2020. No such Material Customer
or Material Supplier has terminated or adversely changed its relationship with the Company, nor has the Company received any written
or verbal indication that any such Material Customer or Material Supplier intends to terminate or adversely change such relationship.
The Company has not granted any credit, rebate, trade-in, free return or other sales terms to customers or others which substantially
differ from terms granted by the Company in the ordinary course of business consistent with past practice. There are no currently
pending or, to the Knowledge of the Sellers, threatened disputes between the Company and any of its Material Customers or Material
Supplier that (i) would reasonably be expected to adversely affect the relationship between the Company and any Material Customer
or Material Supplier or (ii) would reasonably be expected to adversely affect the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.23<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Labor Matters</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company has delivered the Business Employee List to Purchaser and all of the information included on the Business Employee
List is true and accurate as of the date hereof. Other than the Business Employees included on the Business Employee List, no employee
or other individual service provider primarily provides services to the Seller Group Companies. To Knowledge of the Sellers, the
services provided by the Business Employees constitute all of the services reasonably required to conduct and operate the business
in the same manner as of the Closing Date, in all material respects, as conducted by the Seller Group Companies as of the date
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>The
Seller Group Companies are and have been in compliance in all material respects with all applicable Laws relating to the
hiring of employees and employment of labor, including all applicable Laws relating to wages, hours, overtime, collective
bargaining, employment discrimination, civil rights, safety and health, workers&#8217; compensation, pay equity,
classification of employees and independent contractors, and the collection and payment of withholding and/or social security
Taxes. Each of the Seller Group Companies has met in all material respects all requirements required by Law or regulation
relating to the employment of foreign citizens, and none of the Seller Group Companies currently employs, or has ever
employed, any Person who was not permitted to work in the jurisdiction in which such Person was employed. The Seller Group
Companies have complied in all material respects with all Laws that could require overtime to be paid to any current or
former employee of the Seller Group Companies, and no Person has ever brought or, to the Knowledge of the Sellers, threatened
to bring a claim for unpaid compensation or employee benefits, including overtime amounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>None of the Seller Group Companies is delinquent in payment to any of its current or former employees, officers, directors
or other individual service providers for any wages, fees, salaries, commissions, bonuses, or other direct compensation for service
performed by them or amounts required to be reimbursed to such employees, officers, directors or other individual service providers
or in payments owed upon any termination of such Person&#8217;s employment or service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>None of the Seller Group Companies is a party to or otherwise bound by any collective bargaining agreement or other agreement
with a labor union, works council or similar organization applicable to employees of the Seller Group Companies and, to the Knowledge
of the Sellers, there are no activities or proceedings of any labor union, works council or similar organization to organize any
such employees. Additionally, (i)&nbsp;there is no unfair labor practice charge or complaint pending before any applicable Governmental
Entity relating to the Seller Group Companies or any employee or other individual service provider thereof; (ii)&nbsp;there is
no labor strike, material slowdown, material dispute, or material work stoppage or lockout pending or, to the Knowledge of the
Sellers, threatened against or affecting any of the Seller Group Companies, and none of the Seller Group Companies has experienced
any strike, material slowdown or material work stoppage, lockout or other collective labor action by or with respect to its employees;
(iii)&nbsp;there is no representation claim or petition pending before any applicable Governmental Entity; and (iv)&nbsp;there
are no charges with respect to or relating to any of the Seller Group Companies pending before any applicable Governmental Entity
responsible for the prevention of unlawful employment practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To the Knowledge of the Sellers, no employee or other individual service provider of the Seller Group Companies is bound
by any contract (including licenses, covenants or commitments of any nature) or subject to any judgment, decree or order of any
Governmental Entity that would materially interfere with the use of such Person&#8217;s best efforts to promote the interests of
the Seller Group Companies or that would materially conflict with the Seller Group Companies&#8217; business as currently conducted.
To the Knowledge of the Sellers, (i)&nbsp;no officer or key employee, or group of key employees, intends to terminate their employment
with the Seller Group Companies, and no Seller Group Company has a present intention to terminate the employment of any of the
foregoing, and (ii)&nbsp;no officer or key employee has received an offer to join a business that is competitive with the business
activities of the Seller Group Companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Any individual who performs or performed services for the Seller Group Companies and who is not treated as an employee for
federal income tax purposes by the Seller Group Companies is not an employee under applicable Laws or for any purpose, including,
without limitation, for Tax withholding purposes or Company Plan purposes, and none of the Seller Group Companies has any liability
by reason of any individual who performs or performed services for such Seller Group Company, in any capacity, being improperly
excluded from participating in any Company Plan. Each of the employees of the Seller Group Companies has been properly classified
by the Company as &#8220;exempt&#8221; or &#8220;non-exempt&#8221; under applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> To the Knowledge of the Sellers, since 2016, (i)&nbsp;no allegations of sexual harassment or other misconduct have been
made against any director, officer or other managerial employee of the Seller Group Companies, and (ii)&nbsp;none of the Seller
Group Companies has entered into any settlement agreement related to allegations of sexual harassment or other misconduct by any
employee, officer, director or other individual service provider of the Seller Group Companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.24<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Employee Benefits</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Schedule 3.24(a)</U> sets forth a true and complete list of each Company Plan. With respect to each Company Plan, the
Company has provided to Purchaser or its counsel a true and complete copy, to the extent applicable, of: (i)&nbsp;each writing
constituting a part of such Company Plan and all amendments thereto, and a written description of any material unwritten Company
Plan; (ii)&nbsp;the most recent annual report and accompanying schedules; (iii)&nbsp;the current summary plan description and any
summaries of material modifications; (iv)&nbsp;the most recent annual financial and actuarial reports; (v)&nbsp;the most recent
determination or opinion letter received by any of the Seller Group Companies from the IRS regarding the tax-qualified status of
such Company Plan; (vi)&nbsp;the most recent written results of all required compliance testing; and (vii)&nbsp;copies of any material
correspondence with the IRS, Department of Labor or other Governmental Entity. There has been no amendment to, announcement by
any of the Seller Group Companies relating to, or change in employee participation or coverage under, any Company Plan which would
increase materially the expense of maintaining such plan above the level of the expense incurred therefor for the most recent fiscal
year. The Seller Group Companies may amend or terminate any Company Plan at any time without incurring any liability thereunder
other than in respect of claims incurred prior to such amendment or termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Each
Company Plan (and each related trust, insurance contract or fund) has been established, administered and funded in accordance
with its express terms, and in compliance in all material respects with all applicable Laws, including ERISA and the Code.
There are no pending or, to the Knowledge of the Sellers, threatened actions, claims or lawsuits against or relating to the
Company Plans, the assets of any of the trusts under such plans or the plan sponsor or the plan administrator, or against any
fiduciary of the Company Plans with respect to the operation of such plans (other than routine benefits claims). Neither the
Seller Group Companies nor, to the Knowledge of the Sellers, any &#8220;party in interest&#8221; or &#8220;disqualified
person&#8221; with respect to a Company Plan has engaged in a non-exempt &#8220;prohibited transaction&#8221; within the
meaning of Section 4975 of the Code or Section 406 of ERISA. To the Knowledge of the Sellers, no fiduciary (within the
meaning of Section&nbsp;3(21) of ERISA) has breached any fiduciary duty with respect to a Company Plan or otherwise has any
liability in connection with acts taken (or the failure to act) with respect to the administration or investment of the
assets of any Company Plan. No Company Plan is presently under audit or examination (nor has written notice been received of
a potential audit or examination) by any Governmental Entity. All payments required to be made by any of the Seller Group
Companies under, or with respect to, any Company Plan (including all contributions, distributions, reimbursements, premium
payments or intercompany charges) with respect to all prior periods have been timely made or, for any such payments that are
not yet due, properly accrued and reflected in the most recent consolidated balance sheet prior to the date hereof, in each
case in accordance with the provisions of each of the Company Plans, applicable Law and GAAP. There is not now, nor do any
circumstances exist that could give rise to, any requirement for the posting of security with respect to a Company Plan or
the imposition of any lien on the assets of any of the Seller Group Companies under ERISA or the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>With respect to each Company Plan that is intended to qualify under Section&nbsp;401(a) of the Code, such plan, and its
related trust, has at all times since its adoption been so qualified and has received a current determination letter (or is the
subject of a current opinion letter in the case of any prototype plan) from the IRS on which the Seller Group Companies can rely
that it is so qualified and that its trust is exempt from tax under Section&nbsp;501(a) of the Code, and nothing has occurred with
respect to the operation of any such plan which could cause the loss of such qualification or exemption or the imposition of any
material liability, penalty or tax under ERISA or the Code. No stock or other securities issued by any of the Seller Group Companies
forms or has formed any part of the assets of any Company Plan that is intended to qualify under Section&nbsp;401(a) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> No Company Plan is, and none of the Seller Group Companies or any ERISA Affiliate of the Seller Group Companies have ever
sponsored, established, maintained, contributed to or been required to contribute to, or in any way has any liability (whether
on account of an ERISA Affiliate or otherwise), directly or indirectly, with respect to any plan that is, (i)&nbsp;subject to Title
IV or Section&nbsp;302 of ERISA or Section&nbsp;412, 430 or 4971 of the Code or a &#8220;defined benefit&#8221; plan within the
meaning of Section&nbsp;414(j) of the Code or Section&nbsp;3(35) of ERISA (whether or not subject thereto), (ii)&nbsp;a Multiemployer
Plan, (iii)&nbsp;a plan that has two or more contributing sponsors at least two of whom are not under common control, within the
meaning of Section&nbsp;4063 of ERISA, (iv)&nbsp;a &#8220;multiple employer welfare arrangement&#8221; (as defined in Section&nbsp;3(40)
of ERISA), or (v)&nbsp;a plan maintained in connection with any trust described in Section&nbsp;501(c)(9) of the Code. None of
the Seller Group Companies has withdrawn at any time within the preceding six years from any Multiemployer Plan, or incurred any
withdrawal liability which remains unsatisfied, and no events have occurred and no circumstances exist that could reasonably be
expected to result in any such liability to any of the Seller Group Companies. With respect to any Company Plan that is a &#8220;multiple
employer plan&#8221; (as defined in Section&nbsp;413 of the Code) such Company Plan complies in all respects with the requirements
of the Code and ERISA and none of the Seller Group Companies nor any ERISA Affiliate has any liabilities other than the payment
and/or remittance of premiums and/or required contributions on behalf of enrolled individuals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No event has occurred and no condition exists that would subject any of the Seller Group Companies by reason of their affiliation
with any ERISA Affiliate to any (i)&nbsp;Tax, penalty, fine, (ii)&nbsp;lien, or (iii)&nbsp;other liability imposed by ERISA, the
Code or other applicable Laws, in each case, in respect of any employee benefit plan maintained, sponsored, contributed to, or
required to be contributed to by any ERISA Affiliate (other than the Seller Group Companies).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Each
Company Plan that is subject to Affordable Care Act has been established, maintained and administered in compliance with the
requirements of the Affordable Care Act, including all notice and coverage requirements, and the Seller Group Companies and
each ERISA Affiliate offer minimum essential health coverage, satisfying the affordability and minimum value requirements, to
their full time employees (as defined by the Affordable Care Act) sufficient to prevent liability for assessable payments
under Section&nbsp;4980H of the Code. None of the Seller Group Companies has attempted to maintain the grandfathered heath
plan status under the Affordable Care Act of any Company Plan. None of the Company Plans provide medical, health, life or
other welfare benefits for former employees or for present employees after termination of employment, except as may be
required by Section&nbsp;4980B of the Code and Section&nbsp;601 of ERISA, any other applicable Law or at the sole expense of
the participant or the participant&#8217;s beneficiary. No Company Plan is a self-insured arrangement by any of the Seller
Group Companies or funded through a trust and no event has occurred and no condition exists that could reasonably be expected
to result in a material increase in the premium costs of any Company Plans that are fully-insured. None of the Seller Group
Companies has incurred (whether or not assessed), or is reasonably expected to incur or to be subject to, any Tax or other
penalty with respect to the reporting requirements under Sections&nbsp;6055 and 6056 of the Code, as applicable, or under
Section&nbsp;4980B, 4980D or 4980H of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby will (either
alone or in combination with another event) (i)&nbsp;result in any payment becoming due, or increase the amount of any compensation
or benefits due, to any current or former employee, officer, director or other individual service provider of any of the Seller
Group Companies or with respect to any Company Plan; (ii)&nbsp;increase any benefits otherwise payable under any Company Plan;
(iii)&nbsp;result in the acceleration of the time of payment or vesting of any such compensation or benefits, or the forgiveness
of indebtedness of any current or former employee, officer, director or other individual service provider of any of the Seller
Group Companies; or (iv)&nbsp;result in an obligation to fund or otherwise set aside assets to secure to any extent any of the
obligations under any Company Plan. No person is entitled to receive any additional payment (including any tax gross-up or other
payment) from any of the Seller Group Companies as a result of the imposition of the excise taxes required by Section&nbsp;4999
of the Code or any taxes required by Section&nbsp;409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby will (either
alone or in combination with another event) result in any payment or benefit (whether in cash or property or the vesting of property)
to any &#8220;disqualified individual&#8221; (as such term is defined in Treasury Regulation Section&nbsp;1.280G-1) that could,
individually or in combination with any other such payment, constitute an &#8220;excess parachute payment&#8221; (as defined in
Section&nbsp;280G(b)(1) of the Code).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No Company Plan is or has ever been (and none of the Seller Group Companies have sponsored, maintained or had any obligation
with respect to) a &#8220;nonqualified deferred compensation plan&#8221; within the meaning of Section&nbsp;409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No Company Plan covers any employees, officers, directors or other individual service providers of any of the Seller Group
Companies residing or working outside of the United States or is otherwise subject to the laws outside of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section
3.25<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B><U>Environmental
and Safety</U>. The Company has complied in all material respects with all, is in compliance in all material respects with
all, and has not received any notice alleging or otherwise relating to any violation of any, Environmental and Safety
Requirements, and there are no Proceedings pending or, to the Knowledge of the Sellers, threatened against the Company
alleging any failure to so comply or involving any of its past operations or any real property used by the Company. The
Company has not received any written notice or report with respect to it or its facilities regarding any (i) actual or
alleged violation of Environmental and Safety Requirements, or (ii) actual or potential Liability arising under Environmental
and Safety Requirements, including any investigatory, remedial or corrective obligation. The Company has not expressly
assumed or undertaken any Liability of any other Person under any Environmental and Safety Requirements. The Company has not
treated, stored, disposed of, arranged for or permitted the disposal of, transported, handled or released any substance, or
owned or operated any real property in a manner that has given rise to Liabilities pursuant to any Environmental and Safety
Requirement, including any Liability for response costs, corrective action costs, personal injury, property damage, natural
resources damage or attorney fees, or any investigative, corrective or remedial obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.26<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Related Party Transactions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Schedule 3.26</U> sets forth a true, accurate and complete list of the following: <FONT STYLE="color: red"><STRIKE></STRIKE></FONT>(i)
each Contract entered into between the Company, on the one hand, and any current or former officer, manager, employee, Affiliate
or equityholder of the Company or any member of their respective immediate family, on the other hand; <FONT STYLE="color: red"><STRIKE></STRIKE></FONT>(ii)
all Indebtedness (for monies actually borrowed or lent) owed during the three-year period ended on the date hereof by any current
or former officer, manager, employee, Affiliate or equityholder of the Company or any member of their respective immediate family
to the Company; and <FONT STYLE="color: red"><STRIKE></STRIKE></FONT>(iii) to the Knowledge of the Sellers, each direct or
indirect ownership interest (other than non-affiliated holdings in publicly held companies) in any Person which is a present or
potential competitor, supplier or customer of the Company held during the three-year period ended on the date hereof by any current
or former officer, manager, employee, Affiliate or equityholder of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No such Person described in <U>Section 3.26(a)(iii)</U> in whom an Affiliate of the Company or any member of their respective
immediate family has or had a direct or indirect ownership interest receives or has received income from any source other than
the Company which should properly accrue, or should properly have accrued, to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No current or former Affiliate of the Company or any member of their respective immediate family is a guarantor or is otherwise
liable for any Liability (including Indebtedness) of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as set forth on <U>Schedule 3.26</U>, none of the Sellers or any of their Affiliates (other than the Company) or
any member of their respective immediate family owns or has any rights in or to any of the Assets, properties or rights used by
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.27<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Material Contracts</U>. <U>Schedule 3.27</U> sets forth a true and complete list of each Contract to which the Company
is a party or otherwise relating to or affecting any of its Assets, which fall within the following categories (each, a &#8220;<U>Material
Contract</U>&#8221;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Contract for the employment of any officer, individual employee or other Person on a full-time, part-time, consulting or
other basis;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Contract providing for payment upon the severance of any officer, individual employee or other Person on a full-time, part-time,
consulting or other basis;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> Contract or benefit plan that provides for a payment, benefit, or accelerated vesting, upon the execution of this Agreement
or the Closing or in connection with any of the transactions contemplated by this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Collective bargaining agreement, labor contract or other written agreement or arrangement with any labor union or any employee
organization or contract, agreement or arrangement with a professional employer organization;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Contract
relating to Indebtedness or to the mortgaging, pledging or otherwise placing a Lien on any Asset or group of Assets of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Contract involving the sale of the accounts receivable of the Company to any other Person at a discount;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>guarantee of any obligation for borrowed money or otherwise;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Contract with respect to the lending or investing of funds;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Contract under which the Company is the lessee, holder or operator of any real or personal property owned by any other Person;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Contract under which the Company is the lessor of, or permits any third Person to hold or operate, any real or personal
property owned or controlled by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Contract involving (i) an assignment, license, covenant, indemnification or other agreement with respect to any form of
Intellectual Property, and (ii) Contracts pertaining to the Company Intellectual Property, including the right of the Company to
use the Intellectual Property of any Person (&#8220;<U>Company IP Agreements</U>&#8221;), with the exception of (i) agreements
for generally commercially available, shrink-wrap, click-wrap, or similar nonexclusive, royalty-free licenses to non-custom, off-the-shelf
software granted to the Company, in the ordinary course of business, having annual aggregate fees of less than $50,000, on non-discriminatory
terms, used solely for the internal business operations of the Company; or (ii) customer contracts entered in the ordinary course
of business providing for a non-exclusive license of limited duration;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Contract or group of related Contracts with the same Person for the sale of Assets or services which generate in excess
of $50,000 in revenues in any 12-month period;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Contract that restricts the Company from, or, to the Sellers&#8217; Knowledge, following the Closing will restrict the Purchaser
or any of its Affiliates from, (i) freely engaging in business anywhere in the world, (ii) freely setting prices for its products,
services or technologies (including most-favored nation pricing provisions) or (iii) soliciting or hiring any Person, including
any potential contractors or other suppliers or customers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Contract under which the Company grants any exclusive rights, non-competition rights, rights of first refusal or rights
of first negotiation to any Person;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> Contract that involves the sharing of profits, losses, costs or Liabilities, or relates to a partnership, joint venture
or relationship for joint marketing or joint development, with any other Person;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Contract relating to the purchase, distribution, marketing or sales of the Company&#8217;s or any other Person&#8217;s products
having a value in excess of $50,000 with respect to any 12-month period;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Contract with any Affiliate of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Contract to provide marketing and/or advertising over the Internet;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Contract with any customer or supplier which gives rise to payments in excess of $50,000 in any 12-month period;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(t)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Contracts with Governmental Entities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(u)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Contract that contains a material indemnification obligation, except as entered into in the ordinary course of business
consistent with past practice, or a material indemnification obligation that could subject the Company to a Liability in excess
of one and a half times the value of the goods or services provided by the Company thereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>settlement agreement relating to any material administrative or judicial proceeding (including any agreement under which
any employment-related claim is settled) entered into by the Company; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(w)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>other Contracts (that are not included in any of the clauses (a) through (u) above) that require the payment by, or to,
the Company after the date hereof of an amount in excess of $50,000 in any 12-month period (not including purchase orders entered
into in the ordinary course of business).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each Material Contract
(i) is valid, binding and enforceable against the Company and, to the Knowledge of the Sellers, against each other party thereto,
in accordance with its terms, except as such enforcement may be limited by bankruptcy, insolvency, reorganization, moratorium or
other similar laws now or hereafter in effect relating to creditors&#8217; rights and general principles of equity; and (ii) is
in full force and effect on the day hereof. The Company has performed all obligations, including the timely making of any rental
or other payments, required to be performed by it under, and is not in default or breach of, any Material Contract, and no event
has occurred which, with due notice or lapse of time or both, would constitute such a default, and, to the Knowledge of the Sellers,
each other party thereto has performed all obligations, including the timely making of any rental or other payments, required to
be performed by it under, and is not in default or breach of, any Material Contract, and no event has occurred which, with due
notice or lapse of time or both, would constitute such a default. There has been made available to the Purchaser (i) a true and
complete copy of each of the Material Contracts required to be listed on <U>Schedule 3.27</U>, together with all amendments, waivers
or other changes thereto, and (ii) a complete description of all oral Contracts to which the Company is a party or by which any
of its Assets may be bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.28<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
 &nbsp;</FONT></B><U>Sufficiency of Assets</U>. As of the date hereof, and before taking into account the consummation of the transactions
contemplated hereby, the Assets and properties of the Company are sufficient to enable the Company to conduct its business in
all material respects as it is being conducted on the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.29<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Exclusivity of Representations</U>. The representations and warranties made by the Sellers in this <U>Article III</U>
are the exclusive representations and warranties made by the Sellers. The Sellers hereby disclaim any other express or implied
representations or warranties, whether written or oral. The Sellers are not, directly or indirectly, making any representations
or warranties regarding the pro-forma financial information, financial projections or other forward-looking statements of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.30<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Brokers or Finders</U>. There are no claims, and will not be any claims, for brokerage commissions or finder&#8217;s
fees or similar compensation in connection with the transactions contemplated by this Agreement based on any arrangement made by
or on behalf of the Company or any of its Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.31<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Books and Records</U>. The minute books of the Company (including any former subsidiaries of the Company) that have
been made available are complete and up-to-date and have been maintained in accordance with sound and prudent business practice.
The minutes of the Company (including any former subsidiaries of the Company) contain true, correct and complete records of all
actions taken, and summaries of all meetings held, by the respective stockholders (or similar equityholders) and the board of directors
of the company since the time of incorporation of the Company. The Company (including any former subsidiaries of the Company) has
made and kept business records, financial books and records, personnel records, ledgers, sales accounting records, tax records
and related work papers and other books and records (collectively, the &#8220;<U>Books and Records</U>&#8221;) that are true, correct
and complete in all respects and accurately and fairly reflect, in all respects, the business activities of the Company and each
of its subsidiaries. The Company (including any former subsidiaries of the Company) has not engaged in any transaction, maintained
any bank account or used any corporate funds except as reflected in its normally maintained Books and Records. At the Closing,
the minute books and other Books and Records will be in the possession of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.32<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Privacy and Data Security</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>The
Company complies with, and has at all times complied with, (i) all applicable laws pertaining to data protection, data
privacy, data security, cybersecurity, cross-border data transfer, including, but not limited to, the California Consumer
Privacy Act, the Health Insurance Portability and Accountability Act, as amended, and all rules and regulations promulgated
thereunder, and general consumer protection laws as applied in the context of data privacy, data breach notification,
electronic communication, telephone and text message communications, marketing by email or other channels, and other similar
laws (&#8220;<U>Data Protection Laws</U>&#8221;), (ii) all published, posted and internal policies, procedures, agreements
and notices relating to Company&#8217;s collection, use, storage, disclosure, or cross-border transfer of Personal Data
(&#8220;<U>Privacy Policies</U>&#8221;), (iii) any Contracts and/or codes of conduct relating to the collection, access, use,
storage, disclosure, transmission, or cross-border transfer of Personal Data (&#8220;<U>Privacy Contractual </U>Requirements&#8221;
and, collectively with Data Protection Laws and Privacy Policies, the &#8220;<U>Data Protection Requirements</U>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company has not received any subpoenas, demands, or other notices from any Governmental Entity investigating, inquiring
into, or otherwise relating to any actual or potential violation of any Data Protection Law and, to the Sellers&#8217; Knowledge,
the Company is not under investigation by any Governmental Entity for any actual or potential violation of any Data Protection
Law. No notice, complaint, claim, inquiry, audit, enforcement action, proceeding, or litigation of any kind has been served on,
or initiated against the Company or any of its officers, directors, or employees (in their capacity as such) by any private party
or Governmental Entity, foreign or domestic, under any Data Protection Requirement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company established and maintains, and has maintained, physical, technical, and administrative security measures and
policies, compliant with applicable Data Protection Requirements, that (i) identify internal and organizational risks to the confidentiality,
integrity, security, availability of Personal Data and/or business data and the Company Computer Systems taking into account the
sensitivity of the data or systems; (ii) protect the confidentiality, integrity, security, and availability of the Company&#8217;s
software, systems, and websites that are involved in the collection and/or processing of Personal Data and/or business data and
the Company Computer Systems; and (iii) maintain notification procedures in compliance with applicable Data Protection Requirements
in the case of any breach of security compromising Personal Data and/or business data and the Company Computer Systems.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company has not experienced any failures, crashes, security breaches or incidents, unauthorized access, use, modification,
or disclosure, or other adverse events or incidents related to Personal Data and/or business data and the Company Computer Systems
that would require notification of individuals, other affected parties, law enforcement, or any Governmental Entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">Article
IV</FONT><FONT STYLE="color: red"><BR>
</FONT>REPRESENTATIONS AND WARRANTIES OF THE PURCHASER</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Purchaser represents
and warrants to the Sellers as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Organization; Good Standing; Qualification and Power</U>. The Purchaser is duly organized, validly existing and in
good standing under the laws of its jurisdiction of incorporation, has all requisite power to own, lease and operate its Assets
and to carry on its business as presently being conducted and as contemplated to be conducted, and is qualified to do business
and in good standing in every jurisdiction in which the operation of its business requires it to be so qualified, except where
the failure to be so qualified or in good standing would not have a material adverse effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section
4.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B><U>Authorization</U>.
The Purchaser has the requisite power and authority to enter into this Agreement and to consummate the transactions
contemplated hereby. The execution and delivery of this Agreement and the consummation of the transactions contemplated
hereby by the Purchaser has been duly authorized by all necessary action on the part of the Purchaser. This Agreement has
been duly executed and delivered by the Purchaser and, assuming this Agreement constitutes the valid and binding obligations
of the Sellers, constitutes the valid and binding obligation of the Purchaser, enforceable against the Purchaser in
accordance with its terms, except as such enforcement is limited by bankruptcy, insolvency and other similar laws affecting
the enforcement of creditors&#8217; rights generally and for limitations imposed by general principles of equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Investment Intent</U>. The Shares will be acquired hereunder by the Purchaser solely for its own account for investment
purposes, and not with a view to the resale or distribution thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Brokers or Finders</U>. There are no claims, and will not be any claims, for brokerage commissions or finder&#8217;s
fees or similar compensation in connection with the transactions contemplated by this Agreement based on any arrangement made by
or on behalf of the Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Investigation; Reliance</U>. Purchaser acknowledges that (i) it has conducted its own independent review and analysis
of the business, operations, assets, liabilities, results of operations, condition (financial or otherwise), software, technology
and prospects of the Company, (ii) it and its representatives have been provided such access to the properties, equipment, Contracts,
premises and books and records of the Company that it and its representatives have desired or requested to review for such purpose
and (iii) it and its representatives have had an opportunity to meet with the management of the Company and to discuss the business,
operations, assets, liabilities, results of operations, condition (financial or otherwise), software, technology and prospects
of the Company. Notwithstanding anything contained in this Agreement to the contrary, Purchaser acknowledges and agrees that (i)
none of the Sellers, the Company or any other Person is making any representations or warranties whatsoever, express or implied,
beyond those expressly given by the Sellers in Article III, and (ii) Purchaser has not been induced by, or relied upon, any representations,
warranties or statements (written or oral), whether express or implied, made by any Person, that are not expressly set forth in
Article III of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>No Violations; Consents and Approvals</U>. The execution and delivery of this Agreement by Purchaser, and the consummation
by it of the transactions contemplated hereby will not (i) violate any provision of the organizational documents of Purchaser,
(ii) violate any material Law applicable to, binding upon or enforceable against Purchaser, or (iii) require the consent or approval
of any Governmental Entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Litigation</U>. There are no Proceedings pending or, to Purchaser&#8217;s knowledge, expressly threatened in writing
against Purchaser, at law or in equity, before or by any Governmental Entity which would, individually or in the aggregate, reasonably
be expected to affect the legality, validity or enforceability of this Agreement or the consummation of the transactions contemplated
by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">Article
V</FONT><BR>
SURVIVAL AND INDEMNIFICATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section
5.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B><U>Survival
of Representations, Warranties</U>. Each of the representations and warranties made by the Sellers and the Purchaser in this
Agreement and in any certificate delivered pursuant to this Agreement shall survive the Closing for a period terminating on
the later of (i) the Expiration Date and (ii) with respect to claims asserted pursuant to this <U>Article V</U> before the
expiration of the applicable representation or warranty, the date such claim is finally liquidated or otherwise resolved; <U>provided</U>,
that the Company Fundamental Representations and Purchaser Fundamental Representations shall survive until the seventh
anniversary of the Closing. The covenants and agreements of the Sellers and the Purchaser in this Agreement and in any
schedule, instrument or other document delivered pursuant to this Agreement shall survive until fully performed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 5.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Indemnification by the Sellers</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>From and after the Closing, the Sellers shall indemnify, defend and hold harmless the Purchaser, the Company and their respective
officers, directors (or Persons in similar positions), members, partners, employees, equityholders, representatives, agents, Affiliates,
successors and assigns (collectively, the &#8220;<U>Purchaser Indemnified Parties</U>&#8221;) from and against, and save and hold
each of them harmless from and against, and pay on behalf of or reimburse such Purchaser Indemnified Party for, any Loss which
any such Purchaser Indemnified Party may suffer as a result of, in connection with, relating to, incidental to or by virtue of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any misrepresentation or breach of a representation or warranty of the Sellers set forth in this Agreement (including the
Disclosure Schedules) or in any certificate delivered by the Sellers pursuant to this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any failure of the Sellers to perform or observe any covenant or agreement contained in this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any Indebtedness or Transaction Expenses, in each case, except to the extent the dollar amount of any such item was taken
into account in the calculation of the Final Consideration pursuant to <U>Section 2.6</U>; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>claims by any current or former securityholder or Optionholder or alleged current or former holder of any interest or security
of the Company, relating to or arising out of (x) this Agreement or the transactions contemplated hereby, including the allocation
of the Closing Consideration, the Earn-Out Amount or any other amounts payable hereunder, or (y) such Person&#8217;s status or
alleged status as an equity holder or ownership of interests or securities in the Company at any time at or prior to the Closing,
whether for breach of fiduciary duty or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>All
indemnification rights hereunder shall survive the execution and delivery of this Agreement and the consummation of the
transactions contemplated hereby, regardless of any investigation, inquiry or examination made for or on behalf of, or any
Knowledge of, the Purchaser and/or any of the other Purchaser Indemnified Parties or the acceptance by the Purchaser of any
certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Sellers shall have no Liability in respect of any Loss for which the Sellers are obligated to indemnify the Purchaser
Indemnified Parties pursuant to <U>Section 5.2(a)(i)</U> unless and until the amount that would otherwise be recoverable from
the Sellers in respect of any such Loss, when aggregated with any other amounts so recoverable from the Sellers pursuant to Section
5.2(a)(i), exceeds $250,000 (the &#8220;<U>Deductible</U>&#8221;), after which the Purchaser Indemnified Parties shall be entitled
to recover the full amount of such Loss in excess of the Deductible; <U>provided</U>, that such limitations shall not apply to
any Loss suffered by a Purchaser Indemnified Party with respect to breaches of the Company Fundamental Representations or for
Fraud.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The aggregate Liability of the Sellers in respect of any Loss for which the Sellers indemnify the Purchaser Indemnified
Parties pursuant to <U>Section 5.2(a)(i)</U> shall not exceed $250,000 (the &#8220;<U>Cap</U>&#8221;); <U>provided</U>, that such
limitations shall not apply to any Loss suffered by the Purchaser Indemnified Parties with respect to (i) breaches of the Company
Fundamental Representations, for which the maximum amount recoverable by the Purchaser Indemnified Parties shall be limited to
an amount equal to the Purchase Price actually received by the Sellers, or (ii) Fraud.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 5.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Indemnification by the Purchaser</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>From and after the Closing, the Purchaser shall indemnify, defend and hold harmless the Sellers and their representatives,
agents, Affiliates, successors and assigns (collectively, the &#8220;<U>Seller Indemnified Parties</U>&#8221;) from and against,
and save and hold each of them harmless from and against, and pay on behalf of or reimburse such Seller Indemnified Party for,
any Loss which any such Seller Indemnified Party may suffer as a result of, in connection with, relating to, or incidental to or
by virtue of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any misrepresentation or breach of a representation or warranty of the Purchaser set forth in this Agreement (including
the Disclosure Schedules) or in any certificate delivered by the Purchaser pursuant to this Agreement; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any failure of the Purchaser to perform or observe any covenant or agreement contained in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>All indemnification rights hereunder shall survive the execution and delivery of this Agreement and the consummation of
the transactions contemplated hereby, regardless of any investigation, inquiry or examination made for or on behalf of, or any
Knowledge of, the Sellers and/or any of the other Seller Indemnified Parties or the acceptance by the Sellers of any certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>The
Purchaser shall have no Liability in respect of any Loss for which the Purchaser is obligated to indemnify the Seller
Indemnified Parties pursuant to <U>Section 5.3(a)(i)</U> unless and until the amount that would otherwise be recoverable from
the Purchaser in respect of any such Loss, when aggregated with any other amounts so recoverable from the Purchaser pursuant
to <U>Section 5.3(a)(i)</U>, exceeds the Deductible, after which the Seller Indemnified Parties shall be entitled to recover
the full amount of such Loss in excess of the Deductible; <U>provided</U>, that such limitations shall not apply to any
recovery under the R&amp;W Insurance Policy or any Loss suffered by a Seller Indemnified Party with respect to breaches of
the Purchaser Fundamental Representations or for Fraud.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The aggregate Liability of the Purchaser in respect of any Loss for which the Purchaser is obligated to indemnify the Seller
Indemnified Parties pursuant to <U>Section&nbsp;5.3(a)(i)</U> shall not exceed the Cap; <U>provided</U>, that such limitations
shall not apply to any Loss suffered by the Seller Indemnified Parties with respect to (i) breaches of the Purchaser Fundamental
Representations, for which the maximum amount recoverable by the Seller Indemnified Parties shall be limited to an amount equal
to the Purchase Price actually due to the Sellers, or (ii) Fraud.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 5.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Claim Procedures</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Person entitled to indemnification under this <U>Article V</U> (each an &#8220;<U>Indemnified Party</U>&#8221;) agrees
that after it becomes aware of facts giving rise to a claim by it for indemnification pursuant to this <U>Article V</U>, such Indemnified
Party shall assert its claim for indemnification under this <U>Article V</U> (each a &#8220;<U>Claim</U>&#8221;) by providing a
written notice (a &#8220;<U>Claim Notice</U>&#8221;) within 30 days of becoming aware of the facts giving rise to such claim, to
the Person required to provide indemnification protection under this <U>Article V</U> (each, an &#8220;<U>Indemnifying Party</U>&#8221;)
specifying, in reasonable detail, the nature and basis for such Claim (including identifying the relevant provisions of this Agreement
upon which such Claim is based) and the amount of Losses associated therewith (if known). Notwithstanding the foregoing, no Indemnified
Party&#8217;s failure to send or delay in sending a Claim Notice will relieve the Indemnifying Party from Liability hereunder with
respect to such Claim, except to the extent that the Indemnifying Party is materially prejudiced by such failure or delay.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>If
any Proceeding is begun, made or instituted by a third party as a result of which an Indemnifying Party may become obligated
to an Indemnified Party hereunder, such Indemnified Party shall give a Claim Notice to the Indemnifying Party as described in <U>Section&nbsp;5.4(a)</U>.
The Indemnifying Party shall have the right to defend, contest or otherwise protect the Indemnified Party against any
Proceeding at its sole cost and expense. Except as otherwise provided in this <U>Section 5.4(b)</U>, the Indemnifying Party
shall have the right to (i) control and conduct any such Proceeding, (ii) take all other reasonable steps to defend against
any such third-party claim and (iii) employ counsel designated by the Indemnifying Party to contest any such third-party
claim in the name of the Indemnified Party or otherwise. Notwithstanding the above, the Indemnifying Party shall not have the
right to control or defend any indemnification Proceeding if (1) the Indemnifying Party is also a party to such Proceeding
and the Indemnified Party determines in good faith that joint representation would be inappropriate, (2) the claim for
indemnification relates to or arises in connection with any criminal proceeding, or (3) the claim seeks an injunction or
equitable relief. The Indemnifying Party shall, within 15 days after receipt of a Claim Notice of any such third-party claim,
give written notice to the Indemnified Party of its intention to assume the defense of such third-party claim. The
Indemnified Party shall have the right, but not the obligation, to participate at its own expense in the defense thereof by
counsel of the Indemnified Party&#8217;s choice and shall in any event cooperate with and assist the Indemnifying Party to
the extent reasonably possible. If the Indemnifying Party fails to elect to defend, contest or otherwise protect against such
Proceeding, then (i) the Indemnified Party shall have the right to do so, provided that the Indemnified Party shall not make
any compromise or settlement thereof without the Indemnifying Party&#8217;s prior written consent (which shall not be
unreasonably withheld, conditioned or delayed), (ii) subject to the limitations set forth in this <U>Article V</U>, the
Indemnified Party shall be entitled to recover the amount of Loss thereof from the Indemnifying Party upon final
determination the underlying Claim is subject to indemnification pursuant to this <U>Article V</U>, including reasonable
attorneys&#8217; fees, disbursements and amounts paid as the result of such Proceeding (except with respect to any compromise
or settlement made without the prior written consent of the Indemnifying Party as described above), and (iii) the Indemnified
Party shall keep the Indemnifying Party reasonably informed as to all matters concerning such Proceeding and shall promptly
notify the Indemnifying Party in writing of any and all significant developments relating thereto. If the Indemnifying Party
assumes the defense of any Proceeding as provided herein, (A) it will be conclusively established for purposes of this
Agreement that the claims made in that Proceeding are within the scope of and subject to indemnification; (B) no compromise
or settlement of such claims may be effected by the Indemnifying Party without the Indemnified Party&#8217;s consent (which
shall not be unreasonably withheld, conditioned or delayed) unless (i) there is no finding or admission of any violation of
Law and no adverse effect as to any Indemnified Party on any other claims that may be made against the Indemnified Party and
(ii) the sole relief provided is monetary damages that are paid in full by the Indemnifying Party; and (C) the Indemnified
Party will have no Liability with respect to any compromise or settlement of such claims effected without its consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 5.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Calculation of Losses</U>. Notwithstanding anything contained herein to the contrary, for purposes of this <U>Article
V</U>, in determining the existence of a breach of any representation or warranty in this Agreement and the amount of any corresponding
Losses, no effect shall be given to any &#8220;materiality,&#8221; &#8220;Material Adverse Effect&#8221; or similar qualifier.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 5.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Treatment of Indemnification Payments</U>. Any amounts payable under this <U>Article V</U> shall for all purposes
be treated by the Purchaser and the Sellers as an adjustment to the Purchase Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section
5.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B><U>Escrow
Accounts; Order of Recovery</U>. Upon the final determination of the amount of any Losses in excess of the Deductible for
which a Purchaser Indemnified Party shall be entitled to indemnification pursuant to <U>Section 5.2(a)(i)</U>, the Purchaser
and the Sellers&#8217; Representative shall promptly execute and deliver a joint written instruction to the Escrow Agent to
disburse an amount equal to the amount of such Losses by wire transfer of immediately available funds from the funds
remaining in the Indemnity Escrow Account to an account designed in writing by the Purchaser. Subject to the limitations set
forth in this <U>Article V</U>, in the event that such Losses relate to a breach of the Company Fundamental Representations
or Fraud and the amount of such Losses as finally determined exceeds the funds remaining in the Indemnity Escrow Account, (i)
Purchaser shall set off such Losses against any monies due and payable to the Sellers pursuant to <U>Section 2.9</U> (solely
to the extent it has been finally determined and agreed in writing such monies are due and payable pursuant to <U>Section
2.9</U>) and (ii) if such Losses exceed the amount available for set off, the Sellers shall, severally in accordance with
each Seller&#8217;s Pro Rata Indemnification Share, pay to the Purchaser, by wire transfer of immediately available funds, an
amount in cash equal to the difference between (A) the amount of such Losses (<U>less</U> any amount set off against any
monies due and payable to the Sellers pursuant to <U>Section 2.9</U> (solely to the extent it has been finally determined and
agreed in writing such monies are due and payable pursuant to <U>Section 2.9</U>)) and (B) the funds remaining in the
Indemnity Escrow Account. Upon the final determination of the amount of any Losses for which a Purchaser Indemnified Party
shall be entitled to indemnification pursuant to this Article V (other than pursuant to <U>Section 5.2(a)(i)</U>), subject to
the limitations set forth in this <U>Article V</U>, (i) Purchaser shall set off such Losses against any monies that are due
and payable to the Sellers pursuant to <U>Section 2.9 </U>(solely to the extent it has been finally determined and agreed in
writing such monies are due and payable pursuant to <U>Section 2.9</U>) and (ii) if such Losses exceed the amount available
for set off, the Sellers shall, severally in accordance with each Seller&#8217;s Pro Rata Indemnification Share, pay to the
Purchaser, by wire transfer of immediately available funds, an amount in cash equal to the difference between (A) the amount
of such Losses and (B) any amount set off against any monies that are due and payable to the Sellers pursuant to <U>Section
2.9</U> (solely to the extent it has been finally determined and agreed in writing such monies are due and payable pursuant
to <U>Section 2.9</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 5.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Other Limitations and Agreements</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>For purposes of calculating the monetary amount of Losses for which any Claim may be made against any Indemnifying Party,
such monetary amount shall be decreased to the extent of any amounts actually recovered by an Indemnified Party under insurance
policies (other than the R&amp;W Insurance Policy) and net of any increase in premiums directly attributable to such Losses for
the year of the claim and the following year, or deductibles or co-pays incurred in connection therewith, including costs of collection.
If an insurance or other recovery is made by any Indemnified Party with respect to any Loss for which any such Person has been
indemnified hereunder (other than a recovery under the R&amp;W Insurance Policy), then a refund equal to the amount of the recovery
(net of any premium increase or collection costs) shall be made promptly to the Indemnifying Party that made or directed such indemnification
payments to such Indemnified Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No Indemnified Party shall make any claim for indemnification for Losses under this Agreement in respect of any matter to
the extent such Losses were taken into account in the calculation of the Final Consideration (as finally determined pursuant to
<U>Section&nbsp;2.6</U>) or would otherwise result in double recovery for any such Losses. Without limiting the foregoing, an Indemnified
Party shall be entitled to recover for a Loss only once under this <U>Article V</U> even if a Claim or Claims for indemnification
in respect of such Loss has or have been made as a result of a breach of more than one representation, warranty or covenant contained
in this Agreement. With respect to any claim for indemnification pursuant to this <U>Article V</U>, no Seller shall be required
to pay more than such Seller&#8217;s Pro Rata Indemnification Share of the applicable Loss, and in no event shall the aggregate
maximum liability of any Seller for claims for indemnification pursuant to this <U>Article V</U> exceed the amount of the Purchase
Price paid to such Seller.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Except
in the event of Fraud or with respect to an action for which equitable relief is sought (and solely to the extent such action
seeks equitable relief), Purchaser and the Sellers acknowledge and agree that, after the Closing, the indemnification
provisions in this <U>Article V</U> shall be the sole and exclusive remedy of Purchaser and the Sellers with respect to the
transactions contemplated by this Agreement. In addition, Purchaser agrees that the only source of recovery for any claims
that Purchaser and its Affiliates may have (including indemnification claims under this <U>Article V</U>) related to or
arising from <U>Section 5.2(a)(i) </U>of this Agreement shall be from the recovery of amounts pursuant to the Indemnity
Escrow Account and the R&amp;W Insurance Policy, except with respect to (i) a breach of the Company Fundamental
Representations and (ii) for Fraud. Purchaser and Sellers may not avoid the limitations on liability and recovery set forth
in this <U>Article V</U> by seeking damages for breach of contract, tort or pursuant to any other theory or liability.
Nothing in this <U>Section 5.8(c)</U> shall prevent or prohibit a party from seeking and/or obtaining specific performance in
accordance with <U>Section 7.13</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No Losses shall be recoverable hereunder that constitute punitive damages except for any such damages or Losses awarded
or granted in connection with a claim by a third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">Article
VI</FONT><FONT STYLE="color: red"><BR>
</FONT>AGREEMENTS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 6.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Non-Competition; Non-Solicitation and Interference</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Sellers acknowledge and agree that (i) the agreements and covenants contained in this <U>Section 6.1</U> are reasonable
and valid in geographical and temporal scope and in all other respects and essential to protect the value of the business and Assets
of the Company; (ii) the Purchaser has agreed to purchase the Shares in reliance on the covenants made by the Sellers in this <U>Section
6.1</U>; and (iii) the Purchaser would not have agreed to purchase the Shares in the absence of the covenants made by the Sellers
in this <U>Section 6.1</U>. Therefore, each Management Shareholder agrees that, during the Restricted Period, such Management Shareholder
shall not participate or engage, directly or indirectly, whether as an employee, agent, officer, subcontractor, consultant, director,
stockholder, partner, joint venture partner or investor, in Competitive Activities anywhere in the world. Each Seller further agrees
that, during the Restricted Period, no Seller shall, directly or indirectly, for its own account or for the account of any other
individual or entity, engage in Interfering Activities. Notwithstanding anything herein to the contrary, this <U>Section&nbsp;6.1(a)</U>
shall not prevent a Seller from acquiring investment securities representing not more than 3% of the voting securities of any corporation
where such securities are listed on a nationally recognized stock exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If any court of competent jurisdiction shall at any time deem the duration or the geographic scope of any of the provisions
of this <U>Section 6.1</U> unenforceable, the other provisions of this <U>Section 6.1</U> shall nevertheless stand and the duration
and/or geographic scope set forth herein shall be deemed to be the longest period and/or greatest size permissible by law under
the circumstances, and the parties hereto agree that such court shall reduce the time period and/or geographic scope to a permissible
duration or size.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Without
limiting the remedies available to the Purchaser, each Seller acknowledges that a breach of any of the covenants contained in
this <U>Section 6.1</U> may result in material irreparable injury to the Purchaser and/or the other Purchaser Group Companies
(including the Company) for which there is no adequate remedy at law, that it will not be possible to measure damages for
such injuries precisely and that, in the event of such a breach or threat thereof, the Purchaser or any other Purchaser Group
Company shall be entitled to obtain a temporary restraining order and/or a preliminary or permanent injunction, without the
necessity of proving irreparable harm or injury as a result of such breach or threatened breach hereof, restraining each
Seller from engaging in activities prohibited by this <U>Section 6.1</U> or such other relief as may be required specifically
to enforce any of the covenants in this <U>Section 6.1</U>. Notwithstanding any other provision to the contrary, the
Restricted Period shall be tolled during any period of violation of any of the covenants in <U>Section 6.1</U> hereof and
during any other period required for litigation during which the Purchaser or any other Purchaser Group Company seeks to
enforce such covenants against a Seller if it is ultimately determined that such Seller was in breach of such covenants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 6.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Termination of Related Party Contracts</U>. Except for the Contracts set forth on <U>Schedule 6.2</U> of the Disclosure
Schedules, effective as of the Closing, each Contract between any Seller or its Affiliates (other than the Company) or any member
of their respective immediate family, on the one hand, and the Company, on the other hand (each, a &#8220;<U>Related Party Contract</U>&#8221;),
will be automatically terminated and of no further effect, with no further liability of any party thereto, and the Sellers shall
execute any and all instruments reasonably requested by the Purchaser in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section
6.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B><U>Representative;
Power of Attorney</U>. By their approval of the execution and delivery of this Agreement, the Sellers shall be deemed to have
irrevocably appointed, authorized and directed the Sellers&#8217; Representative to act as the representative, agent, proxy
and attorney-in-fact for the Sellers for all purposes under this Agreement, including the full power and authority on the
Sellers&#8217; behalf to: (i) negotiate disputes arising under, or relating to, this Agreement and the other agreements,
instruments and documents contemplated hereby or executed in connection herewith, (ii) receive and disburse to the Sellers
any funds received on behalf of the Sellers under this Agreement or otherwise, (iii) execute and deliver any amendment or
waiver to this Agreement and the other agreements, instruments and documents contemplated hereby or thereby or executed in
connection herewith or therewith, (iv) exercise in his, her or its discretion, all rights and powers expressly conferred on
the Sellers&#8217; Representative hereunder and (v) take all other actions to be taken by or on behalf of the Sellers in
connection with this Agreement and the other agreements, instruments and documents contemplated hereby or executed in
connection herewith or therewith. The Sellers, by approving this Agreement, further agree that such agency and proxy are
coupled with an interest, are therefore irrevocable without the consent of the Sellers&#8217; Representative and shall
survive the death, incapacity, bankruptcy, dissolution or liquidation of any Seller. All decisions and actions by the
Sellers&#8217; Representative shall be binding upon all of the Sellers, and no Seller shall have the right to object,
dissent, protest or otherwise contest the same. The Sellers&#8217; Representative shall have no duties or obligations
hereunder except those set forth herein and such duties and obligations shall be determined solely by the express provisions
of this Agreement. In addition, the Sellers&#8217; Representative shall have all such incidental powers as may be necessary
or desirable to carry into effect the provisions of this <U>Section 6.3</U>, including, at the expense of the Sellers, to
retain attorneys, accountants and other advisors to assist him in the performance of his duties, and/or the exercise of his
rights and powers, hereunder. Each Seller shall, only to the extent of such Seller&#8217;s Pro Rata Indemnification Share,
indemnify and defend the Sellers&#8217; Representative and hold the Sellers&#8217; Representative harmless against any loss,
damage, cost, Liability or expense actually incurred without fraud, gross negligence or willful misconduct by the
Sellers&#8217; Representative (as determined in a final and non-appealable judgment of a court of competent jurisdiction) and
arising out of or in connection with the acceptance, performance or administration of the Sellers&#8217;
Representative&#8217;s duties under this Agreement. Any expenses or taxable income incurred by the Sellers&#8217;
Representative in connection with the performance of its duties under this Agreement shall not be the personal obligation of
the Sellers&#8217; Representative but shall be payable by and attributable to the Sellers based on their respective Pro Rata
Indemnification Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Split-Segment; Name: a9 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 6.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Release</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In further consideration of the transactions contemplated hereby, each Seller for itself and on behalf of its Affiliates
hereby irrevocably and unconditionally releases, waives and holds the Purchaser, the Company, their respective Affiliates, predecessors
and assigns, and their respective directors (or Persons in similar positions), officers, employees, equityholders and agents harmless
from and against any and all claims of any nature (the &#8220;<U>Seller Claims</U>&#8221;), arising from the beginning of the world
to and through the Closing, except for (i) claims that relate to such Seller&#8217;s rights under this Agreement or any of the
other ancillary agreements or instruments executed pursuant to this Agreement, and (ii) such Seller&#8217;s rights to indemnification
under the Company&#8217;s Fundamental Documents in effect on the Closing Date for having served as an officer or director of the
Company (the &#8220;<U>Release</U>&#8221;). It is further agreed and understood that this Release is a full and final release of
all the Seller Claims whether known or unknown, fixed or contingent, manifested or unmanifested, except for those exceptions described
in the previous sentence. Each Seller hereby waives the protection of any provision of any Law that would operate to preserve claims
that are unknown as of the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>By execution and delivery of this Agreement, as of the Closing, each Seller, on behalf of itself and its Affiliates and
their respective successors and assigns, hereby (A) ratifies all prior actions of the current and former directors and officers
of the Company, and fully releases and forever discharges each such director and officer and his or her respective successors and
assigns from any and all claims, suits, debts and demands whatsoever, whether known or unknown, foreseen or unforeseen, whether
at law, in equity or otherwise, which such Seller and their respective successors and assigns ever had, or now or hereafter may
have arising from or relating to such Person&#8217;s service as a director or officer and his or her acts and omissions as such
director or officer (except for fraud or intentional violation of Law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except for the Contracts set forth on <U>Schedule 6.2</U> of the Disclosure Schedules, by execution and delivery of this
Agreement, as of the Closing, each Seller, on behalf of itself and its Affiliates and their respective successors and assigns,
waives all rights under, and agrees to the automatic termination of any Contract between such Seller and any of its Affiliates
and immediate family members, on the one hand, and the Company, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section
6.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B><U>R&amp;W
Insurance Policy</U>. At or prior to the Closing, Purchaser shall obtain the R&amp;W Insurance Policy attached hereto as <U>Exhibit
D</U> for the benefit of Purchaser and its Affiliates.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP> </SUP></FONT>Purchaser
shall be responsible for fifty percent (50%) of all premiums, fees, costs, and expenses of the R&amp;W Insurance Policy
(whether incurred by the Company directly or by the Purchaser). During the policy period of the R&amp;W Insurance Policy,
Purchaser shall, and shall cause each of the Purchaser Indemnitees to, (i) maintain such R&amp;W Insurance Policy in full
force and effect, (ii) not amend or otherwise modify the subrogation provisions contained in the R&amp;W Insurance Policy or
take any action that would result in the cancellation, termination, amendment or modification of the R&amp;W Insurance Policy
and (iii) continue to honor its obligations under the R&amp;W Insurance Policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 6.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Employee Matters</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>From and after the Closing Date until the first (1st) anniversary thereof (or until such earlier time that the Continuing
Employee (as defined below) is no longer employed by the Purchaser or any of its Subsidiaries), the Purchaser shall, or shall cause
the Company to, provide to each Business Employee who continues their employment with the Purchaser or any of its Subsidiaries
immediately following the Closing (collectively, the &#8220;<U>Continuing Employees</U>&#8221;) (i) base salary at a rate that
is no less favorable than the base salary rate provided to such Continuing Employee immediately prior to the Closing Date and (ii)&nbsp;employee
benefits (including target annual cash incentive compensation opportunities but excluding nonqualified deferred compensation benefits,
defined benefit plan benefits, retiree health and welfare benefits, equity and equity-based awards, severance benefits and change
in control plans, programs and arrangements) that are substantially comparable in the aggregate to either those provided to (x)&nbsp;such
Continuing Employees by the Company as of immediately prior to the Closing Date or (y)&nbsp;similarly-situated employees of Purchaser
or any of its Subsidiaries from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Purchaser shall, and shall cause, service rendered by Continuing Employees prior to the Closing Date to be taken into
account for all purposes including participation, coverage, vesting and level of benefits, as applicable, under all employee benefit
plans, programs, policies and arrangements of the Purchaser and its Subsidiaries (including the Company) from and after the Closing
Date (collectively, the &#8220;<U>New Plans</U>&#8221;), to the same extent as such service was taken into account immediately
prior to the Closing under corresponding Company Plan for such purposes; provided, however, that no service shall be credited (i)&nbsp;to
the extent that it would result in duplication of any benefits for the same period of service, (ii)&nbsp;for purposes of benefit
accrual under defined benefit pension plans or retiree health or welfare plan or arrangement or vesting under any equity or equity-based
plan or arrangement, or (z) to the extent that such service is not generally recognized under such New Plan for similarly-situated
employees of Purchaser or any of its subsidiaries. In addition, Purchaser shall, and shall cause the Company to use commercially
reasonable efforts to, cause to be waived any pre-existing condition exclusions and similar limitations under any New Plans that
provide welfare benefits in which Continuing Employees commence participation during the plan year in which the Closing Date occurs
to the extent such exclusions or limitations were waived or satisfied by a Continuing Employee under any Company Plan providing
welfare benefits in which the Continuing Employee participated immediately prior to the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Nothing
contained in this Section, expressed or implied, shall (i) create or confer any rights, remedies or claims upon any employee
of the Company or any right of employment or engagement or continued employment or engagement or any particular term or
condition of employment or engagement for any Continuing Employee or any other Person, (ii) be considered or deemed to
establish, amend, or modify any New Plan or Company Plan or any other benefit or compensation plan, program, policy,
agreement, arrangement, or contract, (iii) prohibit or limit the ability of Purchaser to amend, modify or terminate any
benefit or compensation plan, program, policy, agreement, arrangement, or contract at any time assumed, established,
sponsored or maintained by any of them or (iv) confer any rights, remedies or benefits (including any third-party beneficiary
rights) on any Person other than the parties to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 6.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Director and Officer Indemnification</U>. For a period of six (6) years after the Closing, Purchaser shall not, and
shall not permit the Company to, amend, repeal or modify any provision of the Company&#8217;s Fundamental Documents relating to
the exculpation or indemnification of any officers or directors, it being the intent of the parties that the officers and directors
of the Company shall continue to be entitled to such exculpation and indemnification to the full extent of the Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 6.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Tax Matters</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding any other provision of this Agreement to the contrary, all transfer, documentary, sales, use, value added,
excise, stamp, registration and other similar Taxes, and all conveyance fees, recording charges and other fees and charges (including
any penalties and interest) incurred in connection with the consummation of the transactions contemplated by this Agreement (collectively,
 &#8220;<U>Transfer Taxes</U>&#8221;) shall be borne and paid fifty percent (50%) by Purchaser and fifty percent (50%) by Seller.
Purchaser shall, at its own expense, file all necessary Tax Returns and other documentation with respect to all such Taxes, fees
and charges, and, if required by applicable law, the Parties shall, and shall cause their Affiliates to, join in the execution
of any such Tax Returns and other documentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> The Purchaser shall prepare or cause to be prepared, and timely file or cause to be timely filed, at Purchaser&#8217;s
expense, all Tax Returns of the Company that are required to be filed after the Closing Date and shall timely pay all Taxes due
as reflected on such Tax Returns. The Purchaser and the Seller&#8217;s Representative shall cooperate, as and to the extent reasonably
requested by the other, in connection with the filing of Tax Returns and any audit or Proceeding with respect to Taxes of the Company.
Such cooperation shall include the retention and (upon request therefor) the provision of records and information reasonably relevant
to any such Proceeding and making employees available on a mutually convenient basis to provide additional information and explanation
of any material provided hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">Article
VII</FONT><FONT STYLE="color: red"><BR>
</FONT>MISCELLANEOUS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 7.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>No Third Party Beneficiaries</U>. Except as expressly provided herein, this Agreement shall not confer any rights
or remedies upon any Person other than the parties hereto and their respective successors and permitted assigns, personal representatives,
heirs and estates, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 7.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Expenses</U>. Except as otherwise provided herein, each of the parties hereto shall pay its own expenses in connection
with this Agreement and the transactions contemplated hereby, including any legal and accounting fees, whether or not the transactions
contemplated hereby are consummated. For the avoidance of doubt, neither the Purchaser, any of its Affiliates or the Company shall
be responsible for any expenses of the Sellers in connection with this Agreement or the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 7.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Confidentiality</U>. Each of the Sellers agrees that it will not, and will cause its respective Affiliates not to,
directly or indirectly, for themselves and on behalf of any other Person, from and after the Closing Date, use for its benefit,
or disclose to any Person, any proprietary information of the Company or its Affiliates or information with respect to customers,
suppliers, employees or the financial affairs of the Company or its Affiliates, or any other confidential matter, obtained or
developed prior to the Closing with respect to any aspect of the business of the Company or its Affiliates. The obligations set
forth in the preceding sentence with respect to any such information shall terminate and be of no further force or effect when
such information is in the public domain through no wrongful act (including negligence and willful misconduct) on the part of
any of the Sellers. Notwithstanding the foregoing, each of the Sellers shall be permitted to make disclosures concerning such
information (i) in connection with any Tax Returns filed by such Seller, (ii) in connection with enforcing such Seller&#8217;s
rights pursuant to this Agreement or (iii) to the extent such information was or becomes available to such Seller from a third
party who is not known to such Seller to be bound by an obligation of confidentiality with respect thereto. No press release or
other public announcement related to this Agreement or the transactions contemplated hereby shall be issued or made by the Sellers
without the prior written approval of the Purchaser unless required by Law (in the reasonable opinion of counsel), in which case
the Purchaser shall have the right to review and comment on such press release, announcement or communication prior to the issuance,
distribution or publication thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 7.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Entire Agreement</U>. This Agreement constitutes the entire agreement among the parties hereto and supersedes any
prior understandings, agreements or representations by or among such parties, written or oral, that may have related in any way
to the subject matter of this Agreement, including any letter of intent, dated as of or prior to the date hereof, among the Company,
the Sellers, the Purchaser or any Affiliates of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 7.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Successors and Assigns</U>. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto
and their respective successors and permitted assigns. No party hereto may assign either this Agreement or any of its rights, interests
or obligations hereunder without the prior written approval of the other parties hereto; <U>provided</U>, that the Purchaser may
assign any of its rights and/or obligations under this Agreement to (a) any Affiliate of the Purchaser; (b) any Person who shall
acquire substantially all of the Assets of the Purchaser or a majority in voting power of the capital shares or equity interests
of the Purchaser (whether pursuant to a merger, consolidation, sale of equity interests or otherwise); and (c) any lender of the
Purchaser (or any agent therefor) for security purposes and the assignment thereof by any such lender or agent to the Purchaser
in connection with the exercise by any such lender or agent of all of its rights and remedies as a secured creditor with respect
thereto; provided, in each case, the Purchaser remains primarily liable for all of its obligations pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 7.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Counterparts</U>. This Agreement may be executed in one or more counterparts (including by facsimile, .pdf or other
electronic method), each of which shall be deemed an original, but all of which, together, shall constitute one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section
7.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B><U>Notices</U>.
All notices, requests, demands, claims and other communications required or permitted hereunder shall be in writing and shall
be deemed to have been duly given if delivered personally, e-mailed, facsimiled, sent by nationally recognized overnight
courier or mailed by registered or certified mail (return receipt requested), postage prepaid, to the parties hereto at the
following respective addresses (or at such other address for any such party as shall be specified by like notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">If to the Purchaser, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">HealthEquity, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">15 West Scenic Pointe Drive, Suite 100</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">Draper, UT 84020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">Attention: Jon Kessler</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;Delano Ladd</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">E-mail: jkessler@healthequity.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in 0pt 0.75in; text-align: left; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dladd@healthequity.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">with a copy to (which shall not constitute
notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 1in; text-align: left">Willkie Farr &amp; Gallagher LLP<BR>
787 Seventh Avenue<BR>
New York, NY 10019<BR>
Attention: Matthew J. Haddad<BR>
E&#45;mail: mhaddad@willkie.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 1in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">If to the Sellers, to the Sellers&#8217;
Representative:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">Evan McCordick</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">216 Purchase Street, Unit P</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">Rye, NY 10580&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">E-mail:&#8239;&nbsp;&nbsp;evan@73dockstreet.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">with a copy to (which shall not constitute
notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">TangoLaw PLLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">801 2<SUP>nd</SUP> Avenue, Suite 1110</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">Seattle, WA 98104</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">Attention: Cameron Smith; Shane Anderson</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: left">E-mail:&#8239;&nbsp;&nbsp;cam@tangolaw.com; shane@tangolaw.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All such notices and other communications
shall be deemed to have been given and received (a) in the case of personal delivery, on the date of such delivery, (b) in the
case of delivery by e-mail or facsimile, on the date of such delivery, (c) in the case of delivery by nationally recognized overnight
courier, on the third Business Day following dispatch and (d) in the case of mailing, on the seventh Business Day following such
mailing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section
7.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></B><U>Amendments
and Waivers</U>. No amendment of any provision of this Agreement shall be valid unless the same shall be in writing and
signed by the Sellers&#8217; Representative and the Purchaser. No waiver by any party hereto of any default,
misrepresentation or breach of warranty or covenant hereunder, whether intentional or not, shall be deemed to extend to any
prior or subsequent default, misrepresentation or breach of warranty or covenant hereunder or affect in any way any rights
arising by virtue of any prior or subsequent such occurrence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 7.9<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Incorporation of Annexes, Disclosure Schedules and Exhibits</U>. The annexes attached hereto, the Disclosure Schedules
and the exhibits identified in this Agreement are incorporated herein by reference and made a part hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 7.10<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Disclosure Schedules</U>. The Disclosure Schedules have been arranged for in separately numbered and lettered sections
corresponding to sections and subsections of this Agreement; <U>provided</U>, <U>however</U>, that each section of the Disclosure
Schedules will be deemed to incorporate by reference all information disclosed in any other section of the Schedules only to the
extent the applicability of such disclosure to another section of the Schedules is reasonably apparent on the face of such disclosure.
Information reflected in the Disclosure Schedules is not necessarily limited to matters required by this Agreement to be reflected
in the Disclosure Schedules. Such additional information is set forth for informational purposes and does not necessarily include
other matters of a similar nature. The disclosure of such additional information shall not be deemed to constitute an acknowledgment
that such information is required to be disclosed, and the disclosure of such information shall not be deemed to enlarge or enhance
any of the representations or warranties in this Agreement or otherwise alter in any way the terms of this Agreement. The inclusion
of information in the Disclosure Schedules shall not be construed as an admission that such information is material to the business,
assets, liabilities, financial position, operations or results of operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 7.11<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Construction</U>. Where specific language is used to clarify by example a general statement contained herein, such
specific language shall not be deemed to modify, limit or restrict in any manner the construction of the general statement to which
it relates. The language used in this Agreement shall be deemed to be the language chosen by the parties hereto to express their
mutual intent, and no rule of strict construction shall be applied against any such party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 7.12<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Independence of Representations and Warranties</U>. All representations and warranties hereunder shall be given independent
effect so that if a particular representation or warranty proves to be incorrect or is breached, the fact that another representation
or warranty concerning the same or similar subject matter is correct or is not breached will not affect the incorrectness of or
a breach of a representation and warranty hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 7.13<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Remedies</U>. The parties hereto shall each have and retain all rights to pursue actions for specific performance
and/or injunctive or other equitable relief (including the remedy of rescission) to enforce or prevent any violations of the provisions
of this Agreement. Each party to this Agreement acknowledges and agrees that any breach by it of this Agreement will cause one
or more of the other parties irreparable harm that may not be adequately compensable by monetary damages. Accordingly, in the event
of a breach or threatened breach by a party of any provision of this Agreement, each party shall be entitled to the remedies of
specific performance, injunction or other preliminary or equitable relief without having to prove irreparable harm or actual damages.
The foregoing right shall be in addition to such other rights or remedies as may be available to any party hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 63; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 7.14<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Further Assurances</U>. Each party hereto shall use its commercially reasonable efforts to comply with all requirements
imposed hereby on such party and to cause the transactions contemplated herein (including the transfer of the Shares to the Purchaser)
to be consummated as contemplated herein and shall, from time to time and without further consideration, either before or after
the Closing, execute such further instruments and take such other actions as any other party hereto shall reasonably request in
order to fulfill its obligations under this Agreement and to effectuate the purposes of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 7.15<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Severability</U>. It is the desire and intent of the parties hereto that the provisions of this Agreement be enforced
to the fullest extent permissible under the Laws and public policies applied in each jurisdiction in which enforcement is sought.
Accordingly, if any particular provision of this Agreement shall be adjudicated by a court of competent jurisdiction to be invalid,
prohibited or unenforceable for any reason, such provision, as to such jurisdiction, shall be ineffective, without invalidating
the remaining provisions of this Agreement or affecting the validity or enforceability of this Agreement or affecting the validity
or enforceability of such provision in any other jurisdiction. Notwithstanding the foregoing, if such provision could be more narrowly
drawn so as not to be invalid, prohibited or unenforceable in such jurisdiction, it shall, as to such jurisdiction, be so narrowly
drawn, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of such provision
in any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 7.16<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Governing Law</U>. This Agreement will be governed by and construed in accordance with the Laws of the State of Delaware,
without giving effect to any choice of law or conflicting provision or rule that would cause the Laws of any jurisdiction other
than the State of Delaware to be applied. In furtherance of the foregoing, Laws of the State of Delaware will control the interpretation
and construction of this Agreement, even if under such jurisdiction&#8217;s choice of law or conflict of law analysis, the substantive
Law of some other jurisdiction would ordinarily apply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 7.17<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Exclusive Jurisdiction and Service of Process</U>. Any suit, action or proceeding brought by any party hereto seeking
to enforce any provision of, or based on any matter arising out of or in connection with, this Agreement or the transactions contemplated
hereby shall be brought in any court located in the County of Wilmington, Delaware, or the United States of America for the District
of Delaware. Each party hereto hereby submits to the exclusive jurisdiction of any such court located in the County of Wilmington,
Delaware, or the United States of America for the District of Delaware having subject matter jurisdiction in any suit, action or
proceeding brought by any other party hereto seeking to enforce any provision of, or based on any matter arising out of or in connection
with, this Agreement or the transactions contemplated hereby. Each party hereto hereby irrevocably waives, to the fullest extent
permitted by Law, any objection that it may now or hereafter have to the laying of the venue of any such suit, action or proceeding
in any such court or that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum.
Process in any such suit, action or proceeding may be served on any party hereto anywhere in the world, whether within or without
the jurisdiction of any such court. Without limiting the foregoing, each party hereto hereby agrees that service of process on
such party in accordance with the provisions of this <U>Section 7.17</U> in respect of any such suit, action or proceeding shall
be deemed effective service of process on such party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 7.18<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B><U>Waiver of Jury Trial</U>. Each of the parties hereto hereby irrevocably waives all right to trial by jury in any
action, proceeding or counterclaim arising out of or relating to this Agreement or any other document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.6pt 0pt 0; text-align: center"><B>[remainder of page intentionally
left blank]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.6pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 64; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the parties hereto have executed this Agreement as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURCHASER</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HEALTHEQUITY, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Jon Kessler</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Jon Kessler</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: President &amp; Chief Executive Officer</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[Stock Purchase Agreement]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 65 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the parties hereto have executed this Agreement as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><B>SELLERS&rsquo; REPRESENTATIVE</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Evan McCordick</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><B>EVAN MCCORDICK</B></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[Stock Purchase Agreement]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: left"></P>

<!-- Field: Page; Sequence: 66; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the parties hereto have executed this Agreement as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">SELLER</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase"><FONT STYLE="font-size: 10pt">2814697
    Ontario Inc.,</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">a Corporation organized
    under the laws of Ontario, Canada</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">/s/ Evan McCordick</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: Evan McCordick</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title: Executive Director</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[Stock Purchase Agreement]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 67 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the parties hereto have executed this Agreement as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%">SELLER</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ E. Sohier Hall</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">E. SOHIER HALL</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[Stock Purchase Agreement]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 68 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the parties hereto have executed this Agreement as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%">SELLER</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Hugh Sullivan</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">HUGH SULLIVAN</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[Stock Purchase Agreement]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 69 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the parties hereto have executed this Agreement as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%">SELLER</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Matt Hall</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">MATT HALL</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 70 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the parties hereto have executed this Agreement as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%">SELLER</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Tyler Simpson</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">TYLER SIMPSON</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 71 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the parties hereto have executed this Agreement as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%">SELLER</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Jonathan Kallay</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">JONATHAN KALLAY</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 72 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the parties hereto have executed this Agreement as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">SELLER</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase"><FONT STYLE="font-size: 10pt">Julie
    H. Sullivan, Trustee of the Hugh D. Sullivan Irrevocable Family Trust under agreement dated September&nbsp;25, 2020</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">/s/ Julie H. Sullivan</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: Julie H. Sullivan</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title: Trustee</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 73 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the parties hereto have executed this Agreement as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%">SELLER</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Michael Beck</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">MICHAEL BECK</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 74 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the parties hereto have executed this Agreement as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%">SELLER</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Michelle Rosenthal</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">MICHELLE ROSENTHAL</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 75 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the parties hereto have executed this Agreement as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%">SELLER</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Jonathan Kallay</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">JONATHAN KALLAY</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 76 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the parties hereto have executed this Agreement as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%">SELLER</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Naomi Pattis</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">NAOMI PATTIS</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 77 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the parties hereto have executed this Agreement as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%">SELLER</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Michael Gottlieb</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">MICHAEL GOTTLIEB</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 78; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>tm218956d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 50%; vertical-align: middle"><IMG SRC="tm218956d1_ex99-1img001.jpg" ALT=""></TD><TD STYLE="text-align: right; width: 50%">&nbsp;<IMG SRC="tm218956d1_ex99-1img002.jpg" ALT=""></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>HealthEquity Expands Commuter Offering
with Luum</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>Acquisition
adds options beyond monthly transit passes,&nbsp;</B></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>strengthening
capabilities for the new hybrid workplace</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>DRAPER, Utah</B></FONT>,&nbsp;(GLOBE
NEWSWIRE) <B>&ndash;&nbsp;March&nbsp;8, 2021</B> - HealthEquity,&nbsp;Inc.&nbsp;(NASDAQ: HQY) (&quot;HealthEquity&quot;), the
nation's largest independent health savings account (&quot;HSA&quot;) custodian, today jointly announced the acquisition of Luum,
a fast-growing technology platform for employee commute management, compliance and sustainability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">This acquisition strengthens
the HealthEquity commuter offering, delivering a critical toolset HR and facilities professionals need to implement flexible return-to-office
and hybrid-workplace strategies.</FONT> Combining technology and deep integrations with parking providers and IT integrations
into HR and Payroll systems, employers can now offer safe, affordable commute alternatives and flexible remote-work benefits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&ldquo;Luum&rsquo;s enterprise
commute platform and connected ecosystem of third-party mobility solutions enable employers to design benefits for every commute,
or no commute at all,&rdquo; said Sohier Hall, CEO of Luum. &ldquo;Adding Luum&rsquo;s powerful platform to </FONT>HealthEquity&rsquo;s
existing commuter offering and reach, we expect to help our clients offer their workforce the most flexible, useful, and sustainable
way to get to and from work. The timing of this acquisition could not be more perfect as employers across the country gear up
for a new commuting and work access environment. They require the unified system that puts their benefit policies into practice.
In support of employee experience to real estate asset optimization to workforce equity to corporate sustainability, the Luum
and HealthEquity combination is that solution.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Among the highlights, HealthEquity and Luum will deliver:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Safe
                                         commute options </B>like closed-network carpool matching, staggered arrival, guaranteed
                                         ride home, and proactive communication. Safety and transparency are a priority for employers
                                         as 64% of workers are uncomfortable returning to the office, with entry-level and older
                                         workers feeling least safe<FONT STYLE="font-size: 10pt"><SUP>1</SUP></FONT>;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Ultimate
                                         policy flexibility </B>for managing and measuring hybrid commute policies. According
                                         to Gartner, 82% of employers expect a post-pandemic hybrid workplace<FONT STYLE="font-size: 10pt"><SUP>2</SUP></FONT>.
                                         Now organizations can easily implement work-from-home cost reimbursements, sustainable
                                         commute incentives, daily parking reservations, flexible subsidies, and private bus/shuttle
                                         demand.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1
</SUP></FONT>Pew, Conference Board: <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>https://www.shrm.org/hr-today/news/hr-news/pages/remote-workers-not-comfortable-returning-to-office.aspx</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>2</SUP> Gartner: <U>https://www.nytimes.com/2021/02/22/business/energy-environment/corporations-climate-change.html</U></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Employee
                                         commute portal </B>for accurate workplace commute and remote work information, customized
                                         to employer objectives and connected to HRIS, benefits, payroll and expense management
                                         systems.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Corporate
                                         sustainability </B>as a part of the hybrid workplace strategy, through measurement and
                                         visibility of tangible outcomes on climate and other environmental conservation areas.
                                         By some estimates, the commute accounts for 98% of the typical employee&rsquo;s carbon
                                         footprint.<FONT STYLE="font-size: 10pt"><SUP>3</SUP></FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Transportation
                                         equity </B>is inextricably linked to housing and transportation affordability. When combined,
                                         50% of household costs are spent on housing and transportation in the US<FONT STYLE="font-size: 10pt"><SUP>4</SUP></FONT>.
                                         The combined solution gives employers an opportunity to create commute policies and subsidies
                                         to help address transportation affordability and equitable access.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Perella Weinberg Partners LP
served as financial advisor </FONT>and Willkie Farr&nbsp;&amp; Gallagher LLP served as legal counsel to HealthEquity on this transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>About&nbsp;HealthEquity</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">HealthEquity and its subsidiaries
administers Health Savings Accounts (HSAs) and other consumer-directed benefits for our more than 12 million accounts in partnership
with employers, benefits advisors, and health and retirement plan providers who share our mission to connect health and wealth
and value our culture of remarkable &ldquo;Purple&rdquo; service. For more information, visit </FONT><U>www.healthequity.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>About Luum</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-size: 10pt">Luum
is on a mission to empower enterprises to match employees&rsquo; dynamic work-life with safe, flexible and sustainable mobility
options. As a leader in enterprise commute management, we engage employees, unify mobility options, and bring about meaningful
behavior change.</FONT> Additionally, we provide safe, trusted and flexible commute options for frontline workers and those preparing
for a return to the workplace. For more information, visit <U>www.luum.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-looking statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">This press release contains &ldquo;forward-looking
statements&quot; within the meaning of the &ldquo;</FONT>safe harbor&rdquo; provisions of the Private Securities Litigation Reform
Act of 1995, including but not limited to, statements regarding our industry, business strategy, plans, goals and expectations
concerning our markets and market position, product expansion, future operations, expenses and other results of operations, revenue,
margins, profitability, future efficiencies, tax rates, capital expenditures, liquidity and capital resources and other financial
and operating information. When used in this discussion, the words &ldquo;may,&rdquo; &ldquo;believes,&rdquo; &ldquo;intends,&rdquo;
 &ldquo;seeks,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;plans,&rdquo; &ldquo;estimates,&rdquo; &ldquo;expects,&rdquo; &ldquo;should,&rdquo;
 &ldquo;assumes,&rdquo; &ldquo;continues,&rdquo; &ldquo;could,&rdquo; &ldquo;will,&rdquo; &ldquo;future&rdquo; and the negative
of these or similar terms and phrases are intended to identify forward-looking statements in this press release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>3</SUP> Sun-Microsystems: <U>https://www.businesswire.com/news/home/20080609005431/en/Sun-Microsystems-Study-Finds-Open-Work-Program</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>4</SUP> U.S. Department of Transportation: <U>https://www.transportation.gov/mission/health/housing-and-transportation-affordability#transportationandhealthconnection</U></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Forward-looking statements reflect our current expectations
regarding future events, results or outcomes. These expectations may or may not be realized. Although we believe the expectations
reflected in the forward-looking statements are reasonable, we can give you no assurance these expectations will prove to be correct.
Some of these expectations may be based upon assumptions, data or judgments that prove to be incorrect. Actual events, results
and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other
factors. Although it is not possible to identify all of these risks and factors, they include, among others, risks related to
the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the
                                         impact of the COVID-19 pandemic on the Company, its operations and its financial results;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">our
                                         ability to realize the anticipated financial and other benefits from combining the operations
                                         of Luum with our business in an efficient and effective manner;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">our
                                         ability to compete effectively in a rapidly evolving healthcare and benefits administration
                                         industry;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>our
                                         dependence on the continued availability and benefits of tax-advantaged health savings
                                         accounts and other consumer-directed benefits;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD>our
                                         ability to realize the anticipated financial and other benefits to the Company from acquiring
                                         Luum;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">our
                                         ability to successfully identify, acquire and integrate additional portfolio purchases
                                         or acquisition targets;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the
                                         significant competition we face and may face in the future, including from those with
                                         greater resources than us;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">our
                                         reliance on the availability and performance of our technology and communications systems;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">recent
                                         and potential future cybersecurity breaches of our technology and communications systems
                                         and other data interruptions, including resulting costs and liabilities, reputational
                                         damage and loss of business;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the
                                         current uncertain healthcare environment, including changes in healthcare programs and
                                         expenditures and related regulations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">our
                                         ability to comply with current and future privacy, healthcare, tax, investment advisor
                                         and other laws applicable to our business;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">our
                                         reliance on partners and third-party vendors for distribution and important services;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">our
                                         ability to develop and implement updated features for our technology and communications
                                         systems and successfully manage our growth;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">our
                                         ability to protect our brand and other intellectual property rights; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">our
                                         reliance on our management team and key team members.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For a detailed discussion of these and other risk factors,
please refer to the risks detailed in our filings with the Securities and Exchange Commission, including, without limitation,
our most recent Annual Report on Form&nbsp;10-K and subsequent periodic and current reports. Past performance is not necessarily
indicative of future results. We undertake no intention or obligation to update or revise any forward-looking statements, whether
as a result of new information, future events or otherwise. Forward-looking statements should not be relied upon as representing
our views as of any date subsequent to the date of this press release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%; text-align: left">Investor Relations Contact:</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 49%; text-align: left">Media Relations Contact:</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Richard Putnam</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Amy Cerny</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">801-727-1209</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">801-508-3237</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><U>rputnam@healthequity.com</U></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><U>acerny@healthequity.com</U></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>hqy-20210308.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWa6FCbOdzZR+yYkxtmB6bRnKzyglHeljry2tJv6mQQoE -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:hqy="http://healthequity.com/20210308" elementFormDefault="qualified" targetNamespace="http://healthequity.com/20210308">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://healthequity.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="hqy-20210308_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="hqy-20210308_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>hqy-20210308_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>hqy-20210308_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://healthequity.com/role/Cover" xlink:href="hqy-20210308.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://healthequity.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm218956d1_ex99-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm218956d1_ex99-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  Y 2@# 2(  A$! Q$!_\0
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MO^4^'P>_Z_?"W_IQ-=V0X"GB,3.EB([1D[:K5&^"H1J5'&HMDS]D_%WBS3O
M?A34]<UB\AT_2-&M);Z]NICB.V@B0O)(Q]%523]*YKX%_M&^!_VF?"]SK7@+
MQ-IGBG2K.Y-G-<V+EDCF"JY0Y YVNI_X$*\"_P""L/[<'PR_9^_9Y\=> /%G
MB)M,\5^.?!6JPZ+9"PN9Q>-+;S01CS(XV1,R$#YV&.IXYKXJ_P"#?O\ ;_\
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MT[X?>#XHC-%8Z3HEFJ>;<2A4MX(DQN=V.  JY))[9KY7-ZN634%ET'%ZWO\
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MS&)?)2"3,>Y0P#.X9RP8@@$*/GC_ (.I?^0I\#O^N6N?ST^OU;^#2A/A!X4
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MT2;7#DVOYO\ V\T_YE[]?U/A;_@LS^QEX-_87_:OTWP=X&&JC1[KPW;:H_\
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M4D;']:^</^"T/@C1?AW_ ,$C?BCI7A_2-+T/2[>+3?*L]/M8[:"/.JV>=J(
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BO179',,3&C]6C-J':^AJJ]10]FI.W8****XS(**** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm218956d1_ex99-1img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm218956d1_ex99-1img002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" != -,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]_**** "B
MBB@ HHHH ***^%OVQ?BYXT_98U/Q/I>I:WXH;1/$/B&T\2^'-6AO)RZ1>:GV
MS2MX;Y%5?F2/(0H&[MMKU\FRB>95_J]*24M+)]=;.WIOZ)OH?+<6\4TL@P?U
M[$TW*FKW:^R[-J_92:Y4_P"9I=3[IHKYFN/VP;30?C7\3_$U_P"(5_X5SX(T
M'3;6T@B*F'5;^Y1KE3"V"7E*$1X#* "-RG&X=K\%?VL;7Q;=^$_"WB98+7XC
MZYIC:E?Z3ID,MQ%I*CYE$[?-Y#%"ORR'AC@GE=U5\AQE*G[3ENK)NW2\>?\
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M]KUNWK]]SZ[ UL+*+H822:I/D:7V6DGR^J36A0\2^*M+\&:2]_K&I6&E6,9
M>YO+A((D)Z99B /SKG?A/^T)X%^/#:E_PA'C#PWXO31VC2]ET;4(KZ&W:0$H
MK21EER0IXSGCFOD?_@XF_P"4;6I_]A_3O_0VKQ7_ (-;_P#DE/Q<_P"PMI__
M *)FH5).DZAHZ[5=4K'ZIT445@=(4444 %%%% !1110 4444 %%%% !1110
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H[J6]O;NXTF)Y;J>1R\DCL1DLS,23W)->T444VV]P44MD%%%%(9__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>tm218956d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hqy-20210308.xsd" xlink:type="simple"/>
    <context id="From2021-03-08to2021-03-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
        </entity>
        <period>
            <startDate>2021-03-08</startDate>
            <endDate>2021-03-08</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-03-08to2021-03-08">0001428336</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-03-08to2021-03-08">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2021-03-08to2021-03-08">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2021-03-08to2021-03-08">2021-03-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2021-03-08to2021-03-08">HealthEquity, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-03-08to2021-03-08">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2021-03-08to2021-03-08">001-36568</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-03-08to2021-03-08">52-2383166</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-03-08to2021-03-08">15 West Scenic Pointe Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2021-03-08to2021-03-08">Suite&#160;100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2021-03-08to2021-03-08">Draper</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-03-08to2021-03-08">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-03-08to2021-03-08">84020</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-03-08to2021-03-08">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-03-08to2021-03-08">727-1000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2021-03-08to2021-03-08">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2021-03-08to2021-03-08">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2021-03-08to2021-03-08">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2021-03-08to2021-03-08">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2021-03-08to2021-03-08">Common stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-03-08to2021-03-08">HQY</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-03-08to2021-03-08">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-03-08to2021-03-08">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140180178597672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 08, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar.  08,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HealthEquity, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001428336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-2383166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">15 West Scenic Pointe Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite&#160;100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Draper<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">727-1000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HQY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MPIY49M"8TQ-E1=88O3.O:21\*5= +ESF] .7HG1BKN5*R"G2:2 J(XTCZ*U
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M$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ &8EH4@=!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M"  9B6A2DQHKMN\    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    "  9B6A2F5R<(Q &  "<)P  $P
M    @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( !F):%+/
M  CC4P0  -D0   8              " @0X(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    "  9B6A2@ZFE ]0!   R!@  #0
M    @ &7#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( !F):%*7BKL<P
M !,"   +              "  98.  !?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M !F):%*JQ"(6,P$  "("   /              "  7\/  !X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    "  9B6A2)!Z;HJT   #X 0  &@
M@ '?$   >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  9
MB6A299!YDAD!  #/ P  $P              @ '$$0  6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     "0 ) #X"   .$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm218956d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm218956d1_8k.htm">tm218956d1_8k.htm</File>
    <File>hqy-20210308.xsd</File>
    <File>hqy-20210308_lab.xml</File>
    <File>hqy-20210308_pre.xml</File>
    <File>tm218956d1_ex2-1.htm</File>
    <File>tm218956d1_ex99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm218956d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "tm218956d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hqy-20210308_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hqy-20210308_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "hqy-20210308.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "hqy",
   "nsuri": "http://healthequity.com/20210308",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm218956d1_8k.htm",
      "contextRef": "From2021-03-08to2021-03-08",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://healthequity.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm218956d1_8k.htm",
      "contextRef": "From2021-03-08to2021-03-08",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001104659-21-033359-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-21-033359-xbrl.zip
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MAP!',@@UH_SC-&<1%\^\]CK%C&]ED[B?\1@>N?1$N45K4!&:@'6&!(39$)\
M;(W0#\4[+XBK.41Y!DCEX)&[BSB6IRLM_[E.&)F"9\&J=<M8A]TF619A0#S!
M[@"*2N4'O8%4#+IE8:%S\H8"G_A'YV0H.B=!HW/R'G26KSPH=$[?4.!3_^B<
M#D7G-&AT3M^%CJS^ -J=F=R\%4O^:GLU'%1Z :=MU8K-018>-"UO?<BH #7.
M42'^8<F'7;?B3O"7A$7P@!J2>\$&,&UEQ]"&!Y#=8!]%U7!9Q_E'J1RX]_[!
M:)F?%J=ITM[<%)KP4&D:ZVUH"K5_,.YXFF'Z[^2Y\Y+=+O8"B=6P%96&,CQ@
M;/;ZL"EBD SR=PE>HJL>C%@GN!GI[J8J6VP=IBK7$H- P>:H/56YN-M2B/Q4
MMN)5$ RT#LUD9U5M,575="TMC(IN&VK5<_XW+C7^_JC5NC3T[I$S^-6#ML15
M?4/F=)V;Z4'4.V#*K/M<AG*=U_OY:H6,U-Z@U]*<]?BFG:J#UPE!U+'IIM5]
MZW0O=?J;2#)Y_!G?;+:L?&9D>U,1T+FJZTZ;NMZMHB 8Z')F\E!J45/L!8X%
MITF49 E;_RHO5D6";66SB5QA 1O43+0500 !VC)I. B15GI!X4X0!221U9%/
M4U1+)8G;AP?K**!+[ J-?L,:$5@9!"J]]DQD9, XJD6@(@3E,2' ,T_3+1%O
M0L@2X@DDT#R 4TL?(E20R5ZTBD#_A"U(M)7]YGYZLEHF&;5=AK8ESGHIP%S5
M1QGI01 "F#*)R-,0?T#3D[^N_H9TE!<(;OA28+4\[F*_67$*K*=E5;E"H<.B
MIL$B"0((V)?)Q U'I1056G_K;34L6PIEI+O"P&I+ ]!(#*+J;8Y:#4&CQKUV
M I>[Z%%:(\#4"+O,=6=@,VEV"'5-$"!T&&M=N)12I+7^ID8<NK)U_^!@[6UP
ML.X9'*Q#'!RLAPX.UIX'!_K@Q4(GLJ6Z7=%DC8$%&#O5KM'HL&Q28I$&!0SL
M#VP_JA!TB/&S=F>^@)OZ0('8Y"ZNY(:EK(#.V>J=73:KY3MMHB!(Z7+66L"S
M6%*O)D9*[8>.;9QD)"XL724,LRC!M%H(TG9/O3_$&3,#S5?X].C#(&F8R194
M19A>K[$*/"SJZ>=F?/&:QV^$TE\8?V4+@E/.2%S<@;$]=^K6NWTOI\=V\]4<
M0!P$5$,< B_HJ*#QDXI".JR\?^:1IV^<;EF&13[_7=A:*4#GEA_ 9I,;0Q00
M+W9G ">5&!5JG]/)B]4OJB%8\44FL)B0W/'D\D[3QAQSJS8@<CH-0C/.RS5+
M#B/G(LKK)-",J"]I)"_D"\YPZ1 L-21W/>VSR[0YW].F#0BD3H/@#,\J1BUX
M@S59GA>^$3,Y$%OSCC?5#97[Y6]:%MLKX%22@""Q^>I8!T<@K?5(Q&*#*?V\
M31-&4KAK,E1NB;!:;!+1D 1$A,T70$0N15KKD8C+#1%KV>W]+/AK]EBN2@N6
M$%"[):33<I,4JS0@8KK\ >3H$%3$Z(6$?2*T.RRL7JPG"9?7(G4,#VC6(*>E
M"PD;R%R+&4HB=7_FAF=HR='7E*#LD:#+\O-]]17QBWS\?H,EBM0$C6+DSF(L
M;"!UB9U_CP4TW/HJ2TL9!$Z]]N OM%012(=X8>=6\BSJ5WRYE7E&-N"\B_X0
M5QP--:]IZM,'P=1 DR99>5CS,CP/1"K2_\I,]:7^X0%@0^1XW&PQ: R;:XH@
M2 %M08/F^I<3?*X,N%W1)+JB',-W91H:Q^L!MNT92P$>! %QT'8%+0"8"U&N
M]$C!9\R>Q/8YB_9W@D>$J#>ZTJK]ZKMK-S#:+3EO*E*3J4&A ='V%K\ AX<L
M4"V/#[4^S/\M0/7BNEJKCD=/BT<L3^/M-DM5SRKMP??1.X,</Z 84 #C,45'
M1$  #K )/;+((U$>^@$5P:@6[?4:+CVL=$CBS_M[\D"$F@&Q)+OLLSS<4\=5
MR(!8UU=X@XMC7O#U!@:!XEO=0I>#*:IG@%;J3;0R"_2[R@3EN=B^#5_?=2VW
MY&Z]2_Y:X93(/?\%4$L#!!0    ( !F):%(LO*A(7 <  #Q9   4    :'%Y
M+3(P,C$P,S X7W!R92YX;6S-G-MRVS80AN\[TW=@E6M9!S<'.W8SMF)E-'%B
MUW*2MC<9B%Q)&(.  H*6]/8%2$G1@0#7-UG[PG&H'^3^WU(@EP!X]FZ1BN@1
M=,:5/&]TCMJ-"&2L$BXGYXTOP^;%L#<8-*+,,)DPH22<-Z1JO/OK]]\B^W/V
M1[,9]3F(Y#1ZK^+F0([5V^@S2^$T^@ 2-#-*OXV^,I&[+:K/!>BHI]*9  /V
M@_+ I]'+HU=QU&PB=OL59*+TE[O!9K=38V:GK=9\/C^2ZI'-E7[(CF*5XO8W
M-,SDV69G[45[]5,V/Q-</IRZ7R.6061IR>QTD?'SQM9AY\='2D]:W7:[T_KG
MT_4PGD+*FEPZ:C$TUJW<7JK:=4Y.3EK%IVOI@7(QTF)]C./6.IS-GNVG/*#?
MBB3CIUD1WK6*F2F27GN8R*MP_VNN94VWJ=GI-H\[1XLL::SA%P2U$G 'X\C]
M:Y.W.>H4F#!3^)%SLW1):SE!JZ?L*6FC+9I.-8RM_L?2'J#;:1^WW[C=O]C1
MF.7,GID9=R=6(VKM''JF(0-I"K?7=L-.$U@8>T)!LMZ1._Q3@C/<N :K<Z83
M-=T)EJ?V>/;/4KD*9AV.4/%.!,(E0NV[M0%D-H("=P;QT40]MA+@%GNW[?YP
M+-K-=F<%^X7=]+TXW,4H,YK%9KT_P48@BJ-\MYH]2>N7Q;:F<F_W6QW:KF(_
MLNTD7N@X4CH!;;FO]\5TO).ZPW-UI6C-F+8[:L93+C99'VN5^ABM>"A/H-NX
M["%^)=,+&T7B(ND+-JF&NB=!4NU08*UT0\OU/62QYC-'IP;OCA))N4M*N<(;
M">SUM^D.)MQ%[0)RUV1P&\,]A:<)$O\Q9=\1=$N:APLI<R;N8*9T#?Y=)9+Z
MGY34J[R1POX[9]J %DL,[P,Q$OE+2N0>AZ34[S63&7>4,-@/U4CNKTAO3CP>
M2<$/IR"$J_Z81)WQ57HD_->4\/T^GPW^JT=W#V O//@,;#5!)N'-<TG"@5O2
M/-R"YBJQEWV-R,"!&,G^A)*]Q^$SH'XE$RSSC11=-=$CW[-'"KS/LYB),JZ^
MW9:%H5?(L>!)ZM5:F\\ _K_ -!K]EA@+GJ2$K;%(@KV7:[T34K"?\:NQX$F*
MUSJ3).2OI.%FZ086/N?IZ.>#V5WBARHL:9*"U6>*D/#ZB84T;MPD1'E?B25-
M4J>&S!'2[EE7FHF!3&#Q$98AW =2+&^2^C1HCQ#XK>8IT\LAC^N[D4,M%CE)
M51HV2,C\GBT&B?7&Q[P<BZQ'[VV"S0!)28JR2YB(@8R5GJFMQ]$]E=MOZ+*G
MDF!77],0FQ226O4)U@E3<Y$D%EJV^N>:2^B$$E(I1X]'T:4A8/-9P>\^#7X7
M#Y^DAJVU^:S@'S\-_C$>/DD=6VN3'G[/_GFC[]7<,_[M%6/!D]2Q-1;IL1?7
MH1M]J]4C+Z=MU;$_:(%- &%Y&S9+GX75C0#FS%\KL=0)2]UJ<_2T;U5FF/B/
MS^KN.:OU6/*$16_(*,U#R_(<< \_?!.<]B18RB1U;J4=&K NVQJ8_U3>56"Q
MDA2O569(J%XK-\XR53+XI/=0A:5+4H7Z3-%TR&XR=.;M#+8^1L^Q(^EN]VV0
MP/RFN;%Q]%2:YG+UQ,<S#N>18B&3E(Y!>R3 ATKPF!LN)Y_L':7F3%33KM)A
M49,4BGYC))QO-;BL@[U9+V::N?43^F8\]O7((3V6.TF=6&_T.? ?9%D.^JE9
MJ&B%S05)R8@U3=/S0)S;[G#9Z8[NW7H@3[]SH,(2)RD7?:9("']6]YJY18G#
M93I2PK_@I5*(Y4Q2' :LD:#>B:8:\IX$BY>D*JRT0]I+7"WB*9,3\,^CJ%9B
M,9-4B2%SQ'WR!-4G3Y[8)Y-4BSY3I(3+&>[V.W8S$GS"_*OE@@W0ZX<HN0>L
MTJQ4+!8TN>7L.BVBZ=L_JN%[I%CL-$M"0_9H@.<)-Y"4@?6Y9#*VY=AF!9^G
MOJ]OA4T#S9I1I&G"081O(,1'J>9R""Q3$I*R0 B-(WB;8'-!.'998Y<P$5^5
MR"TK74Q>U9[O@T>*!4\X9NFQ1SE3M)R4O;DRE>\S"7'WM<#B)QR\#)LEG4%G
MP$7.'^$],VP59R@+OA;8+! .9(;-$J\"T#U[69JH\+C]GA#+G'#Z;J4U0M3#
ME EQF6=<0A;L;?:$6-2$\W0KK1&BODI!3VQG]T&KN9FN5K2&D'L:8-$3SL8-
M6J5,P>+G>OIRI5^0?X4:_:X&0OA>D[0O)(EC-[&CO-K+A&D/^Y >2Y]T(:G?
M* G_&S,%O7VG580TL#5?:/I%?2ML+DA*7:QIRBOOUGL-@A?>'1V6.F%16V6,
M<D58/A(\[@O%@O?Q.S(L9<(*ML(6(>1+)A]T/C/Q\E:K&, -U62;[Q^BC$+N
M )L8PMKV22@H'SBH-'5+I53\,)Q:Z]E-;HK7P]HH@X\=@NVP":)<M(HP3GJG
ME/U<S ;)Y?(.QJ#=A(E[6)A+>[B'\(T3HCDV2Z1O7T)CJ$C66>O U[7=X%X$
M7'[B?KF7W=HM_P-02P,$%     @ &8EH4H]#R-TJ&@  D84  !$   !T;3(Q
M.#DU-F0Q7SAK+FAT;>U=:W?:NM+^GK7R'W0X>Y]%S@Y@(!=(6\XB"4EIKCLD
M39LO6<(6X,;8CF5SZ:]_9R39V& (24EO[SZ7)L'R2)K+HYG12+S]WZAOD0'S
MN.G8[S+%O)8AS-8=P[2[[S*!W\E5,O^KK:^][?G0#MK:_%VFY_ON7J$P' [S
MPW+>\;J%8K5:+8RP348VVANEMBMI6K'PZ>RTI?=8G^9,F_O4UEGTDF7:#_/I
MX].H:=NSS$13_"3LI%R8(0U/C<D+\<8[!?DPT=1/;;HMF_IA4Y,[6Z7B[J)Q
MR!;1"Z-Y;8LX9I@A^[1_=3II[J>WGS0M^!ZU><?Q^M0'&2*E[9Q6RI5V8D1R
MG.D)0O!WONL,GJ13R96+(9T9X21GBH_;E$<<-]@4N\,^X0&\4=)R6C%&W6.=
MN<1W"O T;!CP7)=2-VK<H;PM&JH'*;3AB>=8C*>^(YZDO*0[@>U[X_0YJ(<I
MKW'/G^T&/DQIVGN<4.\Q:OD]]AB8_CBO.WUL7M3*6B4CK(]1 WX2_,];W_0M
M5GM;D#_A:9_YE""='+X_>)<Y<&R?V7[N>NR".'3YU[N,ST9^01II =\K*+)O
M_Y7+D2.36<8>:3'_#3FG?;9'1L;H#6D>BE_NM5+U_J;U9^GPN%Z_A!\X&Y++
M+?MV>?\>9GL_/<O[<);/(+55BMYZR>O;I7L&&@A3@/\U;&#B^ "XXU&K:1ML
M=,+&]QJ@U%:I4B[O/(=N-4:WWF>V ?_WCRS:O>]0B[-GD-K9!U8?WA?O%7A(
MFO#1<VB4[EL]ZC%^7[H76"F)</'9<^@<XE@N%:WRS)#F$F\[QIAP?VRQ=YD.
M:. >*6JN3Z[-/C0Y9T-RY?2IO2D_V(0!>&9'Z+IA#L+W#).[%AWO$=NQF7AH
MCO90:9DGK$'\:1H&LY5QX ?0]CSH SE=:O[(OT)H.?*</JI+3BL#K/G.Y/<,
ML6'BT!LS]U(5(E.;:,3;0J*+;^M7HNV[#"#T7ML!'**VT)7XB!*JE*F)YW,&
M44BR P<%N,D\6- 9#QLA3.]QL?["^(A85/=Z$GT?Q[G0HO(C;F344Q]@Y%V&
MFWW78A(ZHNZFZ,LNN1-XL1Z%ANPIGA#36,B3$.7"UY@02/1I]+EIX)..R3PB
M)L-2E[>#YDE2>-,O3[HKI/:G>G.!S8XQ.PKP,3S_D/JL-IE"2&GR;.8UD.B<
ME\(GT\-*#"#\4+$TR>? -B63P3AGN-EGE <>JRDKWH,V(;'P4;(+I#:'OH2$
MN5TH)HA&+^YC CTS_0!,@!AG>8OO"KN@ON/%'C^?!]-C3*,:Z_20V4[?M)_J
M]FF^3/>;1CA\GN!"&D,+,Q8I82($T;<%( $_\;]OW1!X^]3KFO8>T3+@9[BU
MY$-$\UR']DT+D'DAGK\ADE#.=UP@YOK1!VW']YV^^"Q3^\^_BSO:F^_04=1%
M;.6["BR6NZ1=L4#'%Y\$Q5EZ;\C0-/P>+FO:GYG$FVW' ^;*-_<MJC^0$JQ\
MW+%,XPU1#T,Z\GEQ\EQ,FIM?824NQIF#8E+_QD9?2 S_!\H)1EMY:GD/J0IR
MR$%$KQRUS"Y\I /R,@\8V:[=G#>O&X>D=5V_;K3>%MIS='"57;8:!S=7S>MF
MHT7JYX>D\>G@??W\N$$.+L[.FJU6\^)\X3B>]&R6'<<MY3T(O7T'WC_,'^1)
M2=O>JJZT[VDYKHCH[/B>9Y*O)MJCBZLS-6/N4ENL*^C:5C5->.RYW*&C!^AA
M8;ATKT?!Q23,^'IPU'_\W*)W_JT)-+_5R8SWEZE5<B?3_MS; HZT]BIB?\*(
M5Z;)8$]7C?-K<M6XO+BZ_C[6<QEX/*"V3WP'7M0QCR&G6RP3QR/%[:RQ(3]P
M.M]G1-<]AB,)/-,W@5ICI/>H#6!=UWWB=$BQ6MYZ5>-^I9FACXKCOV*NX_DD
M&_[-*/@?C/N$#:#E^IHGGC-C8X\ ,Z;MKSYE?Y?"R6U(%SC=$/VA1H_&UY^^
M7CZ\V!#C49<!/?7AO9Y!QV,8/;/3##4QL$SMC'IZCU0V"5+]/K;[NZ._3]L6
M _6R+)<:,OFL9<3?P$T]_#OI7^F.95&7@Z,4_C;EDR%=+WQIP#S?U*D5JK(<
M1QA6O/4-I(*B>Y<I3O>TT%E#4I:QU(*5"A+?NO!EE%T]DXJ IVF+;"B+E&F0
M*]8U.::%?<P,I1OD8__C9?'KS<Y5M;V"E3&MWTSMO<@:-D36<),T;3V_T.C4
MKRZF2 W\QUN!)DBVV@@=ULME/2VHT-&7QM!./L+?PRY57#!D9K<7C2-3RS9&
M5/?EP)&+B,%>Q#U".>$NTS'381#3)K#X !I[&PD^Q7A4$&8X$PW^I% C,4.:
M:"I<3,/)LWN.H4D4N,VBC@*:F/XLB1[3B@A8&?59+OVYI XMEUB=MO3]A*6#
M33D>+-5BZZ?EPRIW(#<X#AQCCN%_[@3NT5WO<[VRBH48-Z@P8^8SUW,&J,K)
ME7B)88)7PBPZA#5\+CI,-'Y&5DI/(F$5<<E*1XI(1J4_)RJ>1O-GDO^!T^^;
M''=YR9$)9G/NY,FT3E02.H'-@(-MYJ4K0,_?.;TX&M=/Z?;*D'_2)Z9MB[GR
MSO9.Y1]Q/FW.U83HKNFHJ5+<NK"517)D9P<G_-1B]NXJ8MN% \C4MDNY4KE2
M+N[,;*2D2'6R=,\*(Y79*V1P5L +1HT7?H]YY .$<-PP14SYMNW)71!8;1.0
MM+%0)^?Y'8MT;OEIODZ@EYW@1CAK"1]"GAMR+7ZI#O\X9KU0)YI7+=+HNY8S
M9IYD!TFJ.<+JQD+/ZJ>(\&=YLFP"?39D*":0IVX8'N-<_3@U;59,1YUK<WA4
M83VG:QLK0YV4SC.UXC:YQ8Q$"R8*M"\=$XB30\\<S/<3OBUT7R5W#Y[@;BF=
MNQ6O7QU?#8^U\FMRMY2IM2 F8RK'IFF_ $.K:0P]@%\OO&MG:*>SLUW^N_UH
M?*B>8Q7":MDYZ1K\5X^Z "SI3-R<<==VTZ8BEJT+[Q*\:-/6Y_CNU#:"+:OR
M<><;EOQG.^_I \S4;GS:FS/GF2EK:5.^=*!OZ\YTYP<K^\,MIK78_NWQ[JH%
MF.@]4ZML::6?S@ZR:JSHL+@>L-UTJ478B.F!#S@('\,"QO@&R<(\"$YDXT?9
M:W:>EJ.AU#U&YPMY<+1],_AX=<J,K14(.=X?B%6;E^C=F%'2DAKQJ0.^R&7/
ML1>&4:/'X/A+=<RUS]8*1CW=9Z:V6]K- 33_?#HYR?+]Y]^54G'W#5]?\YG%
M7!P]L<7P-PDHJQ5@*$<@L*? D6_4S>6V;<X=GU#7M<"M [?M.VP598\ 3B',
MD$D\3Z K_$FEW0(;.D3N'(&SB[!)+ H^C=Q>R:^.(2O?/LK4#GH,PF2(H9"A
MG@/P@W%5VQF1-K.<(<X,'^+\9=^5W GIF!:(?'W-Y 3=-=N >?L.3+T?6#ZU
MF1-P:TPX^-R\,Q;ORS>(TP:^2E?<D81CZ=  Z !/[7'XK.-8, 1\#Q<N$Z,<
M3K*)Z$ (RV"ZBO#V)!$LFL[4.&/A0G7,;.8!IC9MZ"L042*IYTMRCAM[KR>@
M9VV<3*6<IRSUZ1J7^3GTF5#K2\ A+!K+W&@4H2ERFFEG5'PT^RQ?VC;M)#&+
M=?S9G$>X,MQZI@\Z@I%J8*M C*>#[6[SL_?Q^L@RW7*2*6&9S"UP#+G(5[*[
M.*^F,W7$4K25-W.!.LFN5&8KPC#8.&7BQO;%L6!(ZM!6:5MJ,^!N<IL:=Z>S
MQ5UR<'1%2F4M#RTW5,@M MKX1D%*T9B$N9G]C7\T=]I#:#FPP@#+[>X9@"(@
MHY6NMI^^CFE9.Q\/OU@_4FUGA[L*G9U0!2E*LG,4MKA%<\527&<3]121QFYI
M>=GT'Z5=H=(>*J6]]!@"%Q9]BR(F7)V]BTYGGH/[X+6<X?&'Z\-^Y4<J[_QA
MKT*)@7I.CY%?#H&+6T:NE&VKFJ3E]%J^\8]FKU"S*^F:W>0\8-Z3^CT<G>JG
M7^^J==[]B?1[9O _4,O+++>5U9^CY>J-);3\YPET8OZ3C#F8!U&+.[<D<6+X
M3D?R ]CPBI'"[UMYL7QASY([N>&F[>Z*-VW;M6L\LQE*7?YL4+TG?SN H)Y/
MU^;,##[:K4X?V[?L8(>D=U8_;X^B,LC!M<;]MF-E^4P=T@^8:[F\\KEBT5I2
MQ"P2,5.0IYXK+!CV3+T7[J_*CR80,J]8:^$:FJ+TKUA]$*;E%02.BZ6V4/3T
M!?-FRVA??B[RTDYG!1G/Z3YEJ8N#LW+TATWB4H\,J!4P\H>6QZ. Q,4S@[T7
MU@D]5PU?D>M'BNO*MJ15S6'YY45E>[2]7ZJO(LF<Z#!3>__WYU^<DY4I_0T=
MD_EEK[L-^^&N>]T=WU57MH.&V#"[>98VIHPX5W!>;QW6_R;'EM.&D+G%+' O
MR!GU'IC_C.*:[U&9D)8 -VVLG$ W77CI,^%)TS;0KP0W8TQTD4,&*@]DV&.B
M'F<JM6MR A(%IQ0[ZJZO=3UGZ/?0/W4QWTLY,5C'M&49++JF9$O;#M/ 4YDO
M>2ZC3+(XG=TW(@$6-H9^0 PN%M%BFEY0 N3)E69IK:^EG?:(J**;.WDQ1C?_
M)/]F*X=?9@:AN**"Z:>EINS/PS+D50^D,4]ZLV73::'5PKJ4D/:QH'P@":>;
M]O:@71]136OUNJ\:L"T8V).Q6O+'JT<,+['?%ZI"L[/(D'$_,!46S)G-GA[8
MO(!$L'G;$?%7P)EH!<-76TIXY8TI-FOD 7L4G.C+&F,^<FCZO?4U5$$;Q@N/
M/#8P.;P(4$)M'3.55!=7P6!KO'#(H)[!Y6Z2L3#Z*V=I%/V1Z6 XOYS*ATKR
M7;1AU3'D]SZ"'7/]4T.#V!'MU1[!_LEB]]C(<<QOH/UC@ D=("LG(/RN65[.
MC:3B4BJ64O;[=P0>I*%)?*+A300SW7N,/N3:#$P3QNB*,<>[W$GI$8?QW"[C
M(EVQ-)] U"6!5P2739_U23$/84P##S[@]KA#* DW9,@ANCFFJ.JI=STFTG3Y
M5RQ@B'*#KWKN-.KEPB:)TY<DB]B)!20ES)\X'($83VF*CXIO-C;7UV:/CVT"
MQ\+#(B16OXW.F: 4?R6B1$30(5Q(Y+EMR)6"X0JC0PA.P;44*PK593I4> O0
M H9CK*_!@D5)"X-2<AG %"B/B2@QC]G'X1C$BB26BYYC@5&*BBY$O]#]= )?
M+$/(!IVZI@\J(0+A];4L9LUP#1HP"_B@^H*PP0(Z40= YPB/]#8Z'0PG#H Y
M>6(4V@5*3H.@CYR;W%&0RCML-N$9LJDQH/;ZVID.Q&#QAI@<@ /&@*ZX<'PI
M9@Y]X:5[S/48AQE359A&U !3O.)?47\Q;DN1OG(8.,B0^DF-!9%;8D-4OM,!
MKS/DR7*2QP8HDX2*R4MUE)B$D'B@@Z\3T]]-$FM?UV$PTE4*99LG\>/V?NK$
M-DEB*BXU#73O:!<:=-&+"^>UON:"@\O2S> 2'T4:"E;%P<D3U3X= FX4^6-K
M=[-4VMW<VBKE=\OBH".HZ"81:35"^^B@332+B[&&6'& U RF=#@1)TKEU:FE
M!\*$X][<YIP)@YEE4DEGE"UDVQLD<)%C?Y0T BZ=A?WBD!WA10IMH..^&"C\
M(C+M!H24Z QCG_[0R>%)]8G'&M8PQ:<E#N3C;8P&](:&JO#)PX/Y 0.WM6?"
MK[(;SGQT? %9$,%2YY4G=1 1M(E55NUCBR3_LLE .YW6!CY"+9"" ?<#5!49
MLJUIFYJFA0(D0T'-A1D) %6P2QC7(2@(/6]1%Z8*P<)9VC"AH>,]Q&T!F>^(
MU($.Q@CV"XLG-= P)1.4#BL&KJ\E)O9[HP^J'K"-KZ]-6!,'8N $&!/U,*["
M)(E<^D"1*#(.0R8:7_BBC ;>&Q>OX)RB*>A,R(H5,HJ*(HQ#H/#P]4U4&#1Z
ME?_!&&B39$WU0KCL8"%IM"YA+667VN979=["GH4^J(_ /<B:(0E1I*CK@4?U
M<8B:$<E)R"<JW96!AH$>:$_2S0"J";)MCCXV4E5*"LP6\1['N%)<EX%S!: 1
MINQ(R):UGH=,9U@-2\I%X?5H2'Z@J L?Q,2K;J5S %Z-!)K!!A$WA"K--C%Z
MQ=/@N+"NK\D%((*D!$P_P7+3G\?@/)FC8=3B3DS-P*3]G*Z@"A,)?7MRA&I2
MPLGEC-2P<1X2T?\H;4N@>!$0K:_%D"@!,60^PK1!A -J6@*.4Q!'MZC9E[8P
M/9^4);U/QZ1'P;^1%:GS(+=I8P&P*1?C! $46V@@7_!$$U;#HD2CV>K 8N0/
MC1MU.QCGD$E3EA@W1/3*.%@ ZI.+E5GCWP3[FK;T'"(54<J3]#( #T*1AORE
M*!!AX32V=-B.C:40+D,G1JRJ,@<$7E3TIO#57(J;<Z8K#=N<+,7R;1FJ(7 .
M5-98XJE:W<4@H7^"2SY?L-C_)E*:@Q^8S&LS9JO%!+T!D(="7_APP$ NGL(+
MTXYNL9Y F4 M"-_Z'.Q*[!=@4C!>7!Y2$_7A O Z(!;T3>($:1L<[236KZ\)
MK':\&9@%=6B#QIG4,R7.TP[6J8.XN(3*Y5=9!9Z+_*KUM2&$I\!FF(1C R*@
M)H'/"NC&^(RZQ\ 9.J*B@;HL1"=X+1*.!NFI8*TCYP=BL %7_9">4&\6ND_K
M:VDQ ,)=6S#CB\)QR^R;D1<@[4NXJ>VQ B^\?U<7%J,ZB/L1;8;_HMLH;S;!
M5+!C=^2MKM1:7S-,CJM+@"N<8$<X^#@W*)B2+JTR[ ^%[9G\ 7KPAZANLS-,
M8R#>-<^H,%;00U@B3!$@"W^=HT!\7P )%QK%92 PRY1)_A@(A:6P NVCDRCA
M(%(8)-898IA8ZR61Q^\YN-HEWXYL!9>7T&PP#2)RY#W3,W)(<*SDK"O=7;10
MR?"QYP26S+1[J"Z.K1+R204''9VGX8X\FF'@XFNZ4C?0#!G*2FR/X8R!*5^5
MXB@-5'+COKJ#3/"8B#R^+1?/*5T5<O$8,,.)GP99WG+/'!C40)Y.FB #= ?0
M;H?@' I62E]>S)/@!6XLQ/U?H1%J#X!V?,5NM$0BN1 &M#@TD;/U$_WCZS!0
M_(%2 -WJ!):%WEQ';8, <DPGMN2Q*S< G06KGYC-;[2<8-ZXZZ!88JHU#8<Q
MIY 8#I.K@T ++_3_PF2?4%M8/R:6*PUZ@D? 9UQM$(U S<"4QC)=@/(0XYP/
MQF @>,C-%4HIQ6UB[&$Q@=&-4<]L _B6\D4YC.CV"7B.6F(*#(UNY?Y-Q!CF
MO7?S6C%/KE@7$S+B*IM#<A@I[>^;Y=XDLSEL"%P7)*M!:WB .H/.*1>1)4-%
MH[8-(8TN08HF'1GPLHPE<MR))&$RR4U$CEMF':.,)9TX O'M4*'<TG+46B&\
M,Y6+C!9%X51$2![/5?E2WS=GYT Q68F36#H_.IWRWHREO">,CF>V\S) %\E9
MQV4B% 8#I3 O!U'7&:*O%JTBPI[C \V3>F3G:: LY88W:*8(CB72+5C[XOM4
M[RD,0,%-H*):#;&"_W^!"T3]^,HH/&:8?H0A<6=2NE,>+OV.U(XXYS:1;=+?
M[ 2PN'-D<K0)<Y-OY>/50V*S0^WC8P8QNG(KVVH<;"@_"?S.<($VT#",,-\M
M4#Y,R4_[[JIZ@!0K*55+:85&FT(=^R*\^=YR_6>/^1E[S+^VK85+<Q6WI(^B
M'&EKDB.51B%,BO\N2_1,#519'$1JU[+&1C39[[#MGCZ.N2>[?KXC&NFEZHKT
M;LD=O>PBU9J2P;('#."]T?+5QS.J]@U5^4\!WXMF+^_^>'+R*9<D?MN9BA<-
M]G 2E;WF48>T>?T0B:<RB1+Y%4Q^OU2L5+=WC.(]&Y5RQ7S/[T>VB57B.7@;
M\R![A$D57X+#$"TF.$MKW\J&5QSOO J939$*"3.5R2*@,%V75NDC7269D+?P
M2(V(-_ +* U1O!U5J)#9 A7*XZ\KUQPOO8_5J.3_2Z89^_J:4:TJ5C\M?/1B
MOXOTEQW3I0A(KU1<(X6:$&?^5?G9KA4U]9T+W\:% TP!"O\6- UH4YDX/*0^
ME5?L9F4$HC)O3?%-FP2_:E/%U;&$?AAR%+7BQJ^#?*L[.K+0E?MO9*W2F51
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M=]@"!47(NZ0H*P]BY%R1FT:Y0"(ZHU#O/'#-T1A1-(M$0KTT,K;B:YY]F%'
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M>DIF-=EA^FNK>CBY+AM>U:;39'[3P?4IB>RIN@)F(XY1TC"6ANMVN& VX.[
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M1<-WI>--.O@K18Q4P1@7!,B49'_762QUKQ1+0"&*76FISA8LDH1N>8O0U0C
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M 0W],=%/3\'0/O52R@:X&O1%$0!1EF>P!0-TWENL>ZR=S#@@P-E8_(WQ:]A
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M"5P.[EPF5:,&/@#VR6SQJ6J7W'U+LR[(NU-0L08&[DWTQ\LWZC/>=I*+B>!
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MM5DS<S$4DOG.Z,!=ODSKHM0^1)J \63"<EU?;EZ(UORUED]7S[=;?JL7U:?
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M$S>\L9_NTR:L294T<;5U45H@M0U@I5(O<X+J3;D1+HJ*ZR1/(RG,0<!C+.Q
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MY0+(Q^W)Y?F\*>>@*$/2>@THU*<,J[G:KB2]&2:%_O[H[:/D9W<0NC?B1M\
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MR#;Q13TKR(7N[[SP'R=#A:VU,+06,AC20@<V5!C-@D"UA=0>XHV /NT3*V,
MS)29<UJOM.*1!.K3ZT8S3 :NIH[A&L5+;O2!T:>\+\!J"! N5$4!:$&&#R.+
M*'Q\9JDK;V;,#<6RPQ'/*G$):B.I%>=6@LJ[5-,PY/>R:22J,I-CA/>2@7.'
M0MTS*6@,GS1I>,[H3K:02H<F62C!@?>9W5F<\G+)6!;:MAO)KL*I=6.$TOM3
M:W,R[BASERT;W^TFEF+(1-$.RNI1H$6*WB/(D6(3"GTP2U9E2^?(:A7>,HI$
MY=T$0F%"Z80+!;]]B% 8WDLJWG"S$]MN0X_^FR_KT;\5BM %6AT=R"X\1+'
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MB,5-)\;D$F]QWSR^N#A_!NA=Z1P'LBNR(^DTN=L>3\VLJB,QJX-,C',+K%B
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M)3+RWB>=P/A;JV@ZG;Q$2=-H!?=>N,I=AKV;OD^/..! _$G$I_0:T(E$+[:
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ML(?H WR'Z<3'EY2[LRDZV93LJ%B$@6]C>KF'LYVQ<)TAF+$HH^[:"K5JSGF
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M><P+Y<5$E20G%:\7X9;@>3]YEJS=E%U3PL -TG=%5C5H-J^@_1= 8EE[#?]
MH!OLS-0\8CIJW'Z:\\ES0]T42VE*E"<*I@0W3;P=QOVF6YGS"HQ4Z\9)@B(@
M7N\6)&[G@2MSMR6=;S?: BGM,?[.&-0#) +:"D7_1C^Z667@!FZ@PRZGB4'T
M5+9@B.IT4D(8!U';*/U&<!#9CUM\?CO:!P"YEA;%?T9'12>;'U7__#NDU<"X
M@#I*:3AU-@,:;4+;&QR8N=M.W7Q.)VLD$^^AU&JK5@3-J]>[%G\0TYH1/A&A
MW%K3O6HD:%,+-+80KC6:9ZC;>NP*I&>*7$!./%NH*$M1,F5WH?S(V@_X:T3<
MX'_69<N>1\R1DG*:*(WR]EBSY4P/]YI+PKD4RY$UU^J2PUCVXVXVVJ*+C;W*
M3R.H//4A.=N%\+8VU#@=7KP*NU X]R!)74"%&=2Z6^V^7*WD=2K<03)H'DHK
M=Z&Q& "??NF\0 O.B5&V<5:Z )0<]<(0;U"7R"3XC(GHM&)]1-U9WCV(>5AA
M6] 1S_M)J9Q]<0/AT!:N#N%TLO>HR&NA^X*-H)^H#=/ZO3PM5 GV)&<ITQJG
M9X/3Y YF-O3\*57+F5F*9P]/SDXG'Y2=M44?-==T.(=*BS88-8($B <.@X\6
MYUOFF4-A,6?WVS^VU4A+*+/)D0$RG]PQ^/DG*99Q4&L=+*BJOI6M#R+D6"P&
M$WOK&MO(EU1C]%AOK/REC$/A+CM)$+J57><[7I73B:0NZN;*K<O_-:WUB_W5
M4)N>X [F<!-V'R%6,VSH8LHSLR:\(Q8JH^XL+YK?[2'=-$[$\"BY5*WW%7:U
M[:5+!+6M;$&%R>F$NB#Z(PMJKEI6^M->C#MU_9M)/OS%H).J95?S>CCUO)>W
M;/2M!679P1D:>W5XT[WO+G"+(Q4B?Y[Z-OFS@!H.W9 Y3"-VS<VSMF3I#NXS
MR+C9@/@7YG#1Y;9#5T2O.5-[Q=UV[Z/[WWT"RP6W^Z9LNJW41!4.ZNN._<*X
M_5MO*/I'LDEF1DG9,.G(3#FMJ(D][:<4PW1[P]"6,6B8IW::'*-&SA"\^A+:
M.-B+$-W5>E5?[;@2Q<X .QH0<0-74(&QM\<^$A8RJ!P0"@A;%#!P'.CF,+#F
M?JO4H$\2@*<M::[S9'?C28@!Z>SIY!9E8;$/TS87;XGWV;EG1*$0TSICS+)D
M5XH[I(6R2%@@XK88^RP@>$8/8R,FUOCS+*V)H6#U!#C,LQH0S').0Y@M$.($
MUS)UUX+2- L,Z.G\<5.P;@_T!#DXHF0(@+PQ#Q*WN![XU+[F$;XE#5O($]?'
MNV-DE--AB@C9X2E%A(1$(,Y.D8WT6K.<CB 61H:36IQM4P-/%6/:]9,:V,VW
M5[C-7CEKP P2/@>AFP#U#$'"7M2X#4[ZLM?)SUPQ'FH-L*2J%-^Q<?C%-3AS
MZ1V9&TI-8'NAI"<VF7DZ&(;O ? %]B6_1E_2UJ8JAFG3UZN0[*/>QUS=HK(-
MU+U8(PX\)%^93 8*D]/)R!QA'<OWA*:(/EC"NJ?**-2<N+@CY,!D",Y76-5<
M^(FK3&/K.YYB))90E+IG3.'<"-_"-W4>.$.I8<PBP*7G?Z@"6?9!2IP30HB_
M.+G*T/.'RM"Q(,2/4>MN#&L""3?GY!!+C$^\BUO70GIP)1N,91I,A&A04EV'
M7044:A'FY;X*+9Q(>VUW7[>_9N1QH4H6R 8H)6A;9 T IG!]8>1ND[@## ![
M0\U?:W]TVO9U[\VJ4RQ":S!;@Y. ,V >+3GXR0@G+22UP1.F-KOL:61).9"R
M@B2AQOAU^0OE)T;;\S'CL6IK>5#,;@>/:IV2TPKG0G6F%U]:G:G=-N!Q/R@R
M'?$F&C51O!BFQ$Y&B; !VXF(H7E=Y2VT%W98(P+X*\JKI="1>8T["D0DP%\4
M$ [A]_#Z\S*GJR!7,Z4 L1/$QUX1NT+(2-T%/<<_P)5Z7<Q($>.\GX5@A:GA
MI!1;A6R!8*#PF;-V"_VVB?G$QE.3Z.^R+<IDZL]:P\$^%JFJFP\@ZW/GJ7_-
MGP AYJ:0_T9J,U7+WOZJ7!;V.EAEHO&:WX+8;XO!WG;M7"2  .I?:1Y\Y@^A
M?DLS OJHX?:"I\7S\+(%RS#L.0F3:X_V^NY_1Z_Y301*5U2F8V HY4Y]11#I
MV=40\4F$J]T#P#4PD>OC!]$@M(=XZPZJK!5:[HV+?LLMU#RS':5=F!IRSY4B
M<FTXPE;#8 ,JU0-X%;E2M%))X0]G=00]2>-G9I_^;1\VTB/=2,&,!JP$$A!C
M-*;X3Z52!FL Z@#3V3<7>(BLJGNR-1/XH8UX96,>:S>\O%AFT!#H"5%55M:W
M5.BVV="SF<2@VSVP?$%<8'UNPE[Q03*(ACQXY"Y(.R/]>HB\@?!+H1LN4&SA
MR;%ESYE.R5V?1)2KJ16\#Z36\&PB-0 ^IL*%)K>]ATP2]V-"\8U*+C9_3/D<
MV5D76=.45%RCZ:!QX/\IBWQ_"@@GH5=IA-R>6=&)NX'W,!S"LD"K$S/3=XAJ
M"=R=@H8'_R9%Y7D1I2;+"M#+$*&<D79\Q&,P,B@F("$) VZ=])>2KA*NO4#S
MBHLD,F)S:M\!0:<D6.-*%R0U61\!? IWSY67$)([((U])M+3D$LBO63[ ;_;
M8V]I3O4Q08!A-^=[$J$PUYDIG^*8G>I\HYAS?\+)H@:V"-,Y$R/7(.7.N*Y]
M33.^],H,*5PTI=) /[_&"!P8@C3'TD^\6VF#$ S&;4KE>KMF5=S6%V3G7%)0
MM@=$[WBT)8EK&S$%JA?[>H@9T2_9[8F=;#Y6 [Z@)X\_[S&7A+':+\[YH/(Q
M!FOH@GVL/)\M#5%AC37'"$L0@%3)L403"0IN_DO2@.(V_\;0EZDH,^2EG5UV
M.R"LQ!WV@!%RNW;@L2+K>$SVM<@VV0)C NY*Q82.K[B-,XWY+(Q^98QF#/9.
MWF'@&I?N&5>E5[OL^B?WW*U(G%S,%L%.-G1L#;U ,ZO3R4!.*"8X&#X.\00N
MJJOLBFF'Y=SU%3MI8:0#W+TP5B0%6E#GTV_QJ*$H#QY0"8A2XLCE(I96\^AT
M)WX#[,E7[,BJ? ?^-^[DT9=&P @:LQS IV<Q&H3+D*2: <:AU!Z@9- +,HJ4
M4&RA<"9,3\&E %^Z88BE? KS9P@ KM"&K0LGEQAP!1/K"2+#7"S<<4)%E&>/
M3ZZ(\LU#$>5(BBA!(O;)Q9=-Q/Z05>^22Y9_P_,]HDYQ XRS?CYS/X=OBWA<
M#Y+<Y^WSN'G 9%XA%U[)F7E2&N9KG:R_!S/^Y,N:Q-\$'/*C, P0ZF(+'KG[
M:=!*GL16 J_[R>/$Q7%7P-2C; 5Q#G".,K(W1;4MB+<Z#5BG>X/I96WA8L_U
M/JV,LG\?A$H";A%O,W@7=Q;S]T/.R$"$4,I(%T_.L4V+2U5P,D,:\J=B02#9
MIQ>IFX&+%SC*Z+=/'B/=$=I\[Q$Q2M??RHBH1TCR0*3 K7 FZ#= /TO17B..
M9(J<6==,URN3,Y2ZP%&XZ\^QJ)=;I6>/;.J-/1D<.I'44(+59K+B!Z"+V@>(
M&C/$N;0DA%)*<#X,^H8HDW .4%!LO&^*;ML8,&^;K8J6TZM=;0V3/]%JE=%D
M/$ 9!=&RU,. WY9!#"-T]C!K]IK9L.U/V-]#?2<?$GNEI_M&6*H,Q?HFO0XX
M$UD,K'[S2OT"2;33_PY"L6'076"D^X9UZ.J06OT'C>:A(OSHR=,O>^K\DLWI
MO79RQ)S6R_AZBAGQ?FQ(%*\-C_1+R;Z &BBL/"VK:;&5MRS;$JI"11SU]BXW
MG>#UH/E!:L]>D7DXM?J;1\$.7K*]^Z[X$-AP4^@X?)Y>TQ62T)&B),"42V<1
MY6HGOVI]TH>W<);E_&M3;S<\L=0?7._/.1ADB]9 ^2@:>$0X<A"8$S9VRA7,
MAFFY#*5[%+LZ,2=2!$A?3(CAA5R\*1PP_C7\N*J1S^8G/)C'L.VH'J#]\/(,
MP],2O>/IA%_RB6T6\R/?+ )-T+$WR:QKOE8>4KW<IQ4":@2]/@=G'&7#Q#P!
M*L&F8%'X90X>E5$(ON/:M]D53.@U.'9I @E2*/ S,FY!5#YS]VJIA36UMS,T
M\*14YW8.IC<'(H=L63"XY+K(5H #WPOX !E5RFP#XG %LA-+51J/']IH%%D]
M(Y] EN&SJ@1+>B98#NRN(7?.5 . ZF#]>$'6.S<]>P^[UDM6+]VSA#%Y6^PA
MW$#&=UNE,F4E>!N4+K]BC62('\/^EO#UBLKWHNR<U0O'>V6DY4;&Z8M1=$$"
M?4I+I"JFY*G-]8(:U"U'*4HAC$;C7J3$!H&X?%E96*-<)M/>]ISRZW:0DK"F
MV;PI/(KD[D6#UART6'*'*YLQ:TP0;J6V53DL0D2"+?NG4/F,^:E\.RF*&73W
MC62P<W-.&%'.I"^1D %':]<&UGQDC'/WW6796=(#_[A<NCRE[/?%R66_OWW(
M?A])]OML<>2NBVDAN/.$*"GZJ<"<.E(MI&-'>JHIIS*N=]5JN;HU$H2'Q1:^
MS,C^R!*OUV:KK,&]%UM VY9H.^9U1926>FFZ7;AK8B*>[@/I)M/[ZKZ"0HX]
MI <=%^Z(7<\ASY7WI*V&GS$YZ!&9[MW+B]>W4A/%]CM.)EIQV:AUW/H"^FRG
M%B[D_UYK+A-Y]8BS-8 \>&<\\;YXJ%O($#GYU71"3A(%!-#S CXV<7)"66I1
MHEKQ(&>%"1>ZVCC>^Y_%>4=]_T?YG".  >>#(4E\0]J[U :M?=6,Y?J T>-$
MXL\%$Z8$"SCF'3DK9_3>+/)A6RVSLN&[2RX;\OJ-\,0#W*"L.L69T+$:X\\L
MX&0Z8<1)[.&/S"?OAQ;X<W>*IJ,4PO>8/PZ?"Q2V^(F %N =J#YIZ_2JOLWK
MV\K\BO/LN,?J+]'O;YVWL&'"_%6]> ?<2 =D\Q4;$J3S!3P2(*4,_'"_+W[G
M B,A12AJ@8_$VM.CCS_^K*D^J;X&LR9I5@F/PA"PF)(NX/=R>P1VDO4-#R2Y
MD#R%;%DEAS=%1SRVA]L; YQ(=NZLO+%W<_/ !1DTZ3Z#7@3[NO.%W']<$.FR
M_/;*UR$W6#Z5,W!;K;+;Y79E#SY9C:=65C\KOI9S[Q#-UOOM:G<>HGA8(@<B
MG9:L@V,8)KUH($#K*Q2[IHU<F47XR'$NV+8!&'1CVOCQ+W]L\RLB*<A!MYX&
MW_  1P&&F)Z@2IX![&&[U)* WUS59MF[(<=O#G" 8@EHA);)*X&PBBL.)"#4
M8G/3_@-E>"S S;$""0,=RO 5)&]G26 MZ0LGO:',?9<)Z*GK;,&+Q2;OBIU5
MD06!/AB!^[;]2YL.%^$[Y!6QXK=W/)"F= ;^S P12F:%=U3*6'O/*$7G]TI,
M,(DDMFARW/78+,NM& 9/; 4J[&Y .OM""HY!#QP/-\:8?%'#^EC[UM&I[:?+
M(]]/HUWUDHB^9(^$U"S'M&W([=1K$1_WU_$J#+'NT"5#J0=H#!%K7&*>M,A1
M=@%H7R"IFKWWW0[[*UQ\<7M%[H2*2A*43J".++JT27"FM)+!_;)L__"%W]U8
M;$;?=V$TG@YFY>XO?[B7ZT@,<=QWBN>+;U/+/NB%D-33P':CXA,"P4_=KL_<
MR-B9"J 9U01'Y XR_2[*#;EI_'7[T&$%X]! 3EO.Y+Z)5&.*G'F&#;1%E4&*
M]^X&G6@=NT?EWY.NK_W;D 4<P>YS1Z+YR<DEFK][2#0?\P%VC"KQ@T?7W5TG
MSE=9 ,3VXIO0-41V/=]OWQ;O8:MU,:O;C\+$U[IL!=^A-?CIA-3&3&.5I&Q3
MZW[Q%:CG"D+_^Q0$K4\7GRDN(!C*1Z##3KQIA#XMNHZHWDQ*#\-OAOE]R"Q0
M+*2%W<+TDLDD?(+@ZPBV[2^',GSV95&&BN?Z@4O"#TC#(]X$HQZ#9S#R>U#0
ML,"O]>W^&>7L>A^)>DRO,P.N"S",TOQ9;ZNV6 V. ]03-;7+C?'>@X/-Y2]^
MY\:1 /0>.:L4K4=0!_!:^]RDX*(+E-+Y(55..1G,5A(!M_N;,A'D($-<;BSW
MH^9MMY5\2AM=X>I12CQ9URW1',"#$+% 4X"4F\ PZ<M(5L#OK?T^"=.V6@S%
M!D562@D&Q\AO*$+ )S@(U[%:50V\^LW^$2[+*JL0JT2#[+89(V-0A,Y=8>0"
M0!D1%!B!RJ:$L@H3&?F4 R?1]L<(JG[PZLU;@"]EC4KYN>CP_%]NL!@O0,-^
MMZ745.^%PW#'7HF\0Q+P5K8;K=0:;%U7((<!)[IO] 49GAQC'V"/#:6>\T()
M!OA1TN2G NQ3<CD$Y-9C<B"])PT.5F)%[9>IXRNH6-&I#AU"=\^N2;T3ZS<U
ME)0FBC:Q'[U.90S!Z"KMQ8*,R\+D'R!=F27"I %I95-;$1IIJ<(5^.K0N-V$
MW%#6:P4\?AI;\O?<=5'\G1;NDJ/Z^.4NG9L";V)79$T?$&8F F@U<#8Q>:E)
MM]ZS"8,M8* D4T!#D7*29[O"D>$D"8,'HJE#]BTLO+3^<39-63>*!O OV SK
M!$G5OQ;D+F1!#/\R6 P*$N YI8YVLP58O.&PD3("6+$SF)E?Y&['<<=>V5XC
M8#('YI"6G'H4QMIB\US 8\*Y:"P#OH><,K=MJ6+:QX"%+1;PY9M7;R\-CT)>
M*,M%C]3\?IU7W&^?RN) ]J;;=@O/9,JX/>"RG7<F8<Z$!L,>-?@"6M&1E1U'
MJ01P^\&*(6W)^CN9_R:CP*X)21^6+JYQ1V;3T_K$\?2UPZXCI2(SDK,^![GB
M,7E69H^<S9?\L7&\>'48;8<;)6?1""0"TI]<[NDGVO*RU7,7 4]<08)/Q4^9
MA?LGA:6&WL(G[70 37U=SDM:*<J^8*]/>&"49:L8J2[!TK,7WS[WTT\24_JW
MQ]_ G]!N#R"H -5 ?:-G^^]+N\#3LR<7,[T%KV(2%Z2V/'^]?-OM[IJK *7#
M2>+IQ)\O VI=2#M$DGAG;+FL$D Z4]ULT R-82O[TXU[]>*=X%.'2RF,$'ZM
MPZ&75K21L[!NU^B([#Q3[_!,^FHCYB_<^]11!)_.N?,UUL7 )1VXU$S<R4'7
M"1D)!0T7@? P=3/NBUK4.'L\?=3%@!=T%G9&!'HJ::";W*8>"(@C3#WSF(?P
M43]PP]&"X"GZ[Q/Y.-&)D YKWRK"C(KXQ+ O2"&$=AZYE=#\ XZG2W9%YZQ5
M23JA!72Q:+9\ CG7:T5=H@S2M]X7Q&.0:R;FO&R%9XX[RHK.NSG2D\1]9]HU
M[KQGYA:+*;H(O6&Y] I3>XC.@/#\PB'_]?+RM3C3I0IJ48MW7M,B6Y3-8KN&
M1F8HIY"RAD'_7T$%M(%E*:_>-%YXB$G=BL*U2BG<N>2IL([ZTZ6-.E=EH=K2
M@X?:R/Y/BX_.:J7*R?]L+.=1 ?>?GEP]Y<5#/>4!N'_/M.&=23Z%@1 DALY/
M\@/EC ^\H6>/+\ZRF77&4N_B<C32M=R'YL,B='1("J7#^:&2#?K^>4W)+CS,
M6KE[R6=1B&?1E%F8C^(D%'A'9<L-P0R^0CD"[3H(DU:B"YM1RH+Y7+L:N9[A
M@69AIJJ6-,B^3CEP[E',5E1;W8AZ3\5_:VE^X"/L+M/]LO=#<_]\8.X)C0!>
M[!7)PRXXY0!G$H$DQR(3[R/X_ Z=A*39A%F:NO7DK_P("_4G:<S\P^ )!S4T
M#D/5Q05B\PK)PN%;^JC]TPQI8;K:;<B>L82.7,*&(/GY(?E&:M5396$&5N#K
MYFQR_P#^M(ODU%([7TV7Q4"0<S#$A_UL,EREH;P3'G-3<-,L9R,@"11DA#S1
M;>HC#.7YYR@J(";@CTC"UR@G]V!(+NB]1BJRZ:2NA&2,C+[_)"96G4GA5W@H
MY:>T[_Y67,K@96.*\@82^SM)"C@_I8Z6S]/'3S3>[OWQV<63U'E_C^$/SUY\
M>Q'G!93+"F3RD%.5,BR2:J#-[H"X_]G%L[,_9B-I!TD-/'WN4P,ZL_ Y"$#T
M8:D*-4M-#2E+_K9=N7V,$O(-%9E26R#*S!PB2=4MOOXUX.-]W G9=3*CUM 1
MPT>7@"E;<]9.*,L!L%Q7]/UZE1XV$8^_>:H/F9HJDT[U&AYELU*,F(NDB]42
M20U E/$*(RAY 6?(DT+OQMTZFM!GCV?8]$/)%M(=N@EGQ/! #R5+()&/ARH5
MTN8#MX&#=#$[>Q%NT0EW7.U%06-:P]TG;[+;?N& '8H-."R8)&C+]PF4*;CD
MA2Q.]KUSH147%!_<>&K*+>RYR4>TBT<A/>E>*#0JMN!2*! 9NQ]XCU%/@/]V
M1_0;T$0!5- */T,13785= 5,/>2 ]HY^L7GTA.W9E$)0&GS[AUC1LXNG]L7.
M!FK%3!+02K(\S)%WUX6-_5MM0\-= .;3I\D/.">JD8,BWIOQ3/$I8K2DC*'H
M3#4!&:2N$WU.)6C7OVIYT^K\!D3[1=5 YU%N0#NG!L/Y>GIA?N4E';KVLJ!%
M#(46<VO;,^3HN3N5%&MGE-A)AQ:*A"*ZJ<;6RZM8C_;?L_?JV:< -2CL>0>9
M+E&1D]^1K9O4-T0/Y-+S6<,%H-PT^@S4KCPA91K588,.2'8$XD,D38P?%KI;
M)#T:998CCXSCCWAVSJ*%/#S[LU-;>5]'U\2>PJ^<4\:1O83&JIP$6<'GN5QT
M(Z5>X[D@ ,=6?L,:KAQ#?8D*,*:!.\:<35QR(1 60SOLI3S5T7A_ASMZ86'U
MXYLE8D5)[@(TCJF 0S1->CN@7P#_9"?(GHQ'[57#Y!HWD,B-AN>5GE$3"%TL
MWX)@CW]N*1B8E)E1V:"^-]I-_9:#M1)0:6[QBU(M$5VKT*UX\=WC_Q[T&._L
M ^F 8)XW#!50@2\!;VJ^S#!"0*(K2-I0J9J03S2.D><;*]OY087%:H;O):!@
MO0!Y&&'60K4TKTDCWKL6IY<#=!W2<R,=;H9A"X5R(D(*W^5&LFL;U-OQJMJ>
MU:HWZ3\DL?L5?.2;QQ<F/,$3;^"DP-B0*$[;>F6A2N3O*R+*2P>87YE6R@KE
MU[-F-U@@S9+63=XYPD!@F?OX9S!3U8=X,UH$,5#(#$5XRK8+?/Q[. 0#[KVR
MP"*)E''O/6C$Z@!Q2 .NIKM:.YPC,T+B*-\F4S"^2$+F+H.6BN-H6J!%3N%@
M&3 TVC@%+Y!0!9)DFOZPA5SH]1(W @F$,0<Y5#DG/"3L6\'N&^P)K1C?\^<X
M_^X?WT2IV3:$N#8)P\;Z!IXF\'\_44XCWF5.J*CW[-2*>L\>/Q3UCJ6H]]4T
M1!F$&)1@%EO%BC/_,!\R@1Q.51^FAY,,R.&0NMR9:!)E*]S1&_99YW+*<ZC(
M0MAP3,U\>!@FD80<;%ZX"Y#<=2%I,#IWT&-<^^3T+F#G0C(L=4_PRSV"QMAC
M^9@6IL,.[J%$>(18U^!7'Q3^J$_BH6&LL&J4'X,K!10P?FYQUA:+8F7J?/B&
MP7V&C%&F_%\WA0)9-*T7TT9ZMDC!G=4-P&2(&@ HW=SHYLY0D%% WM,7>@/?
M4WKA9L#@DMK%8%=*\ 0.5@C$:PMP,\ WYBH@8+6AUJAY#FE:,?0,_J+MR&M"
M%Y&@E%CCK5!'F9.J6-,FJANEE-(79(%FD&%VOLM54[?M.?!9>">&/CWSV>4[
M2+; 0>6)X4^&)5O:4A8(@@(2VV2/8_[B19@7Y2SG7=][_.+RE"NCUP^GS*<_
M988/%[^!^9 "+@8ZZQBXLCXYC]ELB/*G&09(!D=M0=)FQ[)5"=Q((?@E2DPM
M4?P.V_W6S=H;I6L.5\;%HR??/?[K^<7,Q&WIH +@P'1(T&M!GVG =%]YI@44
M/7?1;;:XAC_QQX=+*U&X D,\F\_.+H+:V<GE,<LC7\5CU80X75%[$F_*5YX=
M3&_BSBZ3.#>I3;PF"^GH"<F%!.\<S7RIS]W.+RIG>44C+7KJB]C2GRFTCI>L
M3_N0^>/?P3PQD=P&-9R/X<_=@ZRVF2AGH27W-R&'(_YSVZ%OR%_]>X5]+&\[
MT1<OVT#862L#B*!#>J(]%S@QVXSTG)]_43WGE]5-V=3*L(JI9=2=(&&_WZ]#
M>9_#I0520@L>W)8'[LXJ5< K9#T#(3HIYP"5!QNGM[B8:O.FK%?J>2$W5/"<
MB7_,Z>3-4$W(-_N]-IRZ']SXYP5^?4^]/@EV4/ENIK:F.6-7YZ9>W1A*5PB1
M42#.BQ)+V.%NM_(NW;;MB='AZPSI#'K3'#4L(:0"F_K[?*S">K#,%H+=\(WL
M7!BG%OL55E;P@=UM@I<S]EZ2\+74+.BFES-M4[]H+2MK2E088CCMF&E'UP[C
M3.H0@S.[;G;0P02E(KHE]KT38:T_UH?UKKE%%4#0+IS>KLDIP'%1&QM\V ]<
M-N;.ZVB;>/J@.1H<AW/>B94N!1@QNBE 2XP8 VA*XN),CF4L:JT2C1+H7\*/
MPK,O4XI=P!+@(M=N$"MZ)K?T((F3<PIE3O JP@W4M^P-L5I4/F"G7'1!K2A%
M^F&&13J1=)Z0)G?;M-O,D^H?M*[C=_Q+4/UD&MV"*CNI?<W,2,Q_H#0&EH;^
MV()QZ$/DV1KKO4A]"L;FKEEO&X"9T9^H]N9>057LF)J?5ZVW-W?#X.8$=F+K
M\XF64ZJ&/#^Y:LC%0S7D2*HA(575-U^6JNH--Q.]QB[VWTT>Z8&SZOB"NS'.
MJF^&":M2(UHY1%U%98?5JKYU!]A?DN#9%_6J;O[B#@K8QM[^_N;5_[QT-J/_
MP%$X/XR!3#\*(T= H3>@N)M*3R[D0:Y1F4(T>/O%#2UI, -@:LH="IK">A7)
MTP'5K.?%$Y>%S\,U*6,K%)-=3C@0RS6>AATT_\/+]H-$OPF&^?V'S Y,#P0F
MKVPIYVR)K094-$"O$X C[G1&T1F@[L"\*_Z4;QLE;W)>?W$.@'?N4V<A<!ZI
M:0E7:1*:3YR?^TQH\LGG$U.]YA)$"/4A$^H\]3OC(S1(EAT"9U'Z:1+P&AN4
M@A:JC@!+"LP:@L^%S#GQ%F.LN=DZ-VGAWM-UL:)U1!A328NK*A]T$926G!P&
MX",*(02'.*\UFM(B#QY/-=[N&(W@X6 XEH/!YOBLM&/0H@/'A7$YW./@6L)3
M X4AL<39;[0[>,F[51:M>8+1<;[:+\=DWVKDA('FSC6!P/3F6HJE&,AT=!#0
M4(;+0I?7",^+:#@P/HK_A"EWING0#,R)FOHQ4H=9(^^["1]NMKV3BC;OJVWF
M'&&&4-@,-+$)L2I.&/ ;5($][F<GOG$>+YV#VM1+A4P#5(7\YYKVS-C%3@?J
M=YHF5?M2>VQ[O2IL!3/*6][3-MV.J5LCYKM0SQDV< +FFA+,)4)M-)'$("K^
M F=P@SWSQ.PRC,&__;(Q^-^D;B%1%,7>L05^^P&LQ!R5@3"TLFMHH<!H'(X6
M/>H!]3?(S8N!T667$.68XK$&E<G"/=M5C?2Z9S"FU->FS9-#[8"&"L_(U>C9
M7T[+)H_2R51;55L2MJXA;24.+$RMN"\GQOXI )ZPG>$< )0IVB'_$Q%.*P(,
M:>/,/&O+]HN\EP=?[ Z+(!P O"YL6F*(&,KG8D\00&"DK_H3V@GQEZNA),=E
M)W<4(+XYN0+$DX<"Q#%O-5^!H^[]&0,_]4PN#$=BP7*/U.1/4F%4 /P %R!0
M:NIW*H_%[<%O,8&&WM.J;GG#&:%(N1.3B^ )>_$CV*X>**QX.OAHVZOJG;*N
ML.4AY_9>1KD$ N"V4U6MQ.AG2P I9R#8FI'--C=*[[HP+()ET;;4\:#T+O9Z
MIV9LQ\M($OE1S.S(@5=0,ZJ5^G?M(K^K[ KWK0W4/WJ0-;?)+$C/Y1>FP 7;
MPG@-/JBZK9?*R6<K,R=F',=+FM%WLSUD#[WJ;*6)**::DX0Y9BBC5*BDAZQK
M#3WE@,7"+Y_:FS_&EE1]YYR +GS(Y)OLP+O1<O&Z!MR77?^G]AZ/L>FKOW:'
MJ!!6"OH5K!ZU6T +Y3%$L ]=/WM?*<%H>VE59DEV;]>=KT6:2/E<L*JUMMPB
M7)6PL83^]%USMY6AWS5;]JE9Q;$WVWR05: %I!X53<4<%Q$VN9S,;H< NS$(
MYW309*:3R&8D5B >PA"E?VK&\^X(C6>?5X==#15TR;N'XS"S7 "34HH-6U5&
M@/.\6%<!5SAS,FED.,25 *5R)&1ZY=P*#&XAZ_J:K<<+YOH:%!B9J,R%B(AD
MY!J^ HY,/U!L[+NATXD0H ]>139'7@AGOE:D-W_M$R>M+1>EGF&46+ XD8/S
MJM] PO+DJJC<L@+D'=#V%LV"A/:RFZQ<$:=0>]V4U;OSVR;;@*Y6N9!_ WRD
M=%:4-5@,!MWW%A'V3;T#VJ/SI;N5O#ED.P!@&2&\L,?NW(WPO+TN5J"\6"^[
M6V@(ND)_+X]F.A7BB1J:7T 'R?GJ#5'JS]UM(3B$I@ENY$$ERNSJ"KIEH&S,
MBO(KU#2#$O1_/G^</G[\&/&-,"IP_IL2N<3J!@K")'R&!6*@\EKMM-R#(!TX
MI>2^0:-0&$1J5XWBVA9J51X@.O1@2'N@=P@+"Z)]Q1,N4XQ/Z)ZA([SD2>8X
M5D>XU8UM>#8'(5(6?M/1)=QFZT)V ;%!B7DE==%(*VK+)RXMZXX$.;$7'PV*
MS9X83-U&NF5V8K>;7#PY=S&4NR?A*4_-<-9'93A]8\'$/F #FW)!HL-ZE  8
M,+4=DPS'83Y!#Q!.#1S!9O"1$T.NC7]1W67,]ENT@T?TT&WA3(%]'FCR*LK'
M@47ISN6^>TN"6;3-W=;-*B?27OD>:,O#US8-&O"2FQ[=G@<J\6WJ#@<Q;C#_
M8G%=U:OZ"I$4_J0%^3#WQFZ@!R]AW@JX(EU91+]F2@^,A<%%*353YW0*L(/6
MFCG%":!DP<OT4H*V<$$QMQ;&?'+1:W54R^B^L0GZ'LP&H*<K8<52<EX8M@[&
M);]G+!GD*\H&L;O+;4O1"?T)=U[Z6U5<U1VQ7HL_>C3Q[!UU^F]/KD[_]*%.
M?\Q;37W,6TT2'MP4VQ9T;K?76>,YH(CZ#C2P"NR,;LF?,QW9*3>!XZF+RH\
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M2GZM>293\B4A:DPI"ROS!>0ZSJESO[:(*0EB/4 4IQ-:'Z^"^[XKV7'%+!:
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M_/[?+Y/7?W_SXW]?OGWYYLM,V)?;O'X/ -:*^.$T'J-]VBC< ;>;.,O:$]-
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MR4-3036JNRY]G<%;=&]@4S?=MN+($AH]_(;B3#B[4@<^1NI#.J5L%]NV#2W
MV<1G-H$DL "U26T-^;7NX)DTB^)^Z;9#RBCY_IUHA_3%6O>& 7$QLH9P.<"W
M_'("FHVJSY8SA*/HC'9FV>[IY P[1Y-;=ZNVADQ5.M!WFD+$NZLQ3*\A*42?
M<'X,<%Q6 PVTIG'6<&"$,3J=:05N"ML%'BM"J WY*I"\3H>&[D9C1@XVZ_M$
MSZ+.UYGOB1UX+.W.M>(2 ?V5?U+0IG4+!")?%PV;Y^LG-$[Y-/OF.$\S%_G]
M0^!2[?>(2R\J[CZZW,!.G:U,A^#!J2MG.R:3,I3(<DL':7GNE%SG=):Z>W".
M$L2K8%P32Z7(I2),2%XOMMHL[0<%K%W1E33)BU V#R0 O)QDC%!P'J!7 \DA
M\\2JV6+)WA8TN[@I\=SB)OKUU$8_VW+Y]CB7RR^*\1L(3EXK'A#:3D0@%O&0
M:AF*\'_G)8[\7MI=-X6S03XH8<LF+9^^?;FM&*KL5+N@W%PJ)"-$@C2&G*3Z
M"A8X4E/.%[8#-%35H0,7(@-@P7RU0U(M@$0LV#NB/"35LMRG"9J$.=:2J)AT
MC1@\4K!+L#;8/?/;O2CK"!?*5PPB4 P!0@7>_OW-/U[]X_(7! >\^O6GEW_[
M]=7/KWY$Q,"I 0)L^>OYL92XDYB>J+DIY6")V%_2Y)_J']+^]=*0PGT (XR<
MZ[8B@FO3.8)!%8M[@!<0VF&%O3 U(1=5M=M,0H%@@VBOH3#5XC,5MF^75269
MUA3J+2"$B3MN1641V"P:T1"%7[Q\ORFYGOR3< R@"Q#+?U B"2.JIAL:GR'
M^0?,H[([ <*S\+?AB36>1#C')M;@CG(D/\!04UF#(4*#W7E5NET^1X\HPNYC
MO2C_'H8EH362]#&@RX9#/V^K/./SX,W ^_8O<M\GP[<"G?8KO$N+(#5D0JZ0
M #!K/ J5WANYD2*):Z*Z@,[F3OM*ALQK.FF9J!"K:%VSE4.&PC]Q!#_$].@A
M@5YTYXDE3ZD:=G%RU;!O'ZIAQU<->WXLJ)-^6C@4*@A/R@?F@2.&?O],?72Y
M(5L7=I#@-*(3010IH,6]6!9,/03,.\EUUJQ9L#L DO0RNMBHY6E]P%?K-7@A
MO0_EWC!S*!6J3=UB[K:=I<FZ6,_Q6R*OE_J6L#3D!$KC]#0TIA-&W?-R0:?V
M%O/Q-9^^I&A_!_N-/YYU%;BS]37!P0,FG*5.-86TS(.$&#N>16&/1D]@[>=T
M^*N;;!>6SS!/6J[G2%6/GM3XZ+#<3*G47^JVM3H.=WX3J(2!41/2U, _3*EV
M9(_NEPU3VV&9*H+?N5: X,1P_:9L.E0>^7= #=-_X=+WV3#*(]PP=)/ _&#9
M]AUXWS24[7'O8\_69LUCS_,LH$&?3G[2OI!$F+A)%7IO5!6%:N.>[A=^[<=A
M>L=E>X'5"70YLB"03J- !".<.;87,V<615>89[98RK$:W(,%_!<FZX_#!(*7
M#P?/W,7\%5?H?O=I44AH%!7BH" '#)L09/(4=LJ%5?>P!;-,Y^X,=QX$Z\9P
MX0%/NK)S1^UMQNR$K/\B^"OME%PMMKZQ'G[U,^0FL&CDSC-.>MB-!O)1? P^
M>?0-> *?5M_H*S:WH]/-XJP75PY0UX*V$.'\XTY'\B?A#[^A4H/_V7G'!1#^
M];\KGR&+PP;NHNU(68VN&H,) H\)+]ZP&N@6+??L_6RDF'!7(3%6&7&CKA=<
MD0QS5:%AD]/[,FNJ\]_<&"[7PE7H\06TL%IP2C';9]BUH!ZXF[%;&6H50Y5^
MVZ*$CLP@_PH<2ZGN)'Z>ZUM6TJ9.(9K,ULQF6;2R:#7LZ(B$T1D2_!M;MTL4
MG(K8$ 45L Q<FV69;Q<EI//R+=5V- 'YZ<+:CUC-7S#,/7;2&:D/7 ();2RG
MR+T!'I?;3[A_BFZ5Z>3N54F4Z2O6,:-]PB#ME)(%"XOO,\KWU\PJO*QI99A(
M4+J.IQ,K5)3VVT_^K^=:0?0 087VA;2RU0!T;=-AZT</STS/,)T8Y_Q/3Q>?
M4#KZR<FEH[][2$<?23KZZR+^";.7B$FMZE 85VJ?O.]B+@QV5-^*:R4RN&>.
M,"":#0VWO^ED:-L<"0V>/WIRELT@_0.UU&V%9P 2PFMED4,60U#A"Z!SXEIW
MIQ(Z79 GI JP@5U&3XAN&#PFHB KCW?)O8!YZ-*U=>\FH^D5@Q'@!Z.8K,C;
MY#^?L$#G69A"_:D 0'CIKAW2<5)*VK^(_><2O6. Z0#69X44KSIP_#X*)/H
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MW6&$"1C+(NQIX!"V=\F\(H$FXO, :DTS>_!,IJ3D%J/G(;M6+Z-[^WH41'B
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MVT[.>NM!8$8([K4KLD:\<@]#))SW:E7?PHS!9U(J^4I*"1MR%_7Y!M!B;AC
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M=;# GE4O/EVW:H^[DX7;EVV?EC4%;^!.PY'Z2^UW%:<D)9G,S^JI'2M-2<C
M::DKW>!GH^GL2G--0VL"IJR;VI7I-$^ )V"81,A@CI%)%!DM+',M7^=+!&!+
M]2TL_<8KJJ-V,FI4TQ ;:@S;(&;Y*ENP"PC8(D\XJ:2L4$>\JB&8I$251)M.
ML6 **$C49L+?L+Z<^5ZSZ(*BGI2-'*;E<#JNL!\"9VMPL2*B?R4Z MMDH3IJ
MW#4:5PFP!QH.[H\W%G]V6#1AC6ESP]Y'&/&Z7=F[DF_A!"_W4S0LC(#M!>FL
M@;W-H@4+7VR;PX*^]0I9&R:5;07#L6V_>A![-CEK*48-TE(IIH@"(L #53:K
M*N2PFLMN_O2N+*83MF)3,!FLI()EWVZ[I,N:YT$9@_^=@H'%N18U774#F4Q:
MN#B864)(B6!\8V7/@PED1;H9E(5S0))KI?32"C'5><QVH9\+HTR57E^8(@@'
M&F*S1[MT5&E;@\T-R16TYNPIQ WQ'O(O2MP,97M0W!OCL++.$8P]0P8OBL.#
M/(AR@D\(4U=HDW5L;N0)E.]Q:AAE,1@BUMY"@SBRR'"/O6P]+H2_# D<*?ZE
M+(@]:/C#YH9M Z%=QEF"R%B>D@2P$F M!U283<7/PGQCI.E+-%^KY C LL'D
M/&ND]LLQS[5H,1)];=9F*":0 O+L8"N9"$BK6(QFQ&/1)]30;.J2F<-M61IF
M7<*:'>O!/%9ZO%Z?$69NI+V0#*2-07[>>=:I+TK@ CI&UIEUG Q9@R5%A*7
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M:)HS=\^;]@6Q>M_6PE]KM8F-6W>*&ERRC*.[Z]YJ)Y]C.5X@1X:D,5&60.X
M>:@GF6F'B:3:X.^'F%JH)0\7&*'GDMIZ-+;S=TT3QT+<QC3EC9.(:[ZB233$
M9,\@RC^7TTD-T$UUCI0+,Y5X:)8JGS=V/&H&I0>]#.@CAAR21BG&QX#4?T.&
MM;()J?,R8"I2I#7&0^5,CTP3OWZ@25-=( =$B'Q"E4CQ)DVV<&<C)%F) &>W
MYPY5.$#CJ;3S-03E2G:96R+=3,Z4.FA&TXE\%N!-4\X:QO:#;%6H/7I&@;-=
MQ3>Y-:,P"_=\]7FQ)HG\%Q3K&V+7FR@3*6+"1100BZ V#HL/J[24Z.LP*J$H
M$$J)F+?/38"T)S">>FS38<#(;&%X]\\%A$S*A,)^0D8=2IHS$N' XB-6[R[*
MBNGK@;3]S#1<L,&PZBTP--J=T [-:OE+'^&N";:0#8VL=/.^G+E%C'FC9/7Z
MU2ZA*8J\9+V&O1H6DPJ0]5[@HQ#0I+[!5K%N!D4UZHYA6#C$4L?0;KE8ZMW2
MQ;>Z %5$V0@0W&%P6D*MDS)EU-E/N*X4'!YE&P5CI<ZXP<=BTF0+";SUA<%(
M,%'<D/3('R@AGD24(/AK&I\*C6!T50IPFYE\V+Z"":C/%KY3PQK,[N\=NN>*
MF);S%.*[=BV=.S$7_7Z>Z!/!XJ+-["&Z0UYX:C0>?>&$ [:[T5O@XD)FO'+6
MS+Q;@F;'[$$YG/SR?? 5,TO<Z3[#\W<7ND)HN2@T) /V2+U":MO*P!9;;%.[
M?KW<+XNSW[Y@2X^)VI&]B;I*#XX3/*(2T(M>4USLNP9/7ZU=\/19%SQ=Q>#I
MBC8M/4HRH /HD+&K!R(PN)]<.VU#IWR=M?'LTD)R)UTP 4/NDHR:2CCNKAN%
M)@<!&H[:$2WUG6FN6S<PE P/405UVTI35=IDJWQ4@Q-T;F@X\VKPA)(8S?6"
MHBS4N.@T-X@;][N"DX38><F$')A"%);L25'AB*MM#;R$P#UC,N&?4(]Z2?A*
M]@Y/T4,7JW)S@T!]IOV:$V/F^DCV.;E+YQ;,V(30>0^HPMZ)G =.K21\:Y"H
M<YUS3Q0-SN3N?[ ")13=>JD&D]_ [G-6%PO#P-IFO+-?,"M"9?+2RG4B[T3Y
M65F&3#<&B<V-#R70H6,83>Y$$X_0E9)SAM6D8X2.2<*:P@=*?\EFDMW5<1;@
M,R;/CI,=O&C!+J9*B+R @);E.;6\ 7(".BF&WJ0H]4)(-MS;8TNDRNXJSQ:3
MWT[L)>:[!,>MAD9Q7->K/L>/P%YT%'B%CY)SP)<-S5#A!7".E48=8]-5&/DT
MQW^&Z@E?J-<*2 DU5]P )=_2$65!\+/F9^<\46R ?H&21C<?TO7D ()-BRED
MTW+DW'<]2I8F+"/8OY9>NIJG1D 6PN497=#",-<&MS-#;'V"6^66.4-8BN?;
MS,7A7J^;GKLS^-:WE]=(Q<S*L])9"QMZ3?2=EVA%1[FA3)0H8M43.)J'3S"P
M:8(*'F$P#(N;H767J& !\(#_RD%A;*-56DJ*LJ"DA?S"#Y*)<.V-:I6G $H6
M(^=**6$18B1-FK5XLAY-BC@E:I9DSA2Q11;,D7'K#;4&-0HI!++C9" A[$2=
MF!C$3517!0PLG"=Z"KBN"?]2?M+?@.9L!/,#.8V:V,N,6/VH!1;99@>T;UV
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ML".X'S3H0C0\W@H?B![MQ5FA56;%SA:-$!6QAC@L,LK-#;N?C"%BM[=A2^C
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M1NV*>,3RA?4,D$*6UZ<Y!^4G\1#CN9^2XND4FN*4&-O%V+"1(?->(PS';=?
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ML0:7=L$]PWQ:ODT]@>2%7B!*4]#.YH0B2 KVG&WB IT[%C$T!1A#O79J-C4
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M/M&DDMS'4Z\_6C17/#RM;'X"]<BH9) TPC&C8=+RY(?0)LTF.!!^"?8Z6L\
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M_)1S\6>A<P>&E'F.5R(5\S;+!1^+8LRBV@-#B[&TK@_^F6$9\%>4Y&"BR5R
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MKL<:O!,8QR78TK)R-E E\ +V)]41Z226[-+(",I+#38W3J 'J[(LC",<&\-
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M4$L! A0#%     @ &8EH4O%"4>A% P  F0P  !               ( !
M &AQ>2TR,#(Q,#,P."YX<V102P$"% ,4    "  9B6A2*F-?8/X*  #@AP
M%               @ %S P  :'%Y+3(P,C$P,S X7VQA8BYX;6Q02P$"% ,4
M    "  9B6A2++RH2%P'   \60  %               @ &C#@  :'%Y+3(P
M,C$P,S X7W!R92YX;6Q02P$"% ,4    "  9B6A2CT/(W2H:  "1A0  $0
M            @ $Q%@  =&TR,3@Y-39D,5\X:RYH=&U02P$"% ,4    "  9
MB6A23TIF=K8< 0"*70< %               @ &*,   =&TR,3@Y-39D,5]E
M>#(M,2YH=&U02P$"% ,4    "  9B6A2;2PGRXX4  "@;P  %0
M    @ %R30$ =&TR,3@Y-39D,5]E>#DY+3$N:'1M4$L%!@     &  8 A@$
' #-B 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
